Gastroenteropancreatic neuroendocrine tumour disease is a rare and complex group of cancers that develop from hormone-producing cells in the digestive system and pancreas, often growing slowly over many years and presenting unique challenges in diagnosis and treatment.

Understanding Gastroenteropancreatic Neuroendocrine Tumours

Gastroenteropancreatic neuroendocrine tumours, often shortened to GEP-NETs, are uncommon cancers that start in special cells scattered throughout the digestive system and pancreas. These cells are called neuroendocrine cells, which work like a combination of nerve cells and hormone-making cells. They produce hormones that help control digestion and manage blood sugar levels^[2].

These tumours can develop anywhere along the gastrointestinal tract, from the stomach to the rectum, and in the pancreas. The disease is sometimes called by other names, including carcinoid tumours or islet cell tumours, depending on where they form^[3][5].

What makes GEP-NETs particularly challenging is their varied nature. Some tumours release extra hormones into the bloodstream, causing specific symptoms. These are called functional tumours. Other tumours, known as nonfunctional tumours, do not produce excess hormones but can still cause problems as they grow and affect nearby organs^[5].

Epidemiology: How Common Are These Tumours

Although GEP-NETs were once considered extremely rare, the number of people being diagnosed has increased dramatically over recent decades. Data from the United States shows a remarkable rise of more than 400 percent in the incidence of this disease over a 29-year period, climbing from 1.09 cases per 100,000 people in 1973 to 5.25 cases per 100,000 people in 2004^[3].

This increase is likely not because more people are developing the disease, but rather because doctors have better tools to find these tumours. Improved imaging techniques like CT scans and more widespread use of procedures such as colonoscopy and endoscopy mean that tumours are being detected that might have gone unnoticed in the past^[12].

Recent data suggests that GEP-NETs now represent about 6.33 percent of all cancers affecting the digestive system and pancreas. Interestingly, they are more common than some other well-known cancers, including stomach and pancreatic adenocarcinomas combined^[3][12].

People are typically diagnosed with GEP-NETs in their fifth decade of life, meaning most patients are in their 40s or 50s when they discover they have the disease. The condition is generally younger at diagnosis compared to other gastrointestinal cancers^[3].

Causes and Origins

The exact cause of gastroenteropancreatic neuroendocrine tumours remains unclear. Scientists know that GEP-NETs form when neuroendocrine cells begin to divide and multiply in an uncontrolled way, eventually forming tumours that can affect the organs where these cells are located. However, what triggers this abnormal cell growth is not yet understood^[4].

Most GEP-NETs occur spontaneously, meaning they happen without any obvious trigger or inherited condition. However, in some cases, these tumours can be linked to rare genetic syndromes that run in families. These inherited conditions involve changes, or mutations, in certain genes that control cell growth^[3].

Unlike infectious diseases, GEP-NETs are not contagious and cannot be transmitted from one person to another. They develop from changes within a person’s own cells rather than from any outside organism or pathogen.

Risk Factors: Who Is More Likely to Develop GEP-NETs

Several factors can increase a person’s risk of developing gastroenteropancreatic neuroendocrine tumours. Understanding these risk factors can help both doctors and patients recognize who might be more vulnerable to the disease.

Having a family history of certain rare inherited syndromes significantly increases the risk of GEP-NETs. One of the most important is multiple endocrine neoplasia type 1, or MEN1, which causes tumours to form in various hormone-producing glands. About 5 to 10 percent of people with specific types of pancreatic NETs also have MEN1^[4][10].

Other hereditary conditions that increase risk include Von Hippel-Lindau disease and neurofibromatosis type 1. These genetic syndromes can predispose individuals to developing multiple neuroendocrine tumours over their lifetime^[3][11].

Certain stomach conditions also raise the risk of developing GEP-NETs in the digestive system. These include conditions that affect the stomach’s ability to produce acid, such as atrophic gastritis, pernicious anemia, or Zollinger-Ellison syndrome. When the stomach cannot make enough acid, it can lead to changes in the cells lining the stomach, potentially increasing cancer risk^[10].

It’s important to remember that having one or more risk factors does not mean a person will definitely develop GEP-NETs. Many people with these risk factors never develop the disease, while others without any known risk factors do. If you believe you might be at increased risk because of family history or other factors, discussing this with your doctor can help determine whether any monitoring or testing might be appropriate.

Symptoms: How GEP-NETs Affect the Body

The symptoms of gastroenteropancreatic neuroendocrine tumours vary considerably depending on where the tumour is located and whether it produces excess hormones. Many people with GEP-NETs have no symptoms at all in the early stages, and their tumours are discovered only incidentally during tests for other conditions^[10].

When symptoms do appear, they can be vague and easily mistaken for more common, less serious conditions. Common symptoms include persistent diarrhea, which can be severe and disruptive to daily life. People may also experience ongoing fatigue that doesn’t improve with rest, unexplained weight loss even when eating normally, and loss of appetite^[2][4].

Digestive problems are frequent, including heartburn, indigestion, nausea, and vomiting. Some people develop pain in the abdomen or back. Constipation can occur, alternating with or instead of diarrhea. These symptoms happen because the tumours can interfere with normal digestion and the movement of food through the intestines^[2].

When tumours produce excess hormones, they cause additional specific symptoms. Some people experience uncomfortable flushing of the face and neck, where the skin suddenly becomes red and feels warm. Wheezing and other breathing difficulties may occur. These symptoms are part of a condition called carcinoid syndrome, which happens when certain hormones like serotonin are released into the bloodstream in large amounts^[4][5].

Pancreatic NETs can cause symptoms related to blood sugar problems. People might experience weakness, frequent urination, increased thirst and hunger, dizziness, blurred vision, and headaches. These occur when tumours affect insulin, glucagon, or other hormones that control blood sugar levels^[2][4].

Some individuals develop yellowing of the skin and the whites of the eyes, a condition called jaundice. This happens when a tumour blocks the bile ducts or affects liver function. Muscle cramps and skin rashes may also appear in certain types of GEP-NETs^[2].

Prevention: Can GEP-NETs Be Prevented

Unfortunately, there are no proven ways to prevent gastroenteropancreatic neuroendocrine tumours because the exact causes of these tumours are not well understood. Unlike some other cancers where lifestyle changes can reduce risk, GEP-NETs do not have clear links to behaviors such as smoking, diet, or alcohol use that can be modified^[3].

For people with inherited genetic syndromes that increase GEP-NET risk, such as multiple endocrine neoplasia type 1 or Von Hippel-Lindau disease, genetic counseling and testing can be valuable. If you have a family history of these conditions, speaking with a genetic counselor can help you understand your risk and determine whether testing for family members might be appropriate^[10].

Regular medical monitoring may be recommended for people with known genetic syndromes that increase NET risk. This surveillance typically involves periodic blood tests and imaging studies to detect tumours early when they are most treatable. While this doesn’t prevent the tumours from forming, it can catch them at an earlier, more manageable stage.

For stomach NETs specifically, managing conditions that affect stomach acid production, such as chronic atrophic gastritis, might help reduce risk. However, more research is needed to confirm whether treating these conditions actually prevents NET development^[10].

Because early detection improves outcomes, being aware of symptoms and seeking medical attention for persistent digestive problems or other concerning symptoms is important. While this doesn’t prevent the disease, it can lead to earlier diagnosis and treatment.

Pathophysiology: What Happens in the Body

To understand how gastroenteropancreatic neuroendocrine tumours affect the body, it helps to know what neuroendocrine cells normally do. These cells are scattered throughout the digestive system and pancreas, where they make and release hormones that help control various bodily functions. These hormones regulate digestion, blood sugar levels, and the movement of food through the intestines^[10].

When GEP-NETs develop, the normal control mechanisms that limit cell growth break down. The neuroendocrine cells begin dividing uncontrollably, forming a mass or tumour. Because these cells come from hormone-producing tissue, many tumours retain the ability to make and release hormones, sometimes in much larger quantities than normal cells would produce^[2].

The tumours are classified based on their origin within the digestive system. Foregut tumours develop in the esophagus, stomach, first part of the small intestine, liver, or pancreas. Midgut tumours form in the second part of the small intestine, the end of the small intestine called the ileum, the jejunum, and the beginning portions of the colon. Hindgut tumours arise in the lower colon and rectum^[3][11].

Each location tends to produce different patterns of hormone release and symptoms. Midgut tumours, for example, often produce serotonin, a hormone that affects mood and many body functions. When large amounts of serotonin enter the bloodstream, it can cause flushing, diarrhea, and other symptoms of carcinoid syndrome. These tumours are generally slow-growing but have a high tendency to spread to other parts of the body^[11].

Pancreatic NETs can produce various hormones depending on which type of cell in the pancreas becomes cancerous. Insulinomas make too much insulin, causing dangerously low blood sugar. Gastrinomas produce excess gastrin, leading to too much stomach acid and resulting in painful ulcers. Glucagonomas make too much glucagon, which raises blood sugar levels. Each of these functional tumours creates its own specific set of problems in the body^[2][4].

As GEP-NETs grow, they can cause mechanical problems in addition to hormone-related symptoms. Large tumours may block the intestines or bile ducts, preventing normal flow of food or digestive fluids. Tumours in the pancreas can interfere with the production of enzymes needed for digestion. When NETs spread to other organs, particularly the liver, they can affect liver function and cause additional complications^[4].

The behavior of GEP-NETs varies considerably. Most grow slowly, taking many years to develop and spread. However, some tumours are more aggressive and can grow and spread more rapidly. The speed of growth and the tendency to spread are influenced by factors including the tumour’s grade, which measures how abnormal the cells look under a microscope and how quickly they are dividing^[3][12].

When tumours do spread beyond their original location, they most commonly travel to nearby lymph nodes first, then to the liver, and sometimes to bones or lungs. This process, called metastasis, occurs when cancer cells break away from the original tumour, travel through the bloodstream or lymphatic system, and establish new tumours in other parts of the body^[4].

Pancreatic neoplasm, commonly known as pancreatic cancer, is a serious condition where abnormal cells in the pancreas grow out of control and form tumors. Understanding what to expect as the disease progresses, how it affects daily life, and how families can support their loved ones through treatment and clinical trial participation can help patients and caregivers navigate this challenging journey with greater confidence and preparedness.

Prognosis and What to Expect

Understanding the likely course of pancreatic neoplasm is important for patients and their families, though it can be difficult to hear. The outlook for pancreatic cancer remains challenging compared to many other cancers. In the United States, the five-year survival rate ranges from 5% to 15%, with an overall survival rate of only 6%^[4]. This means that out of 100 people diagnosed with this disease, only about 6 are expected to be alive five years after their diagnosis. These numbers reflect the reality that pancreatic cancer is often discovered at an advanced stage when treatment options are more limited^[1].

The main reason for these sobering statistics is that pancreatic cancer rarely causes noticeable symptoms in its early stages. By the time most people experience symptoms like jaundice, weight loss, or abdominal pain, the cancer has often already spread to other parts of the body or grown large enough to affect nearby organs^[2]. About 80% of patients present with metastatic or locoregional disease at initial diagnosis, meaning the cancer has either spread beyond the pancreas or has grown extensively in the area^[4].

Even for those fortunate enough to have cancer that can be removed with surgery—which represents only about 20% of patients at diagnosis—the prognosis remains guarded^[4]. At high-volume specialty centers where outcomes are better than average, only 10% to 27% of patients with early-stage disease who underwent surgical removal of the tumor survived at least five years^[14]. The pancreas is the fourth leading cause of cancer deaths in the United States, and trends suggest it may become the second leading cause by 2030 as cases continue to rise^[2].

Several factors influence an individual’s prognosis. The most important is whether the tumor can be completely removed with surgery. Other factors include whether the cancer has spread to lymph nodes or other organs, the overall health and fitness of the patient, and how well the cancer responds to treatment^[17]. It’s essential to remember that statistics describe large groups of people and cannot predict what will happen to any individual person. Every patient’s situation is unique, and some people live longer than the average suggests.

Natural Progression Without Treatment

If pancreatic neoplasm goes untreated, the disease follows a predictable but distressing course. The cancer begins as abnormal cells in the pancreas that multiply uncontrollably. Most commonly, these cancerous cells start in the ducts of the pancreas—the small tubes that carry digestive enzymes from the pancreas to the intestine. This type is called adenocarcinoma, and it accounts for about 90% of all pancreatic cancers^[5].

As the tumor grows larger within the pancreas, it begins to press on nearby structures. The pancreas sits deep in the abdomen, nestled between the stomach and spine, surrounded by important blood vessels, the bile duct, and parts of the intestine^[6]. When the tumor pushes against the bile duct—which carries digestive fluid from the liver—it can block the flow of bile, causing jaundice. This is when the skin and whites of the eyes turn yellow, and the urine becomes dark while stools turn pale^[2].

The growing tumor can also press on nerves in the abdomen, causing pain that may start in the upper abdomen and radiate to the back. This pain often gets worse after eating or when lying down^[2]. Because the pancreas produces enzymes needed for digestion and hormones that control blood sugar, a tumor can interfere with these vital functions. Patients may experience severe digestive problems, difficulty absorbing nutrients, and development or worsening of diabetes^[11].

Without intervention, cancer cells eventually break away from the original tumor and travel through the bloodstream or lymphatic system to other parts of the body. The liver is a common site where pancreatic cancer spreads, but it can also reach the lungs, bones, and other organs^[14]. This spreading process, called metastasis, causes the disease to become even more difficult to control. As the cancer spreads and grows, patients experience progressive weight loss, severe fatigue, loss of appetite, and increasing pain that becomes harder to manage.

Possible Complications

Pancreatic neoplasm can lead to several serious complications that significantly affect a patient’s health and quality of life. These complications can arise from the tumor itself, from the cancer spreading, or as side effects of treatment. Understanding these potential problems helps patients and families prepare and seek timely help when issues arise.

One frequent complication is the blockage of the bile duct. As mentioned earlier, when the tumor presses on or invades the bile duct, bile cannot flow properly from the liver to the intestine. This causes jaundice and can lead to severe itching, infection of the bile duct called cholangitis, and problems with liver function^[2]. Sometimes doctors must place a small tube called a stent into the bile duct to keep it open and allow bile to drain properly.

The tumor can also block the passage of food through the digestive system if it grows large enough to press on the stomach or the first part of the small intestine. This causes persistent nausea, vomiting, and an inability to eat adequate amounts of food. In some cases, a surgical bypass or placement of a stent may be needed to allow food to pass^[12].

Pain is a significant complication for many patients with pancreatic cancer. The pain can result from the tumor pressing on nerves, from the cancer spreading to other areas, or from inflammation of the pancreas. As the disease progresses, pain often becomes more severe and constant, requiring strong pain medications and sometimes specialized pain management procedures^[11].

Digestive problems are common because the pancreas normally produces enzymes that help break down food. When cancer damages the pancreas, these enzymes may not be produced in sufficient quantities. This leads to difficulty digesting food, especially fats, causing diarrhea, oily stools, bloating, and malnutrition. Patients may need to take enzyme supplements with meals to help with digestion^[15].

Diabetes can develop or worsen in patients with pancreatic cancer because the pancreas also produces insulin, the hormone that controls blood sugar. When cancer damages the insulin-producing cells, blood sugar levels rise. Some patients develop new-onset diabetes months before their cancer diagnosis, which can sometimes be an early warning sign^[2].

Blood clots are another concerning complication. Cancer can make blood more likely to clot, leading to deep vein thrombosis (clots in the legs) or pulmonary embolism (clots that travel to the lungs). These conditions are serious and require immediate medical attention^[11].

Research has shown that even after successful surgery to remove the tumor, recurrence is common. Studies from specialized cancer centers found that among patients who had surgery after receiving chemotherapy and radiation, 11% had cancer return in the pancreas area, 23% developed liver metastases, and 59% had the cancer spread to distant organs^[14]. This high rate of recurrence reflects the presence of microscopic cancer cells that may have already spread beyond the pancreas at the time of surgery, even when they couldn’t be detected by tests.

Impact on Daily Life

A diagnosis of pancreatic neoplasm brings profound changes to every aspect of daily living. The disease affects not just physical health but also emotional well-being, relationships, work, and the ability to enjoy hobbies and activities. Understanding these impacts can help patients and families adapt and find ways to maintain quality of life during treatment.

Physically, many patients experience severe fatigue that doesn’t improve with rest. This overwhelming tiredness can make simple tasks like getting dressed, preparing meals, or walking short distances feel exhausting^[11]. The fatigue often worsens during chemotherapy or radiation treatment. Patients may need to rest frequently throughout the day and may not have energy for activities they previously enjoyed.

Digestive symptoms significantly affect eating and nutrition. Many patients lose their appetite, find food tastes different, experience nausea, or feel full after eating only small amounts. Weight loss is common and can be substantial. The fear of pain after eating or experiencing diarrhea can make mealtimes stressful rather than enjoyable. Family meals and social gatherings centered around food become difficult^[2]. Patients may need to eat smaller, more frequent meals and take enzyme supplements to help digest food. Working with a dietitian who specializes in cancer care can provide valuable guidance on meeting nutritional needs despite these challenges.

Pain can interfere with sleep, movement, and concentration. Chronic pain affects mood and can lead to depression and anxiety. Patients may need to take strong pain medications, which can cause side effects like drowsiness, constipation, or confusion. Finding the right balance of pain control while minimizing side effects requires ongoing communication with the healthcare team^[20].

Emotionally, patients often experience a range of intense feelings. Shock, fear, anger, sadness, and anxiety are all normal responses to a cancer diagnosis, especially one with a serious prognosis. Some patients feel overwhelmed by the uncertainty of their future. Others struggle with loss of independence as they need more help with daily activities. Many worry about the burden their illness places on loved ones^[18].

It’s natural for emotions to fluctuate. A patient might feel hopeful one day and despondent the next. These ups and downs are part of adapting to life with cancer. Acknowledging these feelings rather than trying to suppress them is important for emotional health. Many patients find it helpful to talk with a counselor, join a support group, or connect with others who have faced similar experiences^[20].

Relationships with family and friends often change. Loved ones want to help but may not know what to say or do. Some people become uncomfortable around illness and may pull away, which can feel hurtful. On the other hand, the crisis can bring families closer together. Open communication about needs, fears, and preferences helps maintain strong relationships during this difficult time^[18].

Work life is usually affected. Treatment schedules, fatigue, and symptoms may make it impossible to continue working at the same level. Some patients need to reduce their hours, take medical leave, or stop working entirely. This can create financial stress in addition to the loss of workplace relationships and sense of purpose that work provides. Discussing options with employers and exploring disability benefits or financial assistance programs can help ease these concerns^[18].

Hobbies and recreational activities may need to be modified or temporarily set aside. Patients who enjoyed active pursuits like hiking, gardening, or sports may need to find gentler alternatives. However, staying engaged in activities that bring joy and meaning remains important. Adapting activities to current abilities rather than giving them up entirely helps maintain quality of life. Reading, listening to music, gentle crafts, spending time outdoors when possible, or simply enjoying time with loved ones all have value^[18].

Many patients talk about finding a “new normal” after diagnosis. This means accepting that life has changed while still finding ways to live meaningfully. It involves focusing on what can be controlled, asking for help when needed, and making choices about how to spend time and energy. Some people discover new interests or find deeper appreciation for simple pleasures. Being open to change and flexible about expectations helps in adapting to this new reality^[18].

Support for Family Members

When someone is diagnosed with pancreatic neoplasm, the entire family is affected. Family members and close friends play a crucial role in supporting the patient, but they also need information, resources, and care for themselves. Understanding clinical trials and how to help a loved one explore all treatment options is an important part of that support.

Clinical trials are research studies that test new treatments or new ways of using existing treatments. They are essential for advancing cancer care and may offer patients access to promising therapies that aren’t yet widely available. For pancreatic cancer, where standard treatments have limited effectiveness, clinical trials can be especially important to consider^[6].

Family members should know that participating in a clinical trial is always voluntary. Patients have the right to join a trial or decline participation without affecting their access to standard care. Clinical trials have strict guidelines to protect participants’ safety and rights. Before enrolling, patients receive detailed information about the study’s purpose, what will be involved, possible risks and benefits, and other treatment options. This process, called informed consent, ensures patients can make educated decisions.

To help a loved one find and consider clinical trials, family members can take several practical steps. First, talk openly with the patient about whether they’re interested in exploring trials. Some patients are eager to try new approaches, while others prefer to stick with standard treatments. Respecting the patient’s preferences and comfort level is essential.

If the patient is interested, family members can help by researching available trials. Several resources make this easier. The National Cancer Institute maintains a database of clinical trials at cancer.gov. Many cancer centers and patient advocacy organizations also provide trial search tools and assistance. When researching, look for trials that match the patient’s specific type and stage of pancreatic cancer^[6].

Prepare questions to ask the healthcare team about clinical trials. Important questions include: Are there trials that might be appropriate for this situation? What are the potential benefits and risks? How would participating affect daily life and the treatment schedule? What happens if the experimental treatment doesn’t work? Would insurance cover the costs? Many research-related costs in clinical trials are covered by the trial sponsor, but some standard care costs must be covered by insurance.

Family members can help organize information about different trials, keep track of eligibility requirements, and assist with the enrollment process if needed. Some trials require travel to specific medical centers, so families may need to help with logistics like transportation and accommodation.

Beyond clinical trials, families support patients in many other important ways. Providing practical help with daily tasks—cooking, cleaning, transportation to appointments, managing medications—allows the patient to conserve energy for healing. Emotional support through listening, spending time together, and maintaining a sense of normalcy is equally valuable.

Caregivers must also take care of themselves. The stress of caring for someone with serious illness can lead to physical exhaustion and emotional burnout. It’s important for family members to ask others for help rather than trying to do everything alone. Friends and extended family usually want to help but may not know what’s needed. Being specific about requests—bringing a meal, running an errand, sitting with the patient for a few hours—makes it easier for others to contribute^[21].

Caregivers should maintain their own health by eating well, getting adequate sleep when possible, and staying physically active. Taking breaks from caregiving responsibilities is not selfish; it’s necessary to maintain the strength and energy needed to provide good care over time. Many caregivers find support groups for family members helpful, providing a space to share experiences with others who understand^[21].

Learning about pancreatic cancer helps families feel more prepared and confident. Understanding the disease, treatments, and what to expect allows family members to participate more effectively in care decisions and anticipate needs. Patient advocacy organizations offer educational materials, webinars, and resources specifically designed for families^[18].

Communication within the family is vital. Patients and family members should talk honestly about fears, hopes, and practical matters. Discussions about advance care planning—what kind of care the patient wants if they become unable to communicate their wishes—are important, though difficult. Having these conversations when the patient is relatively well and thinking clearly helps ensure their preferences are known and respected.

Remember that there’s no perfect way to handle a cancer diagnosis in the family. Each person copes differently, and that’s okay. Being patient with each other, expressing appreciation, and maintaining meaningful connections helps families navigate this challenging journey together.

Pancreatic Neuroendocrine Tumour

Pancreatic neuroendocrine tumours are rare growths that start in special hormone-making cells inside the pancreas. Though uncommon, accounting for only 1 to 2% of pancreatic cancers, many of these tumours grow slowly and can be treated effectively, offering better outcomes than other types of pancreatic cancer.

Table of contents

• What are pancreatic neuroendocrine tumours?
• Other names for this condition
• Associated organs
• Types of pancreatic neuroendocrine tumours
• Signs and symptoms
• Causes and risk factors
• Possible complications
• How doctors diagnose the condition
• Treatment options
• Outlook and survival
• Living with pancreatic neuroendocrine tumours

What are pancreatic neuroendocrine tumours?

Pancreatic neuroendocrine tumours are growths that develop in the hormone-making cells (also called islet cells) of the pancreas^[1]. The pancreas is a long, flat organ about 6 inches in length that sits behind the stomach. It has three main sections: the head, the body, and the tail^[3].

The pancreas contains two types of cells. Endocrine cells make hormones such as insulin that help control blood sugar levels. These cells cluster together in small groups called islets throughout the pancreas. Exocrine cells make enzymes that are released into the small intestine to help digest food. Most of the pancreas consists of exocrine cells^[3].

Pancreatic neuroendocrine tumours start in the endocrine cells. These tumours may be benign (not cancer) or malignant (cancer). When they are malignant, they are sometimes called pancreatic endocrine cancer or islet cell carcinoma^[3].

These tumours are much less common than the usual type of pancreatic cancer, which starts in the exocrine cells. Only 1 or 2% of clinically significant pancreas growths are pancreatic neuroendocrine tumours^[5]. However, pancreatic neuroendocrine tumours generally have a better outlook than other types of pancreatic cancer^[3].

islet cell tumours, pancreatic endocrine tumours, PanNETs, PETs, PNETs

Other names for this condition

Pancreatic neuroendocrine tumours are known by several other names. They are often referred to as islet cell tumours because they arise from the islet cells in the pancreas^[5]. Doctors also call them pancreatic endocrine tumours or use the shortened terms PanNETs, PETs, or PNETs^[5][6].

Associated organs

• Pancreas
• Liver (when cancer spreads)
• Small intestine
• Stomach

Types of pancreatic neuroendocrine tumours

Pancreatic neuroendocrine tumours can be divided into two main groups based on whether they produce excess hormones. Functional tumours make large amounts of hormones that cause noticeable symptoms. Nonfunctional tumours do not produce excess hormones. Signs and symptoms from nonfunctional tumours happen as the tumour grows and spreads. Most nonfunctional tumours are malignant^[3].

Most pancreatic neuroendocrine tumours are functional tumours^[3]. There are several types of functional tumours, named according to the main hormone they produce:

Insulinomas are the most common type of functioning pancreatic neuroendocrine tumour. They release insulin, which is the hormone that keeps blood sugar from getting too high. About 10% of insulinomas are cancerous^[2].

Gastrinomas affect cells that release gastrin, which triggers the stomach to produce gastric acid. About 60% of gastrinomas are cancerous^[2]. When increased stomach acid, stomach ulcers, and diarrhoea are caused by a gastrinoma, the condition is called Zollinger-Ellison syndrome^[3].

Glucagonomas are often cancerous. They affect the cells that release glucagon, the hormone that keeps blood sugar from getting too low^[2].

VIPomas can be cancerous. “VIP” stands for “vasoactive intestinal peptide.” This hormone relaxes the muscles in the stomach and bowels and manages the balance of sugar, salt and water in the digestive tract^[2].

Somatostatinomas are slow-growing cancerous tumours that release somatostatin. This hormone manages several bodily functions^[2].

Signs and symptoms

Some pancreatic neuroendocrine tumours do not cause any symptoms. In such cases, they may be discovered by chance during a scan performed for a different reason^[5].

When symptoms do occur, they can include heartburn, weakness, fatigue, muscle cramps, indigestion, diarrhoea, weight loss, skin rash, constipation, pain in the abdomen or back, yellowing of the skin and the whites of the eyes, dizziness, blurred vision, headaches, and increased thirst and hunger^[1].

Other common symptoms include severe acid reflux, loss of appetite, nausea and vomiting, frequent urination, uncomfortable flushing of the face and neck with wheezing, and unexplained weight loss. Some people experience big swings in blood sugar levels, either up or down^[2].

The specific symptoms depend on which type of tumour is present and which hormones are being produced in excess. For example, insulinomas cause symptoms of low blood sugar such as dizziness and weakness. Gastrinomas lead to stomach ulcers and severe diarrhoea. Glucagonomas can cause a distinctive skin rash, diabetes, and blood clots^[5].

Causes and risk factors

Researchers do not know the exact cause of pancreatic neuroendocrine tumours^[2]. However, some of these tumours occur alongside other conditions.

About 5% to 10% of people with insulinomas or glucagonomas also have a condition called multiple endocrine neoplasia type 1 (MEN1)^[2]. This is an inherited disorder that increases the risk of developing tumours in hormone-producing glands^[3].

Having certain inherited syndromes can increase the risk of pancreatic neuroendocrine tumours. Doctors may ask if anyone in your biological family has certain inherited disorders that raise the risk^[2].

Possible complications

The most significant complication of pancreatic neuroendocrine tumours is that cancerous forms can spread to other areas of the body. Without treatment, malignant tumours may spread to the bones, liver or lungs^[2].

How doctors diagnose the condition

A healthcare provider will perform a physical examination and ask about symptoms. They may ask when symptoms started and whether they are getting worse. They will also ask if anyone in the biological family has certain inherited disorders that increase the risk of pancreatic neuroendocrine tumours^[2].

Blood tests may show excess hormones or other signs of a pancreatic neuroendocrine tumour. Blood samples can also be used to look for changes in genetic material that signal an increased risk of these tumours. Urine tests may show breakdown products that occur when the body processes hormones^[8].

Imaging tests take pictures of the body to show the location and size of a pancreatic neuroendocrine tumour. Tests might include X-ray, MRI (magnetic resonance imaging), CT (computed tomography), and PET scan (positron emission tomography)^[8].

Doctors may perform imaging with nuclear medicine tests. These tests involve injecting a small amount of radioactive material into the body. The material sticks to pancreatic neuroendocrine tumours so that they show clearly on the images^[8].

During an endoscopic ultrasound, a thin, flexible tube with a camera on the tip is passed down the throat into the stomach and small intestine. The tube has a special ultrasound tool to create pictures of the pancreas. Other tools can be passed through the tube to collect a sample of tissue for examination^[8].

Providers use test results to determine if a tumour is functioning or non-functioning. Functioning tumours release unusually large amounts of hormones. Non-functioning tumours do not release excess hormones. Test results also help providers identify the specific type of pancreatic neuroendocrine tumour^[2].

Treatment options

Surgery is often the main treatment for pancreatic neuroendocrine tumours^[6]. The type of operation depends on where the tumour is located in the body. Surgery might be the only treatment needed, or it might be combined with other types of treatment. Doctors may recommend surgery even if the surgeon cannot completely remove the cancer. Removing part of the cancer can sometimes reduce symptoms. This is called debulking surgery^[6].

For people who have symptoms related to excessive hormone production, treatment may be needed straight away to help them feel better and to make sure they are well enough for surgery. This might include medications called somatostatin analogues, fluids through a drip if there has been severe diarrhoea, vitamin or mineral supplements, tube feeding if there has been significant weight loss, or pancreatic enzyme replacement therapy^[15].

Other treatment options include radiation therapy, chemotherapy, targeted cancer drugs, and a type of radioactive treatment called peptide receptor radionuclide therapy (PRRT). PRRT combines a targeting molecule that binds to specific receptors on tumour cells and a radioactive particle that destroys cancer cells. PRRT is given to patients through an intravenous infusion and has fewer side effects than other chemotherapies. A course of treatment typically includes four doses given eight weeks apart^[15].

Monthly injections of lanreotide, a drug that blocks the growth hormone that feeds these slow-developing tumours, may be used when surgery is not possible^[20].

Recently, a targeted therapy called cabozantinib has been approved for adults with a well-differentiated pancreatic neuroendocrine tumour who have received previous treatment, who are ineligible for surgery, and whose cancer has progressed^[13]. In clinical trials, patients who received this treatment had a median time of 13.8 months before their cancer worsened, compared to 3.3 months for those who did not receive it^[13].

Treatment decisions depend on the type of neuroendocrine tumour, how fast it is growing, how far the cancer has spread, and the patient’s general health and fitness. A team of doctors and other professionals discuss the best treatment and care for each person^[15].

Outlook and survival

Pancreatic neuroendocrine tumours generally have a better outlook than the more common type of pancreatic cancer. The five-year survival rate for a pancreatic neuroendocrine tumour is 95% if the tumour is localized and has not spread^[21].

Most pancreatic neuroendocrine tumours grow slowly. If they are localized and there is no evidence they have spread elsewhere, surgery will likely cure the cancer if caught in an early stage. Even if not cured, patients will often live a long time^[21].

Many pancreatic neuroendocrine tumours are benign, while some are malignant. The behaviour of an individual tumour can be unpredictable. Higher tumour grade, lymph node and liver spread, and larger tumour size generally indicate a less favourable outlook^[7].

The five-year relative survival rate for pancreatic neuroendocrine tumours that have spread is 23%, which highlights the need for new treatment options^[13].

Living with pancreatic neuroendocrine tumours

Living with a chronic disease like pancreatic neuroendocrine tumours can be challenging. Many people experience a range of emotions, including feeling shocked, upset, frightened, uncertain, confused, angry, guilty, or sad^[16].

Some people with pancreatic neuroendocrine tumours have a group of symptoms related to hormone overproduction. Certain foods and drinks may trigger problems like skin reddening, painful gas and bloating, and severe diarrhoea. Foods high in substances called amines—such as aged or blue cheeses, chocolate, red wine, beer, smoked meats, pickled fish, and fermented foods—may cause symptoms. Cutting back on wine and other alcoholic drinks can provide relief from skin flushing. Because these tumours tend to affect the liver, it is a good idea to avoid alcohol^[19].

Other helpful dietary approaches include eating smaller, frequent meals; avoiding fatty, greasy, or highly spicy foods; and choosing whole, natural foods over processed ones high in salt. Eating healthy foods can maintain strength and energy during treatment. If undergoing chemotherapy, it is important to get enough calories and protein^[19].

Maintaining an active lifestyle helps people feel better in general. Regular exercise, such as taking a half-hour walk three times a week or more, is beneficial. If someone smokes, quitting is important. Taking a multivitamin may help, as some people with pancreatic neuroendocrine tumours do not have enough of a nutrient called niacin, which can cause dry, cracking skin around the mouth^[19].

It is natural to feel anxious, stressed, and sometimes depressed when diagnosed with a pancreatic neuroendocrine tumour. Setting up a support network can help a great deal. Joining a support group for people who have these tumours can be beneficial. Meditation helps some people manage stress. Talking to a doctor or counsellor is important if help is needed dealing with emotional challenges^[19][16].

Talking to friends and relatives about the condition can provide help and support. Some people find it easier to talk to someone other than their own friends and family. Counselling can help cope better with the difficulties faced^[16].

Gathering information about the specific type of tumour and its treatment can help with coping and decision-making. Making lists, having a calendar with all appointments, setting goals, and planning enjoyable activities can all be helpful. Asking for help when needed is important^[16].

Pancreatic neuroendocrine tumours are rare growths that develop in the hormone-making cells of the pancreas, behaving very differently from the more common types of pancreatic cancer and often growing much more slowly.

Understanding Pancreatic Neuroendocrine Tumours

Pancreatic neuroendocrine tumours, often called pancreatic NETs or islet cell tumours, are uncommon growths that start in the endocrine cells of the pancreas. These endocrine cells are the ones responsible for making hormones that help control important body functions like digestion and blood sugar levels. The pancreas itself is a flat, pear-shaped gland that sits behind the stomach and in front of the spine, about six inches long. While most pancreatic cancers come from the cells that make digestive enzymes, pancreatic NETs are completely different and make up only about one to two percent of all pancreatic cancers.^[1][2]

These tumours can be either benign, meaning they are not cancerous, or malignant, meaning they are cancerous and can spread to other parts of the body. When pancreatic NETs are malignant, doctors sometimes call them pancreatic endocrine cancer or islet cell carcinoma. The good news is that pancreatic NETs generally have a better outlook than the more common type of pancreatic cancer. They tend to grow more slowly, which gives doctors more time to treat them and patients more time to manage their condition.^[3][5]

Pancreatic NETs are divided into two main groups based on whether they produce extra hormones or not. Functional tumours make too much of a particular hormone, which causes specific symptoms related to that hormone. Nonfunctional tumours do not produce excess hormones, so their symptoms usually come from the tumour itself as it grows and takes up space or spreads to other organs. Most pancreatic NETs that doctors see are functional tumours, though nonfunctional tumours are becoming more common as imaging technology improves and doctors find them by accident during scans done for other reasons.^[3][5]

Epidemiology

Pancreatic neuroendocrine tumours are quite rare in the general population. A conservative estimate suggests that about 25 to 30 people per 100,000 in the United States have these tumours at any given time. The number of people being diagnosed with pancreatic NETs has been increasing over the years, but this is likely because medical imaging has improved and doctors are getting better at finding these tumours rather than because more people are actually developing them.^[7]

There do not appear to be clear differences in who gets pancreatic NETs based on race, sex, where someone lives, or their economic status. These tumours can affect anyone, though they are still uncommon overall. The fact that they represent such a small fraction of all pancreatic cancers means that many people, including some healthcare providers, may not be familiar with them. This can sometimes make it harder for patients to get the specialized care they need.^[7]

Causes

Researchers do not yet know the exact cause of pancreatic neuroendocrine tumours. Unlike some other cancers, there is no clear single factor that makes someone develop a pancreatic NET. Scientists understand some of the genetic causes behind both familial cases, where the condition runs in families, and sporadic cases, where it appears without any family history. However, the molecular processes that actually lead to these tumours forming in the pancreas remain largely unknown.^[7]

What doctors do know is that these tumours start when the endocrine cells in the pancreas begin to grow and divide in an uncontrolled way. These cells normally form small clusters throughout the pancreas called islets of Langerhans, and when they become tumours, they can either stay in one place or spread to other organs like the liver, bones, or lungs.^[2][3]

Risk Factors

While the exact cause of pancreatic NETs is not known, certain conditions do increase a person’s risk of developing these tumours. One of the most important risk factors is having certain inherited genetic syndromes. About five to ten percent of people with pancreatic NETs, particularly those with insulinomas or glucagonomas, also have a condition called multiple endocrine neoplasia type 1, or MEN1. This is a genetic disorder that causes tumours to develop in several hormone-producing glands throughout the body.^[2][3]

Having a family history of these inherited syndromes is a significant risk factor. During diagnosis, doctors will often ask whether anyone in a patient’s biological family has had certain inherited disorders that make pancreatic NETs more likely. If there is a family history, genetic testing might be recommended to see if the patient carries any of these genetic changes. However, it is important to remember that most pancreatic NETs occur sporadically, meaning they happen in people with no family history of the condition.^[2]

Symptoms

The symptoms of pancreatic neuroendocrine tumours vary widely depending on whether the tumour is functional or nonfunctional and, if functional, which hormone it is producing too much of. Some people with pancreatic NETs have no symptoms at all, especially in the early stages. These tumours might be discovered accidentally when a patient has a CT scan or other imaging test done for a completely different reason.^[1][5]

When symptoms do occur, they can be quite varied and sometimes confusing. Common symptoms include heartburn, weakness, fatigue, muscle cramps, indigestion, diarrhea, weight loss, skin rash, constipation, pain in the abdomen or back, yellowing of the skin and the whites of the eyes (called jaundice), dizziness, blurred vision, and headaches. Some people also experience increased thirst and hunger, which can be signs of blood sugar problems. These symptoms can develop slowly over time, and many people initially dismiss them as normal signs of aging or stress.^[1][2]

Functional tumours cause symptoms related to the specific hormone they overproduce. For example, insulinomas, which make too much insulin, can cause dangerous drops in blood sugar that lead to dizziness, confusion, sweating, and weakness. Gastrinomas produce excess gastrin, which makes the stomach create too much acid, leading to severe heartburn, stomach ulcers, and diarrhea. Glucagonomas make too much glucagon, causing high blood sugar, a distinctive skin rash, weight loss, and anemia. VIPomas produce too much vasoactive intestinal peptide, resulting in severe watery diarrhea that can lead to dehydration and dangerous drops in potassium levels. Somatostatinomas release excess somatostatin, which can cause diabetes, gallstones, fatty stools, and weight loss.^[2][5]

About 40 percent of pancreatic NETs are functional, meaning they produce these hormone-related symptoms. The remaining 60 percent or more are nonfunctional, and their symptoms come from the physical effects of the tumour itself. As nonfunctional tumours grow, they can press on nearby organs, block passages, or spread to other parts of the body like the liver. This can cause pain, digestive problems, or symptoms related to where the cancer has spread. Most nonfunctional tumours are malignant, meaning they have the potential to spread to other organs.^[3][5]

Prevention

Because researchers do not yet know what causes most pancreatic neuroendocrine tumours, there are no proven ways to prevent them. Unlike some other cancers where lifestyle changes like quitting smoking or maintaining a healthy weight can reduce risk, pancreatic NETs do not have clear lifestyle-related risk factors that people can modify. However, for people who have a family history of inherited syndromes that increase the risk of pancreatic NETs, genetic testing and regular monitoring may help catch tumours early when they are smaller and easier to treat.^[2]

Living a generally healthy lifestyle is always beneficial for overall health and may support the body’s natural defenses. This includes eating a balanced diet with whole, natural foods rather than highly processed ones, staying physically active, avoiding excessive alcohol consumption, and not smoking. While these habits may not specifically prevent pancreatic NETs, they can help someone feel stronger and better able to handle treatment if a tumour is discovered. For people with inherited syndromes like MEN1, working closely with healthcare providers to develop a screening plan is the best approach to early detection.^[2]

Pathophysiology

Pancreatic neuroendocrine tumours develop when the endocrine cells in the pancreas begin to grow and divide abnormally. These endocrine cells, also called islet cells or islets of Langerhans, are normally scattered throughout the pancreas in small clusters. They produce various hormones including insulin, which lowers blood sugar; glucagon, which raises blood sugar; gastrin, which stimulates stomach acid production; and several others. When these cells become cancerous or develop into tumours, they can either continue producing hormones in excess (functional tumours) or stop producing significant amounts of hormones (nonfunctional tumours).^[3]

In functional tumours, the overproduction of hormones leads to specific physical changes in the body. For instance, when an insulinoma produces too much insulin, it drives blood sugar levels dangerously low, a condition called hypoglycemia. The body responds to this by releasing stress hormones, which causes symptoms like sweating, shakiness, confusion, and in severe cases, loss of consciousness. When a gastrinoma produces too much gastrin, the stomach makes excessive amounts of acid, which can damage the stomach lining and small intestine, creating painful ulcers and causing severe diarrhea. Each type of functional tumour creates its own pattern of hormonal imbalance and resulting physical changes.^[2][5]

Nonfunctional tumours affect the body through their physical presence and growth. As these tumours enlarge, they can press on surrounding tissues and organs, causing pain, blockages, or disrupting normal function. They can grow large enough to be felt through the skin in some cases. Most significantly, many pancreatic NETs have the potential to spread, or metastasize, to other organs. The liver is the most common site for these cancer cells to spread, but they can also reach the bones and lungs. When cancer spreads to the liver, it can affect that organ’s ability to filter blood, produce proteins, and perform other vital functions. The biological behavior of pancreatic NETs is somewhat unpredictable, with factors like tumour grade, the presence of lymph node involvement, liver metastases, and larger tumour size generally indicating a less favorable outlook.^[2][7]

At the cellular level, most pancreatic NETs are relatively slow-growing, which means the cancer cells divide and multiply more gradually than in aggressive cancers. This indolent nature gives patients and doctors more time to make treatment decisions and often allows for longer survival even with advanced disease. However, the fact that most NETs have malignant potential means they require careful monitoring and treatment. The World Health Organization classifies these tumours based on their grade, which reflects how quickly the cells are dividing and growing. Higher-grade tumours, where cells are dividing more rapidly, tend to be more aggressive and harder to control.^[6][7]

Pancreatic neuroendocrine tumors represent a rare but distinct form of cancer that develops in the hormone-producing cells of the pancreas, with outcomes and treatment approaches vastly different from the more common types of pancreatic cancer.

Understanding Your Outlook With Pancreatic Neuroendocrine Tumors

When someone receives a diagnosis of a pancreatic neuroendocrine tumor, understanding what lies ahead becomes crucial for both the patient and their loved ones. The outlook for people with this condition can vary significantly depending on several important factors, and it’s essential to approach this information with both realism and hope.^[1]

Pancreatic neuroendocrine tumors, often called PNETs or islet cell tumors, behave very differently from the more common form of pancreatic cancer known as adenocarcinoma. While the name “pancreatic cancer” might initially sound frightening, PNETs generally grow much more slowly and respond better to treatment than their more aggressive counterparts. This fundamental difference in behavior means that many people with PNETs can live for years, and in some cases, the tumor can be cured completely with appropriate treatment.^[2]

The prognosis depends heavily on whether the tumor is localized or has spread to other parts of the body. When a pancreatic neuroendocrine tumor is discovered early and remains confined to the pancreas, the outlook can be remarkably positive. Statistics show that the five-year survival rate for localized PNETs reaches approximately 95 percent, which means the vast majority of people whose tumors are caught early can expect to live at least five years beyond their diagnosis. This figure stands in stark contrast to other forms of pancreatic cancer, offering genuine reason for optimism when the disease is detected in its early stages.^[21]

However, not all pancreatic neuroendocrine tumors are discovered before they have a chance to spread. When PNETs have metastasized to distant organs such as the liver, lungs, or bones, the five-year relative survival rate drops to approximately 23 percent. While this number is more sobering, it’s important to remember that survival rates are statistical averages based on large groups of patients. Individual experiences can vary widely, and advances in treatment continue to improve outcomes for people with advanced disease. Many patients with metastatic PNETs live significantly longer than five years, particularly with modern treatment approaches.^[13]

The grade of the tumor also plays a significant role in determining prognosis. Tumor grade refers to how quickly or slowly the cancer cells are dividing and growing. Lower-grade tumors, where cells look more like healthy pancreatic cells and divide slowly, generally offer a better outlook than higher-grade tumors, where cells appear more abnormal and multiply rapidly. Most pancreatic neuroendocrine tumors are categorized as well-differentiated, meaning they grow slowly and tend to have better outcomes.^[6]

Another factor that influences prognosis is whether the tumor is functional or nonfunctional. Functional tumors produce excess amounts of hormones, which can cause noticeable symptoms that lead to earlier detection. Nonfunctional tumors, on the other hand, don’t produce hormonal symptoms and may only be discovered when they grow large enough to cause physical discomfort or are found incidentally during imaging for another reason. The timing of discovery can significantly impact treatment options and overall outcomes.^[3]

Approximately 10 percent of insulinomas, one type of functional pancreatic NET, turn out to be cancerous, while about 60 percent of gastrinomas are malignant. Glucagonomas are often cancerous, and VIPomas can also be malignant. Understanding which specific type of NET a person has helps doctors provide more accurate prognostic information tailored to that individual’s situation.^[2]

The biological behavior of individual pancreatic neuroendocrine tumors can be unpredictable. While many PNETs are indolent, meaning they grow slowly over many years, others may behave more aggressively. Higher tumor grade, the presence of lymph node involvement, liver metastasis, and larger tumor size generally indicate a less favorable prognosis. Yet even with these challenging features, many treatment options remain available that can control tumor growth and improve quality of life.^[7]

It’s worth noting that the conservative estimate of PNET prevalence is approximately 25 to 30 per 100,000 people in the United States, and the incidence appears to be increasing due to improvements in diagnostic techniques and increased awareness among healthcare providers. This means more cases are being detected, including many that might have gone undiagnosed in the past, and more research is being conducted to develop better treatments.^[7]

Natural Progression Without Treatment

Understanding how pancreatic neuroendocrine tumors develop and progress when left untreated helps patients appreciate the importance of medical intervention. While every tumor follows its own timeline, certain patterns emerge that help doctors and patients understand what might happen without treatment.^[1]

Pancreatic neuroendocrine tumors originate in the hormone-making cells of the pancreas, specifically in clusters of cells called the islets of Langerhans. These specialized cells normally produce hormones like insulin and glucagon that regulate blood sugar, along with other hormones that control various digestive functions. When cells in these islets begin to grow abnormally, they form tumors that may either continue producing hormones in excess or stop producing them altogether.^[3]

Most pancreatic NETs grow relatively slowly compared to other cancers. This indolent growth pattern means the tumor may be present in the body for years before causing any noticeable symptoms. During this silent period, the tumor gradually increases in size, potentially reaching several centimeters in diameter before being detected. This slow growth offers a window of opportunity for treatment, but it also means symptoms may not appear until the disease has progressed considerably.^[7]

As a nonfunctional pancreatic NET grows larger, it begins to cause problems through physical effects rather than hormonal imbalances. The expanding mass may press against nearby organs, blood vessels, or nerves, leading to abdominal or back pain. The tumor may also obstruct the bile duct, which carries digestive fluid from the liver to the small intestine. This obstruction can cause jaundice, a yellowing of the skin and whites of the eyes, along with digestive problems.^[1]

For functional tumors that produce excess hormones, the progression follows a different pattern. An insulinoma, which makes too much insulin, causes increasingly severe episodes of low blood sugar. These episodes can lead to confusion, weakness, sweating, and in severe cases, loss of consciousness. A gastrinoma produces excessive gastrin, leading to severe acid reflux, stomach ulcers, and chronic diarrhea that worsens over time. Glucagonomas cause a distinctive skin rash called necrolytic migratory erythema, along with diabetes and weight loss. VIPomas produce profuse watery diarrhea that can lead to dangerous dehydration and electrolyte imbalances.^[5]

Without treatment, malignant pancreatic NETs have the potential to metastasize, meaning cancer cells break away from the primary tumor and travel through the bloodstream or lymphatic system to establish new tumors in distant organs. The liver is the most common site of metastasis for pancreatic NETs, partly because blood from the pancreas flows directly to the liver through the portal vein. When NET cells reach the liver, they can form multiple tumors that gradually replace healthy liver tissue, compromising the organ’s ability to function.^[2]

The lungs and bones are other potential sites where pancreatic NETs may spread. Lung metastases can interfere with breathing and cause persistent cough or chest pain. Bone metastases may lead to pain, fractures, or elevated calcium levels in the blood. Each new site of disease adds to the burden on the body and makes treatment more complex.^[2]

The natural history of untreated pancreatic NETs varies considerably. Some tumors remain stable for extended periods, causing minimal symptoms and progressing very slowly. Others advance more rapidly, particularly those classified as higher grade or neuroendocrine carcinomas. In these aggressive cases, the tumor burden increases quickly, symptoms intensify, and the cancer may spread to multiple organ systems within months rather than years.^[6]

As the tumor burden increases throughout the body, patients typically experience worsening constitutional symptoms. These include profound fatigue that doesn’t improve with rest, progressive weight loss despite adequate food intake, and a general sense of feeling unwell. The body’s metabolism becomes disrupted as the tumor consumes resources and interferes with normal organ function. Pain often becomes more severe and difficult to manage as tumors grow and put pressure on surrounding structures.^[1]

Eventually, without intervention, the accumulation of tumor tissue and the loss of normal organ function can lead to life-threatening complications. The liver may become so infiltrated with tumor that it cannot perform its essential functions of filtering blood, producing proteins, and processing nutrients. The pancreas itself may be damaged enough that it cannot produce adequate digestive enzymes, leading to malnutrition. Hormonal imbalances from functional tumors can reach dangerous extremes, causing medical emergencies like severe hypoglycemia or life-threatening diarrhea.^[14]

Possible Complications

Even with treatment, pancreatic neuroendocrine tumors can lead to various complications that affect different body systems. Understanding these potential problems helps patients and families prepare and respond appropriately when difficulties arise.^[1]

The most significant complication occurs when cancerous pancreatic NETs metastasize to other organs. As mentioned, the liver represents the most common destination for these traveling cancer cells. Liver metastases can profoundly impact overall health because the liver performs hundreds of vital functions. When tumor nodules occupy large portions of the liver, they interfere with the organ’s ability to filter toxins from the blood, produce essential proteins for blood clotting, store energy, and metabolize medications. Patients with extensive liver involvement may develop jaundice, confusion from toxin buildup, increased bleeding tendency, and fluid accumulation in the abdomen called ascites.^[2]

Functional pancreatic NETs create complications specific to the hormones they overproduce. Insulinomas can cause dangerous episodes of severe hypoglycemia, where blood sugar drops so low that the brain doesn’t receive enough glucose to function properly. These episodes may occur without warning and can lead to seizures, loss of consciousness, or even permanent brain damage if not promptly treated. Patients with insulinomas often need to eat frequently throughout the day and night to prevent these dangerous drops in blood sugar.^[2]

Gastrinomas lead to a condition called Zollinger-Ellison syndrome, characterized by severe peptic ulcers and chronic diarrhea. The excess gastrin stimulates the stomach to produce extraordinary amounts of acid, which damages the lining of the stomach and small intestine. These ulcers can perforate, meaning they eat through the wall of the digestive tract, causing life-threatening internal bleeding or allowing digestive contents to spill into the abdominal cavity, triggering a serious infection called peritonitis.^[11]

VIPomas cause massive watery diarrhea, sometimes exceeding several liters per day. This extreme fluid loss rapidly leads to dehydration and dangerous imbalances in blood electrolytes like potassium. Low potassium levels can cause muscle weakness, abnormal heart rhythms, and in severe cases, cardiac arrest. The diarrhea associated with VIPomas is so severe that it can prevent patients from leaving their homes and significantly impair their quality of life.^[5]

Glucagonomas often cause a distinctive complication in the form of a skin rash called necrolytic migratory erythema. This painful, itchy rash typically appears on the face, abdomen, buttocks, and legs. The affected skin becomes red, develops blisters, and eventually the outer layer peels away. The rash is not only uncomfortable but can also become infected, requiring antibiotic treatment. Glucagonomas also cause diabetes because excess glucagon raises blood sugar levels, along with weight loss and an increased risk of blood clots forming in the legs or lungs.^[5]

Somatostatinomas, though rare, can lead to a triad of problems: diabetes mellitus, gallstones, and fatty stools. The excess somatostatin interferes with multiple hormone systems, preventing proper regulation of blood sugar and digestive enzyme secretion. Patients may develop diabetes requiring insulin treatment, experience episodes of severe gallbladder pain from stones, and notice that their stools float and appear greasy due to undigested fat.^[2]

Some patients with pancreatic NETs develop a group of symptoms called carcinoid syndrome, especially if the tumor has spread to the liver. This syndrome includes uncomfortable facial flushing, where the skin suddenly turns bright red and feels hot, along with wheezing, rapid heartbeat, and diarrhea. These episodes can be triggered by certain foods, alcohol, or stress. Over time, carcinoid syndrome can damage the heart valves, leading to heart failure if not properly managed.^[2]

A rare but life-threatening complication is carcinoid crisis, which can occur during surgery, anesthesia, or other stressful situations. During a carcinoid crisis, massive amounts of hormones are suddenly released into the bloodstream, causing severe drops in blood pressure, difficulty breathing, rapid heart rate, and extreme flushing. This medical emergency requires immediate intensive treatment to stabilize blood pressure and heart function.^[5]

The pancreatic tumor itself can cause complications by obstructing nearby structures. A tumor in the head of the pancreas may compress the common bile duct, preventing bile from reaching the intestines. This obstruction causes jaundice, itching, dark urine, and pale stools. It can also lead to infection in the blocked bile duct system, a serious condition called cholangitis that requires urgent medical intervention.^[1]

As tumors grow larger, they may invade nearby blood vessels. Involvement of major vessels like the portal vein or superior mesenteric artery can complicate surgical removal and may cause problems with blood flow to the intestines or liver. In some cases, the tumor may erode into blood vessels and cause internal bleeding.^[7]

Nutritional complications frequently develop in patients with pancreatic NETs. The pancreas produces enzymes essential for digesting food and absorbing nutrients. When tumors damage the pancreas or when portions of the pancreas are removed during surgery, patients may not produce enough digestive enzymes. This deficiency leads to difficulty absorbing fats, proteins, and fat-soluble vitamins, resulting in weight loss, diarrhea, and nutritional deficiencies. Patients may require pancreatic enzyme replacement therapy, where they take supplemental enzymes with meals to aid digestion.^[18]

Bone metastases from pancreatic NETs can weaken the skeletal structure, making bones prone to fractures even with minor trauma. These metastases often cause persistent pain that requires strong medications for relief. When tumor cells in bone break down bone tissue, they release calcium into the bloodstream, potentially causing high blood calcium levels. This condition, called hypercalcemia, leads to confusion, kidney problems, irregular heartbeat, and severe constipation.^[14]

Impact on Daily Life

Living with a pancreatic neuroendocrine tumor affects virtually every aspect of a person’s daily existence, from physical capabilities to emotional well-being, social relationships, work life, and leisure activities. Understanding these impacts helps patients and families adjust expectations and find ways to maintain the best possible quality of life.^[16]

Physical limitations often become one of the most noticeable effects of pancreatic NETs. Many patients experience profound fatigue that differs from normal tiredness. This cancer-related fatigue doesn’t improve with rest and can make even simple tasks like showering, preparing meals, or walking short distances feel exhausting. The fatigue may result from the tumor itself, from the body’s immune response to cancer, or from treatments like chemotherapy. Learning to pace activities, taking frequent rest breaks, and prioritizing essential tasks become necessary strategies for managing limited energy.^[1]

Digestive symptoms significantly disrupt daily routines for many patients with pancreatic NETs. Those with functional tumors that cause diarrhea may need to plan their lives around bathroom access, which can make leaving home anxiety-provoking. Severe diarrhea can lead to accidents that are embarrassing and distressing. Patients often become reluctant to eat in restaurants or attend social gatherings where they might not have easy access to a bathroom. Some people find themselves unable to work outside the home or must arrange their workspace to be near restroom facilities.^[2]

Pain, whether from the tumor pressing on nearby organs or from metastases in bones or other sites, can make it difficult to sleep, work, or engage in activities that once brought joy. Chronic pain affects concentration, mood, and the ability to interact positively with others. Finding effective pain management becomes crucial not just for physical comfort but for maintaining mental health and social connections.^[1]

Eating, which should be a source of pleasure and social connection, becomes complicated for many patients with pancreatic NETs. Those with carcinoid syndrome must avoid foods that trigger flushing episodes, including aged cheeses, cured meats, fermented foods, chocolate, and alcohol. This means declining foods at social gatherings, explaining dietary restrictions repeatedly, and sometimes feeling left out when others are enjoying meals freely. Some patients experience early satiety, feeling full after only a few bites, which makes maintaining adequate nutrition challenging. Others deal with nausea that makes food unappealing or painful abdominal symptoms that worsen with eating.^[19]

For patients with insulinomas, the constant need to prevent hypoglycemia means eating frequently throughout the day and night, carrying emergency snacks everywhere, and remaining vigilant for warning signs of dropping blood sugar. This hypervigilance creates stress and interrupts sleep when midnight snacks become necessary to prevent dangerous blood sugar crashes.^[14]

The emotional impact of living with a pancreatic NET cannot be overstated. Fear about the future, uncertainty about prognosis, and worry about how the disease will progress create ongoing anxiety. Many patients experience feelings that alternate between hope and despair, especially around the time of scans or doctor appointments when they’ll learn whether the tumor is growing or treatment is working. This emotional rollercoaster is exhausting in itself.^[16]

Depression commonly affects people living with cancer. The combination of physical limitations, changed appearance, inability to do things one used to enjoy, and existential concerns about mortality can lead to persistent sadness, loss of interest in activities, changes in sleep patterns, and feelings of hopelessness. Recognizing and treating depression is essential because it not only affects quality of life but can also impact how well patients adhere to treatment plans.^[16]

Social relationships often change when someone has a pancreatic NET. Some friends and family members may not know how to respond to the diagnosis and pull away, leaving patients feeling isolated precisely when they need support most. Others may become overly solicitous or treat the patient as fragile, which can feel infantilizing and frustrating. Patients themselves may withdraw from social activities due to fatigue, symptoms, or not wanting to burden others with their health problems.^[16]

Intimate relationships face particular challenges. Physical symptoms, fatigue, changes in body image from weight loss or surgical scars, and the emotional burden of illness can all affect sexual desire and function. Partners may be afraid of causing pain or may themselves be dealing with fear and grief about the diagnosis. Open communication becomes essential, yet many couples find it difficult to talk about these sensitive issues.^[16]

Work life often requires significant adjustments. Some patients can continue working throughout treatment, while others need to reduce their hours, take medical leave, or stop working entirely. Financial concerns about lost income, insurance coverage, and mounting medical bills add another layer of stress. Even for those who continue working, taking time off for frequent medical appointments, managing symptoms at work, and dealing with cognitive changes from treatment can be challenging. Some patients face difficult decisions about whether and when to disclose their diagnosis to employers and colleagues.^[17]

Hobbies and recreational activities may need to be modified or abandoned. Someone who loved hiking may find they no longer have the stamina for long trails. A gardener may lack the physical strength for heavy digging. A person who enjoyed traveling may feel constrained by the need to be near their medical team or worried about symptoms occurring far from home. Finding adapted versions of beloved activities or discovering new pursuits that fit current capabilities helps maintain a sense of identity and purpose.^[20]

Many patients report feeling like they’re living in two worlds simultaneously: the world of the well, where they try to maintain normalcy and focus on things other than cancer, and the world of illness, filled with medical appointments, treatments, symptom management, and constant awareness of their disease. Balancing these two realities requires ongoing psychological work and support from healthcare providers, family, and friends.^[16]

Despite these challenges, many people with pancreatic NETs find meaning and even unexpected positives in their experience. Some report that facing mortality clarifies priorities and helps them focus on what truly matters. Relationships may deepen as people learn to express love and appreciation more openly. Small pleasures and everyday moments can take on new significance. While no one would choose to have cancer, many patients develop resilience and coping skills they didn’t know they possessed.^[20]

Practical strategies can help manage the impact on daily life. Keeping a symptom diary helps identify triggers and patterns. Planning activities during times of day when energy is typically highest maximizes functioning. Building in extra time for tasks reduces stress when fatigue slows things down. Accepting help from others, even though it may feel uncomfortable, allows patients to conserve energy for priorities. Using assistive devices or making home modifications to reduce physical demands can preserve independence.^[17]

Support for Family Members

When someone receives a diagnosis of pancreatic neuroendocrine tumor, the entire family is affected. Family members and loved ones play a crucial role not only in providing emotional support but also in helping patients navigate the complex world of medical treatment, including participation in clinical trials.^[17]

Understanding what pancreatic NETs are and how they differ from other cancers is the first step family members can take to provide effective support. Learning that PNETs generally grow more slowly and often have better outcomes than other pancreatic cancers can help family members maintain hope while remaining realistic. Reading reliable information from medical centers and cancer organizations helps families understand what their loved one is facing and prepares them to be informed advocates and supporters.^[3]

Clinical trials represent an important treatment option for many patients with pancreatic NETs. These research studies test new treatments or new combinations of existing treatments to determine if they’re safe and effective. For patients with pancreatic NETs, clinical trials may offer access to promising therapies not yet available through standard care. However, finding appropriate trials, understanding what participation involves, and deciding whether to enroll can feel overwhelming. This is where family support becomes invaluable.^[3]

Family members can help research clinical trials that might be suitable for their loved one. Numerous online databases list active trials, including the website at ClinicalTrials.gov, which is maintained by the National Institutes of Health. Searching for pancreatic neuroendocrine tumor trials allows families to see what studies are recruiting participants, what the entry requirements are, where the trials are located, and what treatments are being tested. Major cancer centers like MD Anderson, Mayo Clinic, and others often list their own clinical trials on their websites.^[4]

Understanding the types of clinical trials available helps families have informed conversations with the medical team. Phase I trials test new treatments in small groups of people for the first time to evaluate safety and appropriate dosing. Phase II trials involve larger groups and focus on whether the treatment works for specific cancer types. Phase III trials compare new treatments against standard treatments in even larger groups to determine which approach is better. Knowing these distinctions helps families understand what questions to ask about specific trials.^[9]

When a potentially suitable trial is identified, family members can help compile questions to ask the research team. Important questions include: What is the purpose of this trial? What treatment will be provided, and how does it differ from standard treatment? What are the potential benefits and risks? What tests and procedures are involved? How often will visits be required? Will there be costs, or does the trial cover expenses? How long will participation last? Can the patient stop participating if they wish?^[3]

Practical support around clinical trial participation is equally important. Trials often require frequent visits to the medical center, sometimes weekly or even more often during certain phases. Family members can help with transportation to and from appointments, especially if the trial is at a center far from home. They can accompany the patient to appointments, help take notes during discussions with researchers, and provide a second set of ears when complex information is being presented. Stress and anxiety can make it difficult for patients to absorb and remember everything they’re told, so having a family member present to help recall the information is valuable.^[21]

Emotional support throughout the decision-making process about clinical trial participation is crucial. Patients may feel uncertain about enrolling, worried about potential side effects, or anxious about receiving a placebo in trials that include one. Family members can listen to these concerns without judgment, help weigh the pros and cons, but ultimately support whatever decision the patient makes. It’s the patient’s body and life, and they must feel comfortable with their choice.^[16]

If the patient enrolls in a clinical trial, family members can help track symptoms and side effects. Trials typically require detailed reporting of any problems that arise, and keeping good records helps ensure accurate reporting. Family members might notice changes in the patient’s condition that the patient themselves doesn’t recognize, providing valuable information to the research team.^[17]

Beyond clinical trials, family members support their loved ones in countless other ways. Accompanying patients to regular medical appointments, helping manage medications, preparing foods that are easy to eat and align with dietary restrictions, taking over household tasks that have become too difficult, and simply being present provide immeasurable value. Sometimes the most important support is just sitting quietly together, offering companionship without needing to fix anything.^[17]

Family members must also remember to care for themselves. Caregiver burnout is real and can lead to physical and emotional exhaustion. Taking breaks, maintaining their own health appointments, staying connected with friends, and seeking their own counseling or support groups for cancer caregivers helps family members sustain their ability to provide support over the long term.^[17]

Open communication within the family is essential. Patients need to feel they can express fears, frustrations, and needs without burdening loved ones, while family members need to be able to share their own concerns and limitations. Regular family meetings where everyone can speak honestly about how they’re doing and what they need can prevent misunderstandings and resentment from building up.^[16]

Children and teenagers in the family deserve age-appropriate explanations about what’s happening. Shielding young people from the reality of a parent’s or grandparent’s illness often backfires, as they sense something is wrong and imagine scenarios that may be worse than reality. Honest, simple explanations that answer their questions and reassure them that they’ll be cared for no matter what happens helps reduce anxiety and allows them to provide their own forms of support.^[17]

Financial concerns often weigh heavily on families dealing with cancer. Family members can help by researching financial assistance programs, communicating with insurance companies about coverage questions, and helping the patient understand medical bills. Some hospitals have financial counselors who can suggest resources for patients struggling with costs. Organizations like the Pancreatic Cancer Action Network and others may have programs or information about financial assistance.^[17]

Advance care planning, while difficult to discuss, is an important conversation families should have. Understanding the patient’s wishes regarding medical care if they become unable to make decisions themselves, discussing goals of care, and completing advance directive documents ensures that the patient’s preferences will be respected. Family members can help facilitate these conversations and ensure documents are properly completed and available to medical providers when needed.^[16]

Pancreatic Neuroendocrine Tumour Metastatic

Pancreatic neuroendocrine tumours that have spread to other parts of the body represent a challenging form of cancer, yet they often grow more slowly than other pancreatic cancers and can be managed for extended periods with appropriate treatment.

Table of contents

• What is a Pancreatic Neuroendocrine Tumour?
• When the Tumour Spreads
• Symptoms
• How It Is Diagnosed
• Treatment Options
• What to Expect

What is a Pancreatic Neuroendocrine Tumour?

A pancreatic neuroendocrine tumour (also called a PNET or pancreatic NET) is a rare type of cancer that starts in the hormone-making cells of the pancreas^[1]. The pancreas is a gland about 6 inches long that sits behind the stomach and in front of the spine. It has two main types of cells: those that make digestive enzymes and those that produce hormones^[2].

Pancreatic neuroendocrine tumours develop from the hormone-producing cells, which are called islet cells. This is why these tumours are sometimes referred to as islet cell tumours or islet cell cancer^[1]. These tumours are much less common than the usual type of pancreatic cancer and tend to have a better outlook^[2].

• Pancreas
• Liver

Some pancreatic neuroendocrine tumours continue to make hormones. These are called functional tumours because they produce extra amounts of hormones such as gastrin, insulin, or glucagon, which cause specific symptoms^[2]. Most pancreatic neuroendocrine tumours, however, do not produce extra hormones and are called nonfunctional tumours. These often do not cause symptoms until they grow large or spread^[2].

When the Tumour Spreads

Pancreatic neuroendocrine tumours are frequently malignant, meaning they are cancerous and can spread to other parts of the body. Between 50 and 80 percent of these tumours are malignant, except for a type called insulinoma, which is usually not cancerous^[6]. When the tumour is metastatic, it means the cancer has spread beyond the pancreas to other organs or distant parts of the body.

The most common place for these tumours to spread is the liver. They may also spread to lymph nodes, bones, and other distant sites^[3][6]. Because nonfunctional tumours do not produce hormones that cause noticeable symptoms, they are often quite large or have already spread by the time they are discovered^[2].

Despite being metastatic, pancreatic neuroendocrine tumours generally grow more slowly than other types of pancreatic cancer. Well-differentiated tumours, where the cancer cells look more like healthy cells, tend to be more slow-growing. Patients with these tumours often live longer, even with advanced disease^[3].

Symptoms

Pancreatic neuroendocrine tumours sometimes do not cause symptoms, especially in the early stages^[1]. When symptoms do appear, they can vary depending on whether the tumour is functional or nonfunctional and where it has spread.

General symptoms that may occur include^[1]:

• Heartburn
• Weakness and fatigue
• Muscle cramps
• Indigestion
• Diarrhea
• Weight loss
• Skin rash
• Constipation
• Pain in the abdomen or back
• Yellowing of the skin and the whites of the eyes
• Dizziness
• Blurred vision
• Headaches
• Increased thirst and hunger

Functional tumours produce specific symptoms based on the type of hormone they make. For example, tumours that make too much gastrin can cause stomach ulcers and severe diarrhea. Tumours that produce too much insulin can cause dangerously low blood sugar levels^[2].

In one reported case, a patient experienced severe digestive problems, including diarrhea and flushing, along with significant weight loss and abdominal pain before being diagnosed with metastatic disease^[3].

How It Is Diagnosed

Diagnosing a pancreatic neuroendocrine tumour and determining whether it has spread involves several types of tests.

Blood and urine tests can show excess hormones or other signs of a pancreatic neuroendocrine tumour. Blood samples can also be checked for genetic changes that may increase the risk of these tumours^[10].

Imaging tests take pictures of the body and can show the location and size of the tumour as well as whether it has spread. Common imaging tests include^[10]:

• Computed tomography (CT) scans
• Magnetic resonance imaging (MRI)
• Positron emission tomography (PET) scans
• Nuclear medicine tests, which involve injecting a radioactive tracer that sticks to neuroendocrine tumour cells

An endoscopic ultrasound may be performed by passing a thin, flexible tube with a camera down the throat and into the stomach and small intestine. The tube has a special ultrasound tool to create detailed pictures of the pancreas from inside the body^[10].

A biopsy involves removing a small sample of tissue to examine under a microscope. This is the only way to confirm the diagnosis and determine the type and grade of the tumour. The biopsy sample can be obtained through the endoscope or by inserting a needle through the skin into the tumour or a metastatic site such as the liver^[10][3].

The tumour tissue is examined for its differentiation and grade. Well-differentiated tumours have cells that look more like normal cells and tend to grow more slowly. The grade is determined by measuring how fast the cancer cells are dividing, often using a marker called Ki67. A Ki67 level of 10 to 15 percent indicates an intermediate-grade tumour^[3].

Treatment Options

The treatment of metastatic pancreatic neuroendocrine tumours is complex and depends on several factors, including the type of tumour, how fast it is growing, where it has spread, and the patient’s overall health. Treatment often involves a team of specialists working together^[6].

Surgery remains the only approach that can potentially cure the disease, even in some cases where the cancer has spread. Surgeons may remove the primary tumour in the pancreas and, in selected patients, also remove metastases from the liver^[6]. However, surgery is not always possible if the tumour has spread too widely.

Medical therapy includes several options^[6]:

• Somatostatin analogues (such as lanreotide and octreotide) are hormone-like drugs that can block the growth of neuroendocrine tumours and help control symptoms caused by functional tumours
• Targeted therapies are newer drugs that specifically target cancer cells. Examples include everolimus and sunitinib
• Chemotherapy uses drugs to kill cancer cells. A combination called CAPTEM (capecitabine and temozolomide) is sometimes used
• Peptide receptor radionuclide therapy (PRRT) is a newer treatment that delivers radiation directly to tumour cells by attaching a radioactive particle to a targeting molecule

One recently approved targeted therapy is cabozantinib, which was shown to significantly slow disease progression in patients with well-differentiated pancreatic neuroendocrine tumours who had received previous treatment^[12].

Liver-directed therapies are treatments aimed specifically at metastases in the liver, since this is the most common site of spread. These may include procedures that block blood flow to the tumours or deliver chemotherapy or radiation directly to the liver^[6].

In very selected cases, liver transplantation may be considered for patients with metastatic neuroendocrine tumours confined to the liver. This option is unique to neuroendocrine tumours among cancers^[6].

In one patient’s experience, treatment included several lines of chemotherapy, somatostatin analogues, and radiotherapy for bone metastases over a period of more than two years^[3].

What to Expect

The outlook for patients with metastatic pancreatic neuroendocrine tumours varies considerably depending on the specific characteristics of the tumour. Well-differentiated, low-grade tumours are generally slow-growing and are described as having a more indolent behavior compared to other cancers^[3][6].

Many patients with metastatic pancreatic neuroendocrine tumours live for years with their disease, especially when it is well-differentiated. The five-year survival rate for metastatic pancreatic neuroendocrine tumours is 23 percent^[12]. This is significantly better than the outlook for the most common type of pancreatic cancer.

However, not all pancreatic neuroendocrine tumours behave the same way. Intermediate-grade tumours have a slightly worse outlook than low-grade tumours^[3]. Poorly differentiated neuroendocrine carcinomas, which are high-grade and fast-growing, behave more aggressively and have a much worse outlook^[3].

Because many patients with metastatic pancreatic neuroendocrine tumours live for extended periods, preserving quality of life and personalizing treatment according to both the tumour’s characteristics and the patient’s individual needs are essential parts of care^[6].

Pancreatic neuroendocrine tumors that have spread to other parts of the body represent a complex and challenging form of cancer that requires specialized care and a multidisciplinary approach to treatment.

Understanding the Disease

When pancreatic neuroendocrine tumors spread beyond the pancreas to other organs, they are called metastatic. These tumors develop from the hormone-producing cells in the pancreas, known as islet cells, which normally help regulate important body functions like blood sugar control. Unlike the more common type of pancreatic cancer called adenocarcinoma, these tumors tend to grow more slowly and often have a different outlook for patients.^[1]

The metastatic form means that cancer cells have traveled from the original tumor in the pancreas to distant organs, most commonly the liver. The liver is frequently affected because of its role in filtering blood from the digestive system, which gives cancer cells an opportunity to establish new tumors there. In some cases, the disease can also spread to the spleen, bones, and other distant sites throughout the body.^[3]

These tumors can be classified as either functional or nonfunctional. Functional tumors produce excess amounts of hormones, which creates noticeable symptoms related to that specific hormone. For example, a tumor making too much insulin might cause dangerous drops in blood sugar, while one producing gastrin might lead to severe stomach ulcers. Nonfunctional tumors, which represent the majority of cases, do not produce extra hormones. Because they don’t cause hormone-related symptoms, these tumors are often discovered only after they have already spread and grown large enough to affect nearby organs.^[2]

Epidemiology

Pancreatic neuroendocrine tumors are considered rare diseases, making up only about two percent of all pancreatic tumors. The clinical incidence is reported to be between one and five new cases per 100,000 people each year, with a prevalence of approximately 10 cases per 100,000 population. However, recent data suggests that the number of people being diagnosed with these tumors has been increasing, likely due to improved diagnostic imaging technologies that can detect tumors earlier and more accurately.^[6]

These tumors account for around eight percent of all pancreatic tumors when including both benign and malignant forms. While they can occur at any age, most people diagnosed are between the ages of 50 and 60 years old. The disease is relatively uncommon in children, teenagers, and young adults, though cases can occur in younger individuals as well.^[5][8]

When it comes to metastatic disease specifically, the outlook varies significantly depending on whether the tumors are well-differentiated or poorly differentiated. Well-differentiated tumors, which grow more slowly, are associated with better survival rates. The frequency of malignancy ranges from 50 to 80 percent for most types of pancreatic neuroendocrine tumors, with the notable exception of insulinomas, which are usually benign. Unfortunately, nonfunctional tumors, which make up as many as 90 percent of cases, often already show signs of metastasis at the time of diagnosis because they don’t produce early warning symptoms.^[6]

Causes

The exact cause of pancreatic neuroendocrine tumors remains largely unknown. Researchers have not yet identified what triggers the neuroendocrine cells in the pancreas to begin dividing and multiplying uncontrollably, eventually forming tumors that can spread to other organs. What is understood is that these tumors develop when there are abnormal changes in the cells’ normal growth and division processes.^[7]

Unlike some other forms of cancer, there are no clear environmental triggers or lifestyle factors that have been definitively linked to the development of these tumors. The disease does not appear to be caused by smoking, excessive alcohol consumption, or dietary factors in the way that pancreatic adenocarcinoma might be. This makes prevention particularly challenging, as there are no obvious behaviors or exposures to avoid.^[1]

Risk Factors

While the direct causes of pancreatic neuroendocrine tumors are not well understood, certain inherited genetic conditions significantly increase a person’s risk of developing these tumors. The most important risk factor is having one of several rare hereditary syndromes that involve mutations in specific genes. These genetic conditions are passed down through families and can cause multiple tumors to develop in various organs throughout the body.^[8]

The most common inherited syndrome associated with pancreatic neuroendocrine tumors is Multiple Endocrine Neoplasia Type 1, also known as MEN1 or Wermer Syndrome. This condition causes overactive tumors to form in various endocrine glands, including the pancreas, parathyroid glands, and pituitary gland. When tumors develop as part of MEN1, they may appear in multiple locations within the pancreas and can have a very high potential to become malignant and spread.^[5][8]

For individuals with these hereditary syndromes, regular monitoring and screening can help detect tumors early, potentially before they have spread to other organs. Genetic testing and counseling are important tools for families with a history of these conditions, as they can help identify who might be at increased risk and would benefit from closer medical surveillance.^[1]

Symptoms

The symptoms of metastatic pancreatic neuroendocrine tumors vary widely depending on whether the tumor is functional or nonfunctional, and where in the body the cancer has spread. Many patients experience a long period where they either have no symptoms at all or have vague complaints that are easily attributed to other, less serious conditions. This is particularly true for nonfunctional tumors, which can grow silently for years without causing any hormone-related problems.^[1]

When functional tumors are present, the symptoms relate directly to the type of hormone being overproduced. A tumor producing excessive insulin, called an insulinoma, causes dangerous drops in blood sugar that lead to dizziness, blurred vision, headaches, weakness, and confusion. Patients may experience intense hunger and sweating as their body tries to cope with the low blood sugar levels. A gastrinoma, which produces too much gastrin, creates severe heartburn, stomach ulcers, abdominal pain, and persistent diarrhea as stomach acid production goes into overdrive.^[2]

Nonfunctional tumors typically only cause symptoms once they have grown large enough to affect nearby organs or have spread extensively throughout the body. Common complaints include persistent abdominal pain that may radiate to the back, a feeling of fullness or bloating, unexplained weight loss, and extreme fatigue. Some patients notice yellowing of their skin and the whites of their eyes, a condition called jaundice, which occurs when tumors block bile ducts. Others experience digestive problems like nausea, vomiting, diarrhea, or constipation.^[1]

When the disease has metastasized to the liver, which is very common, the liver may become enlarged and cause abdominal distension. Patients might notice their abdomen appears swollen or feels uncomfortable. If the cancer has spread to bones, as happened in some documented cases, it can cause pain in the affected areas, such as back pain when vertebrae are involved. The combination of advanced disease and liver involvement often leads to a general decline in health, with patients feeling increasingly unwell, losing their appetite, and struggling with persistent digestive symptoms.^[3]

Prevention

Unfortunately, there are no established methods for preventing pancreatic neuroendocrine tumors in the general population. Because the exact causes of these tumors remain unknown and they are not linked to specific lifestyle factors or environmental exposures, there are no clear preventive measures that people can take to reduce their risk. This stands in contrast to some other cancers where avoiding tobacco, maintaining a healthy weight, or limiting alcohol consumption can meaningfully reduce disease risk.^[7]

For individuals who have inherited genetic syndromes like Multiple Endocrine Neoplasia Type 1, prevention focuses on early detection rather than avoiding tumor development altogether. These high-risk individuals benefit from regular screening programs that include blood tests to measure hormone levels and imaging studies to look for tumors before they cause symptoms or spread. Finding tumors when they are still small and confined to the pancreas offers the best chance for successful treatment and potentially curative surgery.^[8]

Genetic counseling plays an important role for families with a history of inherited syndromes associated with these tumors. Understanding who in the family carries genetic mutations that increase risk allows for personalized surveillance plans. Family members who test positive for these mutations can begin monitoring programs early, while those who test negative can be reassured that they do not face the same elevated risk.^[1]

Pathophysiology

The pathophysiology of metastatic pancreatic neuroendocrine tumors involves complex changes in how cells normally function and regulate their growth. These tumors originate from neuroendocrine cells in the pancreas, which are specialized cells that combine characteristics of both nerve cells and hormone-producing endocrine cells. Under normal circumstances, these cells cluster together in small groups called islets of Langerhans, where they produce vital hormones like insulin and glucagon that help regulate blood sugar levels and other metabolic processes.^[2]

When neuroendocrine cells become cancerous, they lose the normal controls that regulate cell division and death. Instead of dividing at appropriate rates and dying when they should, these abnormal cells multiply uncontrollably and fail to undergo normal programmed cell death. Over time, this leads to the formation of tumors within the pancreas. The tumors themselves can vary significantly in their behavior, with some growing very slowly over many years while others are more aggressive.^[1]

The grade and differentiation of these tumors profoundly affect how they behave. Well-differentiated tumors maintain more characteristics of normal neuroendocrine cells and tend to grow more slowly. They are often classified by their Ki67 proliferation index, which measures how rapidly cancer cells are dividing. A lower Ki67 index indicates slower-growing tumors with a more indolent course. Poorly differentiated tumors, in contrast, have lost most of their normal cell characteristics and behave much more aggressively, similar to small-cell lung cancer. These high-grade tumors divide rapidly and are more likely to spread quickly to distant organs.^[3]

The process of metastasis occurs when cancer cells break away from the original tumor in the pancreas and travel through the bloodstream or lymphatic system to establish new tumors in distant organs. The liver is the most common site of metastasis because blood from the pancreas and digestive system flows through the liver for filtering. This anatomical relationship gives pancreatic neuroendocrine tumor cells direct access to liver tissue. Once established in the liver, metastatic tumors can grow to occupy significant portions of the organ, sometimes appearing as thousands of lesions scattered throughout liver tissue.^[6]

In functional tumors, the cancer cells retain their ability to produce hormones, but without the normal regulatory controls. This leads to excessive, uncontrolled hormone production that overwhelms the body’s ability to maintain balance. For instance, insulinomas produce dangerous amounts of insulin that drive blood sugar to perilously low levels, while gastrinomas flood the body with gastrin, causing the stomach to produce excessive acid that damages the digestive tract lining. These hormonal imbalances create many of the clinical symptoms patients experience and can significantly impact their quality of life.^[2]

The biological differences between pancreatic neuroendocrine tumors and the more common pancreatic adenocarcinoma are substantial and explain why their clinical courses differ so dramatically. Neuroendocrine tumors are believed to originate from different cells within the pancreas and have distinct molecular characteristics. They typically grow more slowly and often remain more responsive to treatments even after spreading, allowing many patients to live for years with metastatic disease. This more indolent behavior contrasts sharply with adenocarcinoma, which tends to be aggressive from the outset and has a much worse prognosis once it has spread.^[9]

Pancreatic neuroendocrine tumors that have spread beyond the pancreas represent a complex and challenging form of cancer that behaves very differently from the more common types of pancreatic disease. Understanding what happens when this rare cancer spreads, how it affects daily life, and what families can expect helps patients and their loved ones navigate this difficult journey with greater confidence and support.

Understanding Your Outlook When Cancer Has Spread

When doctors talk about prognosis, they mean the likely course your disease will take and your chances of recovery. With pancreatic neuroendocrine tumors that have spread to other parts of the body, the outlook varies considerably depending on several important factors. These tumors behave quite differently from the more common pancreatic adenocarcinoma, which tends to grow and spread much more rapidly.^[1]

Pancreatic neuroendocrine tumors are generally described as having a better overall prognosis than pancreatic adenocarcinoma. However, when these tumors have already metastasized—meaning they have spread to distant organs like the liver, bones, or spleen—the situation becomes more serious. The five-year relative survival rate for pancreatic neuroendocrine tumors that have spread is around 23%, which highlights both the serious nature of advanced disease and the ongoing need for new treatment approaches.^[12]

Despite these statistics, it’s important to understand that pancreatic neuroendocrine tumors often show a more indolent, or slow-growing, behavior compared to other malignancies. This means that even with metastatic disease, many patients can live for years with appropriate treatment and management.^[6] Some patients continue to maintain good quality of life and remain active for extended periods, especially when their tumors are well-differentiated, meaning the cancer cells still look somewhat like normal cells under the microscope.^[13]

The grade of the tumor plays a crucial role in determining prognosis. Well-differentiated tumors with low grade tend to be slower growing, while poorly differentiated and high-grade tumors have the potential to behave more aggressively. Intermediate-grade neuroendocrine tumors have a slightly worse prognosis than low-grade tumors.^[3] The Ki67 proliferation index, a measure of how quickly cancer cells are dividing, helps doctors understand how aggressive your particular tumor might be.^[3]

How the Disease Progresses Without Treatment

When pancreatic neuroendocrine tumors are left untreated, they continue to grow and spread, though often at a slower pace than other types of pancreatic cancer. The natural progression of these tumors depends heavily on whether they are functional or nonfunctional, and how well or poorly differentiated they are.^[2]

Functional tumors produce excess amounts of hormones like insulin, gastrin, or glucagon, which create symptoms related to those specific hormones. Without treatment, these hormone-related symptoms worsen over time. For example, a gastrinoma that produces too much gastrin causes increasingly severe stomach ulcers and diarrhea. An insulinoma that makes too much insulin leads to more frequent and dangerous episodes of low blood sugar.^[2]

Nonfunctional tumors, which make up the majority of pancreatic neuroendocrine tumors, don’t produce excess hormones and therefore don’t cause hormone-related symptoms early on. These tumors are often quite large when first discovered because they grow silently for years without causing noticeable problems. By the time they’re found, they have frequently already spread to the liver or other organs.^[5] Without treatment, these tumors continue to enlarge and spread to additional sites in the body.

As metastatic pancreatic neuroendocrine tumors progress, the liver becomes the most common site of spread, though tumors can also travel to the bones, spleen, and other distant organs.^[6] One documented case described a patient with an aggressive pancreatic neuroendocrine tumor that spread to the liver, spleen, and spine, causing progressive symptoms and deterioration over time.^[3]

The speed of progression varies dramatically. Some patients with well-differentiated tumors experience very slow progression over many years, with the tumor burden increasing gradually. Others with poorly differentiated tumors face rapid growth and spread, with the disease behaving more like small-cell carcinoma of the lung—an extremely aggressive cancer type.^[3]

Physical symptoms develop as the tumor grows and spreads. Patients may experience increasing fatigue, weight loss, and pain in the abdomen or back as the pancreatic mass enlarges. When liver metastases become extensive, they can cause the liver to swell, leading to abdominal distension, loss of appetite, and eventually jaundice—a yellowing of the skin and eyes that indicates the liver is struggling to function properly.^[1]

Possible Complications and Unexpected Developments

Metastatic pancreatic neuroendocrine tumors can lead to various complications that affect different organ systems and significantly impact a patient’s health. Understanding these potential complications helps patients and families recognize warning signs and seek timely medical attention.

One serious complication is carcinoid syndrome, which occurs when functional tumors release large amounts of hormones and other substances into the bloodstream. This syndrome causes symptoms including flushing of the skin, severe diarrhea, wheezing, and rapid heartbeat. In severe cases, patients can experience a life-threatening condition called carcinoid crisis, characterized by extremely low blood pressure, confusion, and difficulty breathing.^[8]

When tumors produce too much insulin, patients face the dangerous complication of severe hypoglycemia—extremely low blood sugar. This can cause confusion, shakiness, seizures, loss of consciousness, and if not treated promptly, can lead to permanent brain damage or death. These episodes may become more frequent and severe as the tumor grows.^[2]

Liver metastases can overwhelm the liver’s ability to function properly. As cancer takes over more and more liver tissue, the organ cannot effectively filter toxins from the blood, produce essential proteins, or manage blood sugar levels. This leads to symptoms including jaundice, fluid accumulation in the abdomen, easy bruising and bleeding, and confusion from toxin buildup in the brain.^[19]

Bone metastases cause pain, increase the risk of fractures, and can compress the spinal cord. One case report described a patient who developed metastasis within the T10 vertebra in the spine, requiring radiotherapy to prevent further complications.^[3] Bone complications can severely limit mobility and independence.

Nutritional complications are common because the pancreas plays a vital role in digestion. When tumors affect pancreatic function or when treatments impact the digestive system, patients may struggle to absorb nutrients properly. This leads to weight loss, vitamin deficiencies, and overall weakness. Some patients develop diarrhea that’s difficult to control, leading to dehydration and electrolyte imbalances.^[14]

Pancreatic neuroendocrine tumors can also cause obstruction of the bile duct, leading to cholestasis—a backup of bile that causes severe itching, jaundice, and increases the risk of infections in the bile ducts. Similarly, tumors can block the pancreatic duct or parts of the digestive tract, causing pain and digestive problems.

Patients receiving various treatments face specific complications related to those therapies. Chemotherapy can suppress the immune system, increasing infection risk and causing fatigue, nausea, and changes in blood cell counts. Hormone therapies may cause side effects related to hormone imbalances. Some treatments affect heart function, while others can impact kidney function or cause allergic reactions.^[12]

Impact on Daily Life and Activities

Living with metastatic pancreatic neuroendocrine tumor profoundly affects many aspects of daily life, from physical abilities to emotional well-being, work responsibilities, and social relationships. Each patient’s experience is unique, but many face similar challenges that require adaptation and support.

Physical limitations often develop gradually or suddenly, depending on the tumor’s behavior and location of metastases. Many patients experience persistent fatigue that makes even simple tasks feel exhausting. Activities that once seemed effortless—climbing stairs, carrying groceries, or walking moderate distances—may become difficult or impossible. One patient described struggling to walk up the stairs to her condo and being unable to take more than a few bites of food as her liver became enlarged with tumors.^[16]

Digestive symptoms significantly disrupt daily routines. Chronic diarrhea, a common symptom especially with functional tumors, requires constant access to bathroom facilities and can make leaving home anxiety-provoking. Nausea and changes in appetite affect meal planning and social eating situations. Some patients find they can only tolerate small, frequent meals rather than normal-sized portions. Weight loss may lead to clothing not fitting properly and concerns about appearance.^[1]

Pain management becomes a daily priority for many patients. Abdominal pain, back pain, or bone pain from metastases may require regular medication and lifestyle adjustments. Pain can interfere with sleep, making fatigue worse and affecting mood and cognitive function. Finding comfortable positions for sleeping, sitting, or moving becomes an ongoing challenge.^[1]

Work life often requires significant modifications or may become impossible to continue. Frequent medical appointments for scans, blood tests, and treatments take time away from work. Fatigue and symptoms make it difficult to maintain focus and productivity. Some patients must reduce their hours, change to less demanding positions, or stop working entirely. This transition can affect financial security and sense of identity and purpose. However, some patients do continue working and teaching, finding that maintaining professional engagement provides meaning and normalcy.^[17]

Social relationships undergo changes as the disease progresses. Friends and family members may not understand the unpredictable nature of symptoms or the exhaustion that comes with cancer and its treatment. Social activities that involve food, physical activity, or being away from home for extended periods become challenging. Some patients feel isolated because others don’t know how to offer support or are uncomfortable discussing cancer.

Hobbies and recreational activities may need adaptation. However, many patients find ways to continue enjoying meaningful activities. One patient continued to go canoeing with her sister and exercised at the gym despite her diagnosis.^[17] Another patient traveled and maintained an active lifestyle even while managing multiple tumors.^[15] Finding activities that bring joy and can be modified as needed helps maintain quality of life.

Emotional and mental health impacts are substantial. Anxiety about scan results, disease progression, and the future is common. Some patients experience depression, especially when facing multiple setbacks or dealing with poorly controlled symptoms. The uncertainty of living with a chronic, life-threatening illness creates ongoing stress. One patient described it as “this balance of feeling good—like ‘I don’t have cancer’—but in the back of my mind, I wonder when this is going to become a problem.”^[17]

Coping strategies that help patients manage these impacts include maintaining realistic but positive attitudes, staying engaged with healthcare teams, connecting with others who have similar diagnoses, and focusing on what can be controlled. Some patients practice mental hygiene by staying active and engaged through teaching, exercise, and hobbies.^[17] Others find meaning in planning for the future and setting achievable goals despite their diagnosis.^[16]

Supporting Your Family Member Through Clinical Trials

Clinical trials represent an important opportunity for patients with metastatic pancreatic neuroendocrine tumors to access new treatments that may not yet be widely available. Family members play a crucial role in helping patients learn about, decide on, and participate in these research studies. Understanding how clinical trials work and how to provide effective support can make a significant difference in the patient’s journey.

Clinical trials for pancreatic neuroendocrine tumors test new medications, combinations of existing treatments, different doses or schedules, and novel approaches like targeted therapies. These studies are carefully designed to answer specific questions about safety and effectiveness while protecting patient welfare. Recent approvals of new treatments for pancreatic neuroendocrine tumors, such as cabozantinib (CABOMETYX), came directly from clinical trial research.^[12]

Families can help by researching available clinical trials together with the patient. Many resources exist online, including the National Cancer Institute’s database and hospital-specific trial listings. However, the information can be overwhelming and technical. Family members can assist by organizing information, making lists of questions, and helping compare different trial options. It’s helpful to create a spreadsheet or document that tracks trial names, locations, eligibility requirements, and key details about what each study involves.

Understanding eligibility is crucial. Clinical trials have specific requirements about the type and stage of cancer, previous treatments received, overall health status, and other factors. Family members can help gather medical records, treatment histories, and test results that the research team will need to determine if the patient qualifies. This administrative support reduces stress on the patient who may already feel overwhelmed by their diagnosis and symptoms.

The decision to join a clinical trial is deeply personal and should never be rushed. Families can support decision-making by attending appointments where trials are discussed, taking notes, and asking clarifying questions that the patient might not think of in the moment. Important questions include: What is the goal of this trial? What treatments will be involved? What are the possible side effects? How often will visits be required? Will there be any costs not covered by insurance? What happens if the disease progresses during the trial?

Practical support becomes essential once a patient enrolls in a trial. Clinical trials often require frequent visits for monitoring, additional tests and scans, and careful tracking of symptoms and side effects. Family members can help by providing transportation to appointments, keeping a calendar of visit schedules, organizing medications and supplements, and maintaining a symptom diary. Some trials have specific requirements about diet, activities, or other medications that must be avoided, and family support in following these rules is valuable.

Emotional support throughout the trial is equally important. Patients may feel anxious about whether the new treatment will work, frustrated by additional testing requirements, or discouraged if early results aren’t as hoped. Family members can provide encouragement, help maintain perspective, and remind the patient that participating in research contributes to advancing knowledge that helps future patients—even if the personal benefit is uncertain.

Communication with the research team should be open and ongoing. Family members can help ensure that all side effects and changes in condition are reported promptly. If concerns arise about the trial, families can encourage and facilitate conversations with the study doctors and nurses. It’s important to remember that patients can withdraw from a clinical trial at any time for any reason, and family support for this decision is important if the patient feels participation is no longer right for them.

Financial considerations of trial participation deserve attention. While the experimental treatment itself is typically provided at no cost, there may be expenses related to additional testing, travel to the trial site, or time away from work. Some trials offer assistance with travel and lodging. Family members can help investigate what financial support might be available and plan for these potential costs.

Finding the right clinical trial may require looking beyond local hospitals. Some of the most innovative trials for pancreatic neuroendocrine tumors are conducted at specialized cancer centers with expertise in this rare disease. One patient described traveling from Indiana to New York to see a specialist known for expertise in neuroendocrine tumors and accessing more treatment options than were available locally.^[16] Families can support this process by helping research distant centers, plan travel logistics, and coordinate care between local and specialized teams.

Pancreatic Neoplasm

Pancreatic neoplasm is a serious health condition that forms in the tissues of the pancreas, an organ vital for digestion and blood sugar control. Most people don’t show signs in early stages, making this disease particularly challenging to detect and treat.

Table of contents

• What Is Pancreatic Neoplasm?
• Anatomy and Location
• Types of Pancreatic Neoplasms
• Risk Factors
• Signs and Symptoms
• Diagnosis and Detection Challenges
• How Common Is It?
• Outlook and Survival
• Treatment Options
• Living with Pancreatic Neoplasm

What Is Pancreatic Neoplasm?

Pancreatic neoplasm refers to abnormal growths that develop in the pancreas. These neoplasms (abnormal tissue growths) occur when cells in the pancreas mutate and multiply out of control, forming a tumor^[1][2]. The pancreas is a gland in your abdomen that sits between your spine and stomach, playing crucial roles in both digestion and blood sugar regulation.

The pancreas produces enzymes (special proteins) that help break down food and hormones (chemical messengers) like insulin and glucagon that control blood sugar levels^[6]. When cancer develops in this organ, it can significantly impact these essential functions.

Anatomy and Location

• Pancreas
• Pancreatic duct
• Stomach
• Small intestine
• Common bile duct

The pancreas is shaped like a thin pear lying on its side and is about 6 inches long. It has three main parts: the wider end called the head, the middle section called the body, and the narrow end called the tail^[6]. The location of a tumor within these different areas affects how doctors approach treatment, particularly surgery.

Most pancreatic cancers start in the ducts of the pancreas. The main pancreatic duct connects the pancreas to the common bile duct^[2]. This anatomical connection helps explain why some symptoms, particularly those related to digestion and bile flow, occur in people with pancreatic neoplasms.

Types of Pancreatic Neoplasms

Pancreatic neoplasms can occur in two main types of cells: exocrine cells (which produce digestive juices) or endocrine cells (which produce hormones). About 95% of pancreatic cancers begin in exocrine cells, while about 5% develop in endocrine cells^[6].

Exocrine Tumors

Over 90% of all pancreatic tumors are exocrine tumors^[2][5]. The most common type is adenocarcinoma, which accounts for about 90% of all pancreatic cancers. This type begins in the cells lining the pancreatic duct^[5].

Other less common exocrine tumors include acinar cell carcinoma, which is very rare and may cause excessive production of pancreatic lipase (an enzyme that digests fats)^[5]. Intraductal papillary-mucinous neoplasm (IPMN) is a cystic tumor that grows from the main pancreatic duct or its side branches and may be benign at diagnosis but has a risk of progressing to cancer^[5].

Mucinous cystadenocarcinoma is a rare, malignant cystic tumor filled with a thick fluid called mucin. It usually occurs in one area of the pancreas, more commonly in the tail, and is mostly seen in women^[5].

Neuroendocrine Tumors

Less than 10% of pancreatic tumors are neuroendocrine tumors, also called islet cell carcinomas^[2]. These develop from the hormone-producing cells of the pancreas and may behave differently from exocrine tumors.

Risk Factors

A risk factor is something that increases your chances of developing a disease. Having one or more risk factors does not mean you will definitely get pancreatic neoplasm, and some people with no known risk factors still develop the disease^[6].

Smoking is recognized as a strong risk factor for pancreatic cancer. About 20% of pancreatic cancers are caused by smoking^[4][6]. Cigarette smoke contains harmful chemicals that can damage the DNA in pancreatic cells, leading to cancer development.

Age is another important factor. Most pancreatic cancer is diagnosed after age 65^[1][4]. The disease affects males more than females and African Americans more than whites^[4].

Several medical conditions increase risk. Having excess body weight, diabetes, or chronic pancreatitis (long-term inflammation of the pancreas) all raise the likelihood of developing pancreatic cancer^[1][4][6]. New research has found that the specific combination of smoking, diabetes, and poor diet increases the risk of pancreatic cancer the most beyond any one factor alone^[1].

A family history of pancreatic cancer or pancreatitis increases risk^[6]. About 10% of cases have a genetic cause, associated with genetic mutations or syndromes such as Lynch syndrome, Peutz-Jeghers syndrome, Von Hippel-Lindau syndrome, and multiple endocrine neoplasia type 1 (MEN1)^[4][6].

Other risk factors include cirrhosis (scarring of the liver), infection with Helicobacter pylori bacteria, and work exposure to certain chemicals in the dry cleaning and metalworking industries^[4]. Possible risk factors include heavy alcohol consumption, physical inactivity, high red meat consumption, and drinking two or more soft drinks per day^[4].

Signs and Symptoms

Unfortunately, pancreatic neoplasm typically does not cause any early signs or symptoms^[1][2]. We usually don’t see signs of pancreatic cancer until it’s in more advanced stages^[1]. This lack of early warning signals makes the disease particularly difficult to catch when treatment would be most effective.

Symptoms typically emerge once the tumor starts impacting other organs in the digestive system^[2]. Some people develop vague symptoms up to one year before they receive a diagnosis^[2].

Common symptoms include jaundice (yellowing of the skin and whites of the eyes), which occurs when the tumor blocks the bile duct^[2][6]. Along with jaundice, people may notice dark urine and light-colored stool^[2][6].

Pain is another frequent symptom. Many people report that their first pancreatic cancer symptoms were back pain or stomach pain^[2]. Upper abdominal pain and middle back pain can occur and may get worse after meals or when lying down^[2][6]. These symptoms can come and go at first but may worsen over time.

Digestive symptoms are common and include nausea and vomiting, gas or bloating, and lack of appetite^[2][6]. Weight loss without trying is a significant warning sign^[2][6]. People may also experience fatigue and itchy skin^[2].

Some people develop new-onset diabetes or experience blood clots^[2]. Healthcare providers might suspect pancreatic cancer if someone has recently developed diabetes or pancreatitis^[2].

Diagnosis and Detection Challenges

Pancreatic cancer is difficult to detect and diagnose for several reasons^[6]. There are no noticeable signs or symptoms in the early stages. When symptoms do appear, they are similar to signs of many other illnesses, such as pancreatitis or an ulcer. The pancreas is also hidden behind other organs in the abdomen, making it difficult to visualize clearly on imaging tests^[6].

Early-stage pancreatic tumors don’t show up on imaging tests. For this reason, many people don’t receive a diagnosis until the cancer has spread (a process called metastasis)^[2].

To diagnose pancreatic neoplasm, doctors use tests that examine the pancreas^[6]. Imaging tests may include a helical computed tomographic scan (CT scan), magnetic resonance imaging (MRI), and endoscopic ultrasonography^[6]. These tests create pictures of the inside of the body to help doctors see any abnormal growths.

Blood tests can measure tumor markers such as cancer antigen (CA) 19-9. Most patients with pancreatic cancer have an elevated CA 19-9 level at diagnosis. However, the presence of a normal CA 19-9 level does not rule out cancer^[17].

A biopsy (removal of a small tissue sample for examination under a microscope) may be performed to confirm the diagnosis. Minimally invasive techniques such as laparoscopy and laparoscopic ultrasonography may be used to decrease the need for more extensive surgery^[6].

How Common Is It?

Pancreatic cancer is responsible for approximately 3% of all cancers in the United States. It ranks as the 10th most common cancer in men and the 8th most common cancer in women^[2]. In 2014, the American Cancer Society estimated 46,420 new cases of pancreatic cancer with 39,590 deaths in the United States^[14].

Cases of pancreatic cancer are on the rise. Trends indicate that pancreatic cancer will be the second leading cause of cancer death in the United States by 2030^[2]. The incidence of pancreatic cancer has markedly increased over the past several decades, and it currently ranks as the fourth leading cause of cancer death in men and the third leading cause of cancer death in women^[17].

Globally, based on GLOBOCAN 2012 estimates, pancreatic cancer kills more than 331,000 people per year and ranks as the seventh principal cause of cancer death in both genders^[4]. The estimated global 5-year survival rate for pancreatic cancer is about 5%^[4].

Incidence rates are highest in Northern America, Western Europe, Europe, and Australia/New Zealand. The lowest incidence rates are in Middle Africa and South-Central Asia^[4].

Outlook and Survival

The outlook for pancreatic neoplasm remains challenging. The 5-year survival rate in the United States ranges from 5% to 15%, with an overall survival rate of only 6%^[4]. Pancreatic cancer survival rates are low because the disease is difficult to detect in the early stages^[2].

Several factors influence outlook and survival. The primary factors include whether the tumor is localized and can be completely removed with surgery, whether the tumor has spread to lymph nodes or elsewhere, and the patient’s general health^[17].

Surgical resection is the only current option for a cure, but only 20% of pancreatic cancer is surgically removable at the time of diagnosis^[4]. Unfortunately, 80% of patients diagnosed with pancreatic cancer present with spread to other areas or local advanced disease at initial diagnosis^[14].

Even at high-volume specialty centers where the 5-year survival rate for patients is higher than in the general population, disease recurrence is still a major problem. For patients who have undergone surgical removal of the involved pancreas, published series from high-volume referral centers indicate that only 10% to 27% of patients with early-stage disease who underwent removal survived at least 5 years^[14].

There is a high frequency of undetected cancer spread at initial presentation as well as a high frequency of undetectable disease outside the pancreas at the time of surgical removal, which contributes to the poor long-term outcomes^[14].

Treatment Options

Treatment depends on the position of the cancer in the pancreas, how big it is, the type of pancreatic cancer, whether it has spread, whether doctors can remove it with surgery, and the patient’s general health^[8][15].

Surgery

Surgery is the primary mode of treatment for pancreatic cancer and offers the only option for cure^[16]. However, typically, disease spread outside the pancreas prevents curative removal, and surgical treatment may be palliative (focused on comfort) at best^[16].

The type of surgery depends on where the cancer is located in the pancreas. Common procedures include pancreaticoduodenectomy (also called the Whipple procedure), which is one of the most common procedures for cancer in the head or uncinate process of the pancreas^[10]. Other options include distal pancreatectomy (removal of the tail and sometimes body of the pancreas) and total pancreatectomy (removal of the entire pancreas)^[16].

Chemotherapy

Chemotherapy is one of the main treatments for pancreatic cancer. It uses drugs to kill cancer cells or stop them from growing^[15]. Chemotherapy may be given before surgery (called neoadjuvant therapy) to shrink the tumor, after surgery (called adjuvant therapy) to kill any remaining cancer cells, or for advanced cancer to help control symptoms and prolong life^[12][15].

Radiation Therapy

Radiation therapy uses high-energy x-rays to kill cancer cells^[15]. It may be used alone or combined with chemotherapy (called chemoradiotherapy). Radiation is sometimes given before surgery to shrink tumors or after surgery to kill remaining cancer cells.

Targeted Therapy and Immunotherapy

Doctors may use targeted cancer drugs or immunotherapy to help treat pancreatic cancer^[15]. These treatments work differently from chemotherapy by targeting specific features of cancer cells or helping the immune system fight cancer.

Palliative Treatment

Pancreatic cancer is often diagnosed at an advanced stage. Treatments to control symptoms of advanced pancreatic cancer are an important part of care^[15]. These may include procedures to relieve blockages in the bile duct or digestive system, pain management, nutritional support, and other supportive care measures.

Living with Pancreatic Neoplasm

A diagnosis of pancreatic neoplasm requires adapting to many life changes. The disease brings a wide range of emotions, various physical symptoms, and numerous decisions about care^[20]. While the disease and its treatment can be stressful, there are things patients can do to cope better.

Developing a Support System

A strong support system, including family, friends, clergy, and a good medical team, helps patients deal with different aspects of pancreatic cancer^[20]. Family and friends are important members of a support network. Patients may find comfort in talking to their support network about emotions and physical feelings on a day-to-day basis.

There may be times when patients find comfort in writing in a journal, joining a formal support group, or seeking individual counseling^[20]. Support groups provide opportunities to talk with other individuals who are also dealing with cancer. Many find the process of helping other people with their care rewarding and empowering.

Maintaining a Positive Outlook

Staying positive and hoping for the best can push a patient to continue battling the disease and follow medical advice. A positive outlook can help a patient take better care of themselves and can also inspire appreciation of things that are meaningful in the present^[20].

Nutrition and Diet

Maintaining a balanced diet is essential for pancreatic cancer patients, as it supports overall health and helps manage treatment side effects^[22]. Proper nutrition provides the necessary nutrients to maintain energy levels, support the immune system, and promote healing.

Dietary needs will change after diagnosis. Certain foods can be difficult to digest and worsen symptoms. It’s important to avoid fatty foods such as fried foods and high-fat meats, which can be hard to digest. Sugary foods can lead to blood sugar spikes, potentially worsening fatigue and nausea. Spicy and acidic foods can irritate the digestive tract^[22].

Staying hydrated is crucial, especially if experiencing diarrhea or vomiting^[22]. Water, herbal teas, and clear broths are excellent choices.

Physical Activity

Regular physical activity offers numerous benefits, including improved mood, increased energy levels, and better overall health^[22]. Exercise can help reduce fatigue, enhance physical function, and improve mental health.

Suitable exercises include walking, swimming, yoga, and stretching^[22]. It’s important to start with small, achievable goals and gradually increase activity over time. Listening to your body’s signals is crucial—pay attention to signs of fatigue or pain and rest when needed^[22].

Finding a New Normal

Life changes after a pancreatic cancer diagnosis. Experts agree that living each day as normally as possible, whether you’re a patient or a loved one, is key. Also critical is being open to new meaning in life, altering routines and hobbies if needed, and embracing a “new normal”^[18].

Change in life events can spur interest in new hobbies and pursuits. Consider journaling, meditation, yoga and other relaxation exercises, as well as social activities in the community^[18]. Remember that you are not your cancer. Even though you have the disease, you get to decide how you want to live the rest of your life. You can choose to live with hope.

Pancreatic neoplasm refers to abnormal growths that develop in the pancreas, a vital organ that helps with digestion and blood sugar control. Most of these tumors are cancerous and difficult to detect early, making pancreatic cancer one of the most challenging diseases to treat, with survival rates remaining low despite advances in medicine.

Epidemiology

Pancreatic cancer represents a significant health challenge worldwide. In the United States, it accounts for approximately three percent of all cancers but carries a disproportionately high mortality rate. It ranks as the tenth most common cancer in men and the eighth most common in women. However, its deadliness places it as the fourth leading cause of cancer deaths in the country.^[1][2]

In 2014, an estimated 46,420 new cases were diagnosed in the United States, with 39,590 deaths occurring in the same year. The global burden is also substantial, with more than 331,000 deaths annually worldwide, ranking pancreatic cancer as the seventh principal cause of cancer death in both genders. These numbers reflect the aggressive nature of the disease and the challenges in early detection and treatment.^[4]

Geographically, the disease shows variation in its occurrence. The highest incidence rates are found in Northern America, Western Europe, and Australia/New Zealand. The lowest rates occur in Middle Africa and South-Central Asia. For men specifically, Armenia, the Czech Republic, Slovakia, Hungary, Japan, and Lithuania show the greatest risk of developing pancreatic cancer. Among women, Northern America, Western Europe, Northern Europe, and Australia/New Zealand have the highest incidence rates, while Middle Africa and Polynesia have the lowest.^[4]

A concerning trend is that cases of pancreatic cancer are on the rise. Current projections indicate that pancreatic cancer will become the second leading cause of cancer death in the United States by 2030. This upward trajectory underscores the urgent need for better prevention, detection, and treatment strategies.^[2]

The five-year survival rate for pancreatic cancer remains dismal, ranging from five to fifteen percent in the United States, with an overall survival rate of only six percent. This poor prognosis is largely because most patients—approximately eighty percent—are diagnosed when the disease has already spread beyond the pancreas or has grown extensively in the local area. At the time of diagnosis, only twenty percent of pancreatic cancers are surgically removable, which is currently the only treatment option with curative potential.^[1][4]

Causes

The exact cause of pancreatic cancer remains poorly understood, despite its high mortality rate. What researchers do know is that pancreatic cancer develops when cells in the pancreas undergo certain changes in their DNA (the genetic material that controls how cells function). These changes cause cells to grow and divide in an uncontrolled way, forming clusters called tumors. Most pancreatic cancers begin in the ducts (tubes) of the pancreas—the passages that carry digestive enzymes from the pancreas to the intestines.^[1][6]

Pancreatic cancer is not typically an infectious disease, so it does not spread from person to person through contact or transmission routes like some other illnesses. Instead, it develops through internal cellular changes that accumulate over time. About ten percent of pancreatic cancers have a genetic cause, meaning they are associated with inherited genetic mutations or certain genetic syndromes that run in families.^[4]

When cancer cells form in the pancreas, they can eventually spread beyond the organ if left untreated. These cells may migrate to other parts of the body, a process called metastasis. Understanding that these cellular changes drive the disease helps explain why prevention and early detection remain so challenging.^[1]

Risk Factors

While the exact cause of pancreatic cancer is unclear, several factors can increase a person’s chances of developing the disease. It’s important to understand that having one or more risk factors does not mean someone will definitely get pancreatic cancer. Many people with risk factors never develop the disease, while some people with no known risk factors do get it.^[6]

Smoking is recognized as one of the strongest risk factors for pancreatic cancer. About twenty percent of pancreatic cancers are caused by smoking cigarettes, cigars, or using other forms of tobacco. This is a modifiable risk factor, meaning people can reduce their risk by quitting or never starting to smoke.^[1][4]

Age plays a significant role, with most pancreatic cancers diagnosed in people over 55 years old. The disease is also more common in certain demographic groups: men are at slightly higher risk than women, and African Americans have higher rates than white populations.^[4]

Several health conditions increase risk. Diabetes (a condition where blood sugar levels are too high) is associated with pancreatic cancer, as is chronic pancreatitis (long-term inflammation of the pancreas). Cirrhosis (scarring) of the liver and infection with Helicobacter pylori, a bacterium that can cause stomach problems, also raise the risk.^[4]

Lifestyle factors matter too. Obesity and carrying excess body weight increase the chances of developing pancreatic cancer. Lack of physical activity, high consumption of red meat, and drinking two or more soft drinks per day are possible risk factors, though the evidence for these is less definitive than for smoking or obesity. Heavy alcohol consumption and coffee drinking have also been studied as potential risk factors.^[4][6]

Family history and genetics contribute significantly to risk. Having a family member with pancreatic cancer or pancreatitis increases the likelihood of developing the disease. About ten percent of pancreatic cancers have a genetic cause, linked to inherited genetic mutations or association with syndromes such as Lynch syndrome, Peutz-Jeghers syndrome, Von Hippel-Lindau syndrome, MEN1 (multiple endocrine neoplasia type 1), hereditary breast and ovarian cancer syndrome (involving BRCA1 and BRCA2 genes), and familial atypical multiple mole melanoma syndrome.^[4][6]

Occupational exposure also matters. People who work with certain chemicals in the dry cleaning and metalworking industries face increased risk. If someone believes they might be at risk due to any of these factors, it’s important to discuss concerns with a doctor.^[4]

Symptoms

One of the most challenging aspects of pancreatic cancer is that it rarely causes noticeable signs or symptoms in its early stages. This makes early detection extremely difficult. Symptoms typically only emerge once the tumor has grown large enough to affect other organs in the digestive system or has begun to spread.^[1][6]

Jaundice, which is yellowing of the skin and the whites of the eyes, is one of the most common symptoms. This occurs when the tumor blocks the bile duct, preventing bile from flowing properly. Along with jaundice, patients may notice their urine becomes darker than usual and their stools (bowel movements) become lighter in color or appear pale.^[2][6]

Pain is another frequent symptom. Many people experience discomfort in the upper or middle part of the abdomen (belly area) or in the middle of the back. This pain can come and go initially but may worsen after eating meals or when lying down. Some people report that back pain or stomach pain were their first noticeable symptoms, appearing up to one year before diagnosis.^[2][6]

Digestive problems are common as well. Patients may experience nausea and vomiting, gas, bloating, and a persistent lack of appetite. These symptoms occur because the tumor interferes with normal digestive function. Weight loss often follows, happening without any deliberate effort to lose weight. This unintentional weight loss can be significant and alarming.^[2][6]

Fatigue—feeling extremely tired even with adequate rest—affects many patients. Itchy skin can develop, particularly when jaundice is present, due to the buildup of substances in the bloodstream that normally would be eliminated through bile. Blood clots may form more easily in some patients with pancreatic cancer.^[2]

New-onset diabetes or sudden worsening of existing diabetes can be a warning sign. Healthcare providers may suspect pancreatic cancer if a patient recently developed diabetes or pancreatitis (a painful condition caused by inflammation in the pancreas).^[2]

It’s worth noting that pancreatic neuroendocrine tumors (a less common type of pancreatic tumor) may cause different symptoms than typical pancreatic cancer, such as diarrhea and anemia (low red blood cell count), and may not cause jaundice or weight loss.^[2]

Because these symptoms can resemble many other, less serious conditions like ulcers or pancreatitis, pancreatic cancer often goes unrecognized until it has progressed. Anyone experiencing persistent or worsening symptoms should consult a healthcare provider for proper evaluation.^[1]

Prevention

While pancreatic cancer cannot be completely prevented—since anyone with a pancreas has some risk—there are steps people can take to reduce their chances of developing the disease. Focusing on modifiable risk factors offers the best opportunity for prevention.^[10]

The most impactful preventive measure is to avoid smoking or to quit if currently smoking. Since smoking causes about twenty percent of pancreatic cancers, eliminating tobacco use significantly reduces risk. This applies to cigarettes, cigars, and all forms of tobacco products.^[4]

Maintaining a healthy weight is another important prevention strategy. Obesity increases the risk of pancreatic cancer, so achieving and sustaining a healthy body weight through balanced eating and regular physical activity can help lower risk. Being physically active has multiple health benefits and may contribute to reducing pancreatic cancer risk.^[4][6]

Dietary choices matter. While the evidence is still developing, limiting consumption of red meat, avoiding excessive soft drink intake, and following a balanced diet rich in fruits, vegetables, and whole grains may help reduce risk. Moderating alcohol consumption is also advisable, as heavy drinking has been studied as a potential risk factor.^[4]

For people with a family history of pancreatic cancer or known genetic mutations associated with the disease, genetic counseling and testing may be valuable. Those with hereditary conditions like Lynch syndrome, BRCA mutations, or other genetic syndromes that increase risk should discuss screening options with their healthcare providers. Early detection through screening may be recommended for high-risk individuals, though there are currently no standard screening tests for the general population.^[4][6]

Managing underlying health conditions like chronic pancreatitis and diabetes with proper medical care may also play a role in risk reduction. People exposed to chemicals in certain occupations should follow safety protocols to minimize exposure to potentially harmful substances.^[4]

Pathophysiology

Pathophysiology refers to the changes in normal bodily functions that occur when a disease develops. In pancreatic cancer, these changes begin at the cellular level and eventually affect how the entire organ and surrounding systems work.^[1]

The pancreas is a gland about six inches long, shaped like a thin pear lying on its side. It sits in the abdomen between the stomach and spine. The pancreas has three main sections: the wider end is called the head, the middle section is the body, and the narrow end is the tail. This organ performs two essential jobs in the body: it produces digestive juices (enzymes) that help break down food, and it makes hormones like insulin and glucagon that help control blood sugar levels and how the body uses and stores energy.^[6]

Pancreatic cancer can occur in two main types of cells. About ninety-five percent of pancreatic cancers begin in exocrine cells, which are the cells that produce digestive juices. The remaining cases start in endocrine cells, which produce hormones. Most pancreatic cancers are therefore exocrine tumors.^[6]

Among exocrine tumors, over ninety percent are classified as exocrine tumors, and the most common type is adenocarcinoma, which accounts for about ninety percent of all pancreatic cancers. This type begins in the cells that line the pancreatic ducts—the tubes that carry digestive enzymes through the pancreas.^[2][5]

Less common types of pancreatic tumors include acinar cell carcinoma, a very rare form that may cause excessive production of pancreatic lipase (an enzyme that digests fats). Another type is intraductal papillary-mucinous neoplasm (IPMN), which is a cystic tumor that grows from the main pancreatic duct or from side branches. An IPMN may be benign when first diagnosed but carries a risk of becoming malignant (cancerous), especially when it originates in the main duct. Mucinous cystadenocarcinoma is a rare, malignant tumor that forms a cyst filled with thick fluid called mucin, usually appearing in the tail of the pancreas and more commonly seen in women.^[5]

The disease develops when small changes occur in the cellular DNA, causing cells to multiply in an uncontrolled way and accumulate in clusters that form tumors. If left untreated, cancer cells can break away from the original tumor and spread to other parts of the body through the bloodstream or lymphatic system.^[1]

As the tumor grows, it disrupts normal pancreatic function. The pancreas may produce fewer digestive enzymes, leading to problems breaking down and absorbing food, particularly fats. This causes digestive difficulties, weight loss, and nutritional deficiencies. When tumors block the bile duct—a tube that carries bile from the liver through the pancreas to the intestines—bile cannot flow properly, causing jaundice and related symptoms.^[2]

Early-stage pancreatic tumors typically don’t show up on imaging tests, which is why many people don’t receive a diagnosis until the cancer has grown large or spread to other organs. This spread, called metastasis, significantly complicates treatment. Pancreatic cancer is also notably resistant to many common cancer drugs, making it particularly difficult to treat even when detected.^[2]

The location of the tumor within the pancreas matters for symptoms and treatment. Tumors in the head of the pancreas are more likely to block the bile duct early, causing jaundice and leading to earlier detection. Tumors in the body or tail may grow larger before causing noticeable symptoms, often resulting in later diagnosis.^[17]

A particularly troubling aspect of pancreatic cancer pathophysiology is the high frequency of subclinical metastases—cancer cells that have spread but are too small to detect with current imaging technology. Even at the time of surgical removal, undetectable disease outside the pancreas is often present, which explains why many patients experience cancer recurrence even after apparently successful surgery.^[14]

Diagnosing pancreatic carcinoma stage IV requires a comprehensive approach that combines imaging, laboratory tests, and sometimes tissue analysis to confirm the presence and extent of cancer spread throughout the body.

Introduction: Who Should Seek Diagnostic Testing

Pancreatic cancer is particularly challenging because it rarely causes noticeable signs in its early stages, making early detection extremely difficult. Most people with pancreatic cancer, unfortunately, are diagnosed when the disease has already reached stage IV, meaning it has spread beyond the pancreas to other organs.^[1] This advanced stage is also called metastatic or advanced cancer, terms that describe cancer that has traveled to distant parts of the body.

People should seek medical attention when they experience persistent symptoms that don’t improve or worsen over time. These warning signs include yellowing of the skin and whites of the eyes, which doctors call jaundice, along with unusually light-colored stools and dark urine.^[3] Pain in the upper or middle part of the abdomen and back is another concerning symptom that warrants investigation. Many people also notice unexplained weight loss that occurs without trying to lose weight.^[3]

The difficulty with pancreatic cancer symptoms is that they often appear only after the disease has progressed significantly. Early on, pancreatic cancer may not cause any symptoms at all, which explains why detection happens so late in many cases.^[3] This lack of early warning signs makes it essential for anyone experiencing persistent digestive problems, unexplained pain, or changes in their health to consult with a healthcare provider promptly. While these symptoms don’t always mean cancer, they deserve proper medical evaluation to determine their cause.

Understanding your personal risk factors can also guide decisions about when to seek medical advice. Smoking increases the risk of pancreatic cancer, as does having excess body weight. People with a personal history of diabetes or chronic pancreatitis face higher risk, as do those with a family history of pancreatic cancer or certain hereditary conditions like Lynch syndrome or hereditary breast and ovarian cancer syndrome.^[3] If you have multiple risk factors and develop concerning symptoms, discussing these with your doctor becomes even more important.

Classic Diagnostic Methods for Identifying Stage IV Pancreatic Cancer

When doctors suspect pancreatic cancer based on symptoms, they use a combination of tests to confirm the diagnosis and determine how far the disease has spread. The diagnostic process typically begins with imaging studies that create pictures of the inside of the body, allowing doctors to see the pancreas and surrounding areas.

Computed tomography, commonly called a CT scan, is one of the primary imaging tools used to examine the pancreas. This test uses specialized X-ray equipment and computer processing to create detailed cross-sectional images of the abdomen. A CT scan can show the size and location of tumors in the pancreas and reveal whether cancer has spread to nearby structures or distant organs like the liver or lungs.^[10] Before the scan, patients typically receive contrast material, either by mouth or through an intravenous line, which helps organs and tissues show up more clearly in the images.

Magnetic resonance imaging, or MRI, represents another important imaging technique. Unlike CT scans that use X-rays, MRI uses powerful magnets and radio waves to create detailed pictures of organs and tissues. MRI scans can be particularly helpful in visualizing the pancreas and bile ducts, and they provide excellent detail of soft tissues. These scans take longer than CT scans but don’t expose patients to radiation.

When doctors need to look at the spread of cancer more comprehensively, they may order a positron emission tomography scan, known as a PET scan. This type of imaging uses a small amount of radioactive material to identify areas where cancer cells are actively growing. Cancer cells typically absorb more of this material than normal cells because they’re growing and dividing more rapidly. PET scans can help doctors find cancer that has spread to lymph nodes, bones, or other distant sites that might not be obvious on other imaging studies.^[18]

Beyond imaging, laboratory tests play a crucial role in diagnosis. Blood tests can reveal important information about how organs are functioning and may detect certain markers associated with pancreatic cancer. For instance, when tumors block bile ducts, blood tests will show elevated levels of bilirubin, a yellow pigment that causes jaundice. Tests measuring liver enzymes and pancreatic enzymes can indicate how these organs are working. Some blood tests look for specific proteins that pancreatic cancer cells may release, though these aren’t definitive on their own.

To confirm a pancreatic cancer diagnosis with absolute certainty, doctors often need to obtain a small sample of tissue, a procedure called a biopsy. During a biopsy, a doctor removes a tiny piece of the suspicious tissue so it can be examined under a microscope by a specialist called a pathologist. The pathologist looks at the cells to determine whether they’re cancerous and, if so, what type of cancer is present.

Several techniques can be used to perform a pancreatic biopsy. One common approach involves using a thin needle guided by CT or ultrasound imaging to reach the tumor and extract cells. Another method, called endoscopic ultrasound with biopsy, combines endoscopy with ultrasound. In this procedure, a flexible tube with a tiny ultrasound probe on its tip is passed through the mouth, down the esophagus and stomach, to reach the area near the pancreas. The ultrasound creates images that guide needle placement for the biopsy.

Endoscopic retrograde cholangiopancreatography, abbreviated as ERCP, serves both diagnostic and therapeutic purposes. This procedure uses a flexible tube with a camera to examine the bile ducts and pancreatic ducts. Doctors can take biopsies during ERCP and also place small tubes called stents to relieve blockages that cause jaundice.^[2] While primarily used for diagnosis at earlier stages, ERCP can help stage the disease and manage symptoms in advanced cases.

Staging and Determining Extent of Spread

Once pancreatic cancer is confirmed, doctors must determine the stage of the disease. Staging describes how large the cancer is and whether it has spread beyond its original location. This information is critical because it guides treatment decisions and helps predict outcomes.

Stage IV pancreatic cancer means the cancer has metastasized, which means it has spread to other parts of the body.^[1] At this stage, the tumors in the pancreas may be any size, but what defines stage IV is the presence of cancer in distant organs. Pancreatic cancer most commonly spreads to the liver, lungs, abdominal wall, bones, and lymph nodes far from the pancreas.^[1] Even though the cancer has reached these distant sites, it’s still called pancreatic cancer because that’s where it originated.

Doctors use various imaging studies to map where the cancer has spread. The combination of CT scans of the chest, abdomen, and pelvis provides a comprehensive view of potential metastatic sites. PET scans can identify smaller deposits of cancer that might not be visible on CT scans alone. When staging pancreatic cancer, doctors look carefully at the liver since this is the most common site of spread. They also examine the lungs, lymph nodes throughout the body, and bones to create a complete picture of disease extent.

Interestingly, research has found that tumors originating from different parts of the pancreas may be diagnosed at different stages. Cancers starting in the head of the pancreas are more likely to cause symptoms like jaundice earlier because they can block bile ducts more readily. This often leads to diagnosis at an earlier stage. In contrast, cancers originating in the tail of the pancreas may grow larger before causing noticeable symptoms, which is why stage IV disease shows more tumors from the tail compared to all stages of pancreatic cancer combined.^[5]

Diagnostics for Clinical Trial Qualification

Clinical trials represent an important option for people with stage IV pancreatic cancer, offering access to new treatments that aren’t yet widely available. However, joining a clinical trial requires meeting specific criteria, and diagnostic testing plays a central role in determining eligibility.

One of the most important diagnostic requirements for many clinical trials is biomarker testing of the tumor. Biomarkers are specific characteristics of cancer cells that can be identified through laboratory analysis. These might include particular genetic mutations, protein expressions, or other molecular features that define how the cancer behaves. Understanding these characteristics helps researchers match patients to treatments most likely to benefit them.

The Pancreatic Cancer Action Network strongly recommends that all patients undergo biomarker testing of their tumor to help determine the best treatment options.^[1] This testing examines the genetic makeup of cancer cells to identify specific mutations or abnormalities that might make the tumor vulnerable to certain targeted therapies. Some clinical trials specifically enroll patients whose tumors have particular genetic changes, making biomarker testing essential for trial qualification.

Tissue samples obtained during biopsy can be analyzed for these biomarkers. Increasingly, researchers are also using blood-based testing to detect cancer-related genetic material circulating in the bloodstream. These liquid biopsies can sometimes provide information about the tumor without requiring an invasive tissue biopsy, though tissue samples often provide more comprehensive information.

Beyond biomarker testing, clinical trials typically require recent imaging studies to document the exact extent of disease. Researchers need to know precisely where tumors are located and how large they are before starting any experimental treatment. This baseline information allows them to measure whether the treatment is working by comparing follow-up images to the original ones. CT scans, MRI scans, and PET scans may all be required as part of trial enrollment.

Many clinical trials also require thorough assessment of organ function through blood tests. These tests measure how well the liver, kidneys, bone marrow, and other organs are working. Clinical trials often exclude patients whose organs aren’t functioning adequately because the experimental treatments might place additional stress on these systems. Tests measuring liver enzymes, kidney function markers, blood cell counts, and clotting factors help researchers determine if someone can safely participate in a trial.

Performance status represents another key criterion. Doctors assess how well patients can perform daily activities and how active they are despite their cancer. Various scales exist to measure performance status, and many clinical trials only accept patients who maintain a certain level of function. While this isn’t a diagnostic test in the traditional sense, it’s a standardized assessment that influences trial eligibility.

Some trials require documentation of previous treatments and their outcomes. This means having medical records that show what chemotherapy or other treatments you’ve received, how long you took them, and how the cancer responded. Imaging studies and blood tests from before, during, and after previous treatments provide this documentation.

Advanced molecular testing techniques continue to evolve, and some cutting-edge clinical trials may require specialized genetic testing not available at all medical centers. These might include comprehensive genomic profiling that examines hundreds of genes at once, or testing for specific rare mutations. Patients interested in clinical trials may need to have their tissue samples sent to specialized laboratories for these analyses.

The good news is that many of these diagnostic requirements serve dual purposes. The same biomarker testing and imaging studies needed for clinical trial enrollment also provide valuable information for standard treatment planning. The Pancreatic Cancer Action Network recommends considering clinical trials at the time of diagnosis and during every treatment decision, making early and comprehensive diagnostic testing even more important.^[1]

It’s worth noting that diagnostic testing for clinical trials doesn’t end at enrollment. Most trials require regular monitoring through imaging studies and blood tests throughout the treatment period. These repeated assessments help researchers understand how well the treatment is working and detect any concerning side effects early. Patients participating in trials should expect to undergo more frequent testing than they might with standard treatment, though this intensive monitoring can provide valuable information about their disease.

Pancreatic Carcinoma

Pancreatic cancer begins when cells in the pancreas grow out of control, forming a tumor. This disease is difficult to detect early and often spreads before symptoms appear, making it one of the most challenging cancers to treat.

Table of contents

• What Is Pancreatic Cancer?
• The Pancreas and Its Function
• Types of Pancreatic Cancer
• Risk Factors
• Signs and Symptoms
• Diagnosis
• Stages of Pancreatic Cancer
• Treatment Options
• Prognosis and Survival
• Living with Pancreatic Cancer

What Is Pancreatic Cancer?

Pancreatic cancer occurs when cells in your pancreas change and multiply out of control, forming a tumor^[1][2]. Normally, cells divide to form new cells as the body needs them. When cells get old, they die, and new cells take their place. Sometimes this process breaks down. New cells form when the body does not need them, or old cells do not die^[8].

The extra cells may form a mass of tissue called a tumor. Some tumors are benign (not cancerous), meaning they are abnormal but cannot invade other parts of the body. A malignant tumor is called cancer. The cells grow out of control and can spread to other tissues and organs^[8].

Pancreatic cancer is responsible for approximately 3% of all cancers in the United States. It is the 10th most common cancer in men and the 8th most common cancer in women^[2]. More than 67,000 Americans are expected to be diagnosed with pancreatic cancer in 2025, which is more than 184 people diagnosed every day^[8].

Even when the cancer spreads to other areas of the body, it is still called pancreatic cancer if that is where it started. Pancreatic cancer often spreads to the liver, abdominal wall, lungs, bones and lymph nodes^[8].

The Pancreas and Its Function

• Pancreas
• Stomach
• Intestines
• Liver
• Spleen

Your pancreas is a gland in your abdomen, located between your spine and stomach^[2]. The pancreas is a gland about 6 inches long that is shaped like a thin pear lying on its side^[4]. The wider end of the pancreas is called the head, the middle section is called the body, and the narrow end is called the tail^[4].

The pancreas has two main jobs in the body. First, it makes juices that help break down food into substances the body can use. Second, it makes hormones, such as insulin (a hormone that helps control blood sugar) and glucagon, that help control blood sugar levels and help the body use and store the energy it gets from food^[4].

The pancreas produces digestive juices and hormones. It makes enzymes that aid in digestion and hormones that control blood-sugar levels^[2][6].

Types of Pancreatic Cancer

Pancreatic cancer can occur in exocrine pancreas cells, which produce digestive juices, or the endocrine pancreas cells, which produce hormones. About 95% of pancreatic cancers begin in exocrine cells^[4].

There are two main types of pancreatic tumors^[2]:

Exocrine tumors: Over 90% of all pancreatic tumors are exocrine tumors. The most common type of pancreatic cancer is adenocarcinoma, which begins in the cells that line your organs. Most pancreatic cancers start in the ducts of your pancreas^[2]. Around 92% of pancreatic cancers are classified as exocrine tumors^[8].

Neuroendocrine tumors: Less than 10% of pancreatic tumors are neuroendocrine tumors (NETs), also called islet cell tumors or pancreatic NETs (PNETs). They often grow slower than exocrine tumors^[2][8].

Risk Factors

A risk factor is anything that increases the chance of getting a disease. Some risk factors for pancreatic cancer, like smoking, can be changed. However, risk factors also include things people cannot change, like their genetics and their family history^[4].

Having one or more of these risk factors does not mean that you will get pancreatic cancer. Many people with risk factors never develop pancreatic cancer, while others with no known risk factors do^[4].

Risk factors for pancreatic cancer include^[4][5]:

• Smoking: Smoking cigarettes, cigars and using other forms of tobacco. About 20% of pancreatic cancers are caused by smoking^[5].
• Age: Most pancreatic cancer is diagnosed after age 65^[1].
• Excess body weight: Having excess body weight or obesity^[4].
• Diabetes: Having a personal history of diabetes^[4].
• Chronic pancreatitis: Having a personal history of chronic pancreatitis or inflammation of the pancreas^[4].
• Family history: Having a family history of pancreatic cancer or pancreatitis^[4].
• Gender and ethnicity: Males more than females, and African Americans more than whites^[5].
• Cirrhosis of the liver^[5]
• Helicobacter pylori infection^[5]
• Work exposure to chemicals in the dry cleaning and metalworking industry^[5]

Having certain hereditary conditions also increases risk, such as^[4]:

• Hereditary nonpolyposis colon cancer (HNPCC; Lynch syndrome)
• Peutz-Jeghers syndrome
• Hereditary breast and ovarian cancer syndrome
• Familial atypical multiple mole melanoma (FAMMM) syndrome
• Ataxia-telangiectasia

About 10% of pancreatic cancers are considered familial or hereditary. Most pancreatic cancer happens randomly or is caused by things such as smoking, obesity and age^[8].

Possible risk factors include heavy alcohol consumption, coffee consumption, physical inactivity, high red meat consumption, and 2 or more soft drinks per day^[5].

Signs and Symptoms

Unfortunately, there are not any early signs of pancreatic cancer^[2]. Pancreatic cancer often does not cause any signs or symptoms in its early stages, making it hard to detect^[4]. Early-stage pancreatic tumors do not show up on imaging tests. For this reason, many people do not receive a diagnosis until the cancer has spread^[2].

Symptoms typically emerge once the tumor starts impacting other organs in your digestive system^[2]. Some people develop vague symptoms up to one year before they receive a diagnosis^[2].

Pancreatic cancer symptoms may include^[2][4]:

• Jaundice (yellowing of the skin and whites of the eyes)
• Light-colored stool
• Dark urine
• Pain in the upper or middle abdomen and back
• Weight loss
• Fatigue
• Itchy skin
• Nausea and vomiting
• Gas or bloating
• Lack of appetite
• Blood clots
• New-onset diabetes

Many people report that their first pancreatic cancer symptoms were back pain or stomach pain. These symptoms can come and go at first, but may get worse after meals or when you lie down^[2].

Your healthcare provider might suspect pancreatic cancer if you have recently developed diabetes or pancreatitis, which is a painful condition due to inflammation in your pancreas^[2].

Symptoms of pancreatic neuroendocrine cancer may be different from traditional pancreatic cancer symptoms, such as jaundice or weight loss. Symptoms can vary, but may include diarrhea and anemia^[2].

Diagnosis

Pancreatic cancer is difficult to diagnose early^[4]. Because the pancreas is hidden behind other organs, health care providers cannot see or feel the tumors during routine exams^[9].

Doctors use a physical exam, blood tests, imaging tests, and a biopsy to diagnose it^[9]. Tests that examine the pancreas are used to diagnose and stage pancreatic cancer^[4].

Most people are diagnosed with pancreatic cancer after they become unwell and go to the emergency department. Others start by seeing their primary care doctor^[6].

Some people decide to get a second opinion. You have a right to seek a second opinion, and pancreatic cancer organizations strongly recommend seeking a second opinion, as needed, at any point in your diagnosis^[4].

Stages of Pancreatic Cancer

Stage means the size of the cancer and whether it has spread. Staging describes the size of the cancer, and how advanced the cancer is (whether it has spread)^[6].

Knowing the stage information helps doctors decide about treatment^[6]. Certain factors affect prognosis (chance of recovery) and treatment options^[4].

Typically, extrapancreatic disease precludes curative resection, and surgical treatment may be palliative at best^[15]. Only 20% of pancreatic cancer is surgically resectable at the time of diagnosis^[5].

Treatment Options

Your treatment depends on the position of the cancer in the pancreas, how big it is, the type of pancreatic cancer it is, whether it has spread, if they can remove it with surgery and your general health^[6].

There is consensus that surgery is the primary mode of treatment for pancreatic cancer^[15]. Surgical resection is the only current option for a cure^[5]. However, an important role exists for chemotherapy and radiation therapy in an adjuvant or neoadjuvant setting, and in the treatment of patients with unresectable disease^[15].

Because it is often found late and it spreads quickly, pancreatic cancer can be hard to treat. Possible treatments include surgery, radiation, chemotherapy, and targeted therapy (treatment that uses drugs or other substances that attack specific cancer cells with less harm to normal cells)^[9].

Curative resection options include pancreaticoduodenectomy (also known as the Whipple procedure), with or without sparing of the pylorus; total pancreatectomy; and distal pancreatectomy^[15]. The Whipple procedure is one of the most common procedures done for pancreatic cancer, specifically when located in the head or uncinate process of the pancreas^[10].

In qualified high-volume centers, pancreatic surgery (especially distal pancreatectomy, but including pancreaticoduodenectomy) can often be performed laparoscopically^[15].

Pancreatic cancer patients who participate in clinical research have better outcomes. Every treatment available today was approved through a clinical trial^[21].

Prognosis and Survival

Pancreatic cancer survival rates are low because the disease is difficult to detect in the early stages^[2]. The 5-year survival rate in the United States ranges from 5% to 15%. The overall survival rate is only 6%^[5].

Cases of pancreatic cancer are on the rise. Trends indicate that pancreatic cancer will be the second leading cause of cancer death in the United States by 2030^[2].

Close cooperation among various specialties, including surgeons, oncologists, radiation oncologists, pathologists, and radiologists, is extremely important for the chance of survival in patients with resectable disease and borderline resectable disease^[5].

For patients who have undergone surgical resection of the involved pancreas, published series from high-volume referral centers examining long-term survivors indicate that only 10% to 27% of patients with early-stage disease who underwent resection survived at least 5 years^[13].

There is a high frequency of subclinical metastases at initial presentation as well as a high frequency of undetectable extrapancreatic disease at the time of surgical resection, which also contributes to the poor long-term outcomes^[13].

Living with Pancreatic Cancer

Living with pancreatic cancer means different things to different people. Whether or not you have been diagnosed with pancreatic cancer, or care for someone who has the disease, it will have a large impact on your life^[18].

Managing the symptoms associated with pancreatic cancer, side effects of treatments and conditions that can occur because of the disease, can feel complicated and daunting^[18].

Get practical and emotional support to help you cope with a diagnosis of pancreatic cancer, and life during and after treatment^[6]. Support is critical to improve quality of life and overall well-being^[21].

A diagnosis of pancreatic cancer requires a patient to adapt to many life changes. The disease is accompanied by a wide range of new, and sometimes difficult, emotions, various physical symptoms, and numerous decisions regarding care^[19].

A strong support system, including family, friends, clergy, and a good medical team, will help a patient deal with these different aspects of pancreatic cancer^[19]. Patients may find comfort in writing in a journal, joining a formal support group, or seeking individual counseling^[19].

Getting organized can help patients and their loved ones take control and better understand their options. This includes keeping copies of your medical records and lab results, tracking your symptoms, side effects and questions, and finding out what support resources are available through your hospital^[21].

Maintaining health and staying active are crucial for improving quality of life and managing symptoms. Engaging in healthy habits can help boost energy levels, enhance mood, and support the body during treatment^[20].

Pancreatic carcinoma is a serious disease that develops in the pancreas, a small but vital organ tucked deep in the abdomen. This cancer often goes unnoticed in its early stages, making it one of the most challenging cancers to detect and treat. Understanding this disease, its risk factors, and how it affects the body can help patients and families navigate the difficult journey ahead.

Epidemiology

Pancreatic cancer represents a significant health challenge across the globe. It is responsible for approximately 3% of all cancers in the United States, ranking as the 10th most common cancer in men and the 8th most common cancer in women.^[2] More than 67,000 Americans are expected to be diagnosed with pancreatic cancer in 2025, which translates to more than 184 people receiving this diagnosis every single day.^[8]

The disease is currently the fourth leading cause of cancer deaths in the United States.^[1][5] Unfortunately, trends indicate that pancreatic cancer will become the second leading cause of cancer death in the United States by 2030, showing that cases are on the rise.^[2][14] This upward trend makes understanding and addressing this disease even more urgent.

Looking at global patterns, pancreatic cancer kills more than 331,000 people per year worldwide and ranks as the seventh principal cause of cancer death in both men and women.^[5] The estimated global 5-year survival rate for pancreatic cancer is about 5%, though in the United States this ranges from 5% to 15%, with an overall survival rate of only 6%.^[5][2] These low survival rates reflect the difficulty in detecting the disease early and its resistance to many treatments.

Geographically, incidence rates for pancreatic cancer are highest in Northern America, Western Europe, Europe, and Australia/New Zealand. The lowest incidence rates are found in Middle Africa and South-Central Asia.^[5] There are also some gender differences. For men, the greatest risk of developing pancreatic cancer is in Armenia, the Czech Republic, Slovakia, Hungary, Japan, and Lithuania, while the lowest risk is in Pakistan and Guinea. For women, the highest incidence rates are in Northern America, Western Europe, Northern Europe, and Australia/New Zealand, with the lowest rates in Middle Africa and Polynesia.^[5] Around 10,500 people are diagnosed with pancreatic cancer in the UK each year, making it the 10th most common cancer in that country.^[6]

Causes

The exact causes of pancreatic cancer are not fully understood. Changes in DNA cause cancer, and these changes can be inherited from parents or can develop over time.^[8] Most pancreatic cancer happens randomly or is caused by factors such as smoking, obesity, and age. About 10% of pancreatic cancers are considered familial or hereditary, meaning they run in families.^[8]

Pancreatic cancer is caused by certain changes to the way pancreatic cells function, especially how they grow and divide into new cells.^[4] When cells in the pancreas mutate (change) and multiply out of control, they form a growth called a tumor. The pancreas is a gland in your abdomen, between your spine and stomach, that makes hormones to control blood-sugar levels and enzymes that aid in digestion.^[2][14]

Most pancreatic cancers start in the ducts of the pancreas. Small changes in the cellular DNA result in uncontrolled multiplication and accumulation of cells in clusters called tumors. If untreated, these cancer cells can spread outside of the pancreas to other parts of the body.^[1] Over 90% of all pancreatic tumors are exocrine tumors, which start in cells that produce digestive juices. The most common type of pancreatic cancer is adenocarcinoma, which begins in the cells that line your organs.^[2][14] About 95% of pancreatic cancers begin in exocrine cells.^[4]

Less than 10% of pancreatic tumors are neuroendocrine tumors (NETs), also known as islet cell carcinoma. These tumors often grow slower than exocrine tumors.^[2][14] Around 8% of pancreatic tumors are neuroendocrine tumors.^[8]

Risk Factors

A risk factor is anything that increases the chance of getting a disease. Some risk factors for pancreatic cancer can be changed, like smoking, while others cannot be changed, such as genetics and family history.^[4] Having one or more risk factors does not mean you will definitely get pancreatic cancer. Many people with risk factors never develop the disease, while others with no known risk factors do.^[4]

Smoking is recognized as a strong risk factor for pancreatic cancer. About 20% of pancreatic cancers are caused by smoking cigarettes, cigars, and using other forms of tobacco.^[5][2] New research has found that the specific combination of smoking, diabetes, and poor diet increases the risk of pancreatic cancer the most beyond any one factor alone.^[1]

Age is another important factor. Most pancreatic cancer is diagnosed after age 65, and being older than 55 years is considered a risk factor.^[1][5] Having excess body weight, or obesity, also increases risk.^[4][5] Carrying extra weight that is unhealthy for your body may be a contributing factor to developing this disease.^[1]

Certain medical conditions raise the risk as well. Having a personal history of diabetes or chronic pancreatitis (long-term inflammation of the pancreas) increases the chance of developing pancreatic cancer.^[4][5] Cirrhosis of the liver and Helicobacter pylori infection are also risk factors.^[5] Additionally, work exposure to chemicals in the dry cleaning and metalworking industries has been linked to higher risk.^[5]

Family history plays a role too. Having a family history of pancreatic cancer or pancreatitis can increase risk.^[4] If you are a first-degree relative (such as a parent, sibling, or child) of someone diagnosed with pancreatic cancer, you may have an increased risk of developing the disease yourself.^[8] Ten percent of pancreatic cancers have a genetic cause, such as genetic mutations or association with syndromes like Lynch syndrome, Peutz-Jeghers syndrome, Von Hippel-Lindau syndrome, and MEN1 (multiple endocrine neoplasia type 1).^[5] Other hereditary conditions that increase risk include hereditary breast and ovarian cancer syndrome, familial atypical multiple mole melanoma (FAMMM) syndrome, and ataxia-telangiectasia.^[4]

There are also some gender and racial differences in risk. Males are at slightly higher risk than females, and African Americans are at higher risk than whites.^[5] Possible risk factors that are still being studied include heavy alcohol consumption, coffee consumption, physical inactivity, high red meat consumption, and drinking 2 or more soft drinks per day.^[5]

Symptoms

One of the major challenges with pancreatic cancer is that there are no tell-tale early signs. Unfortunately, there aren’t any early signs of pancreatic cancer, and the disease doesn’t cause symptoms right away.^[2][14] We don’t usually see the signs of pancreatic cancer until it’s in more advanced stages.^[1] Symptoms typically emerge once the tumor starts impacting other organs in the digestive system.^[2][14]

Some people develop vague symptoms up to one year before they receive a diagnosis.^[2][14] Many people report that their first pancreatic cancer symptoms were back pain or stomach pain. These symptoms can come and go at first, but may get worse after meals or when lying down.^[2][14]

As the cancer grows, symptoms may include jaundice (yellowing of the skin and whites of the eyes), which is one of the more noticeable signs.^[4][2] Along with jaundice, patients may notice light-colored stools and dark urine, which happen because of changes in how the body processes bile.^[4][2]

Pain is a common symptom. This includes pain in the upper or middle abdomen and back, which can be persistent and troubling.^[4][2] Digestive issues are also frequent. Patients may experience nausea and vomiting, gas or bloating, and a lack of appetite.^[2][14] Weight loss is another significant symptom, often happening without trying to lose weight.^[4][2]

Other symptoms can include fatigue, itchy skin, and blood clots.^[2][14] A healthcare provider might suspect pancreatic cancer if a patient has recently developed diabetes or pancreatitis, especially if these conditions appear suddenly and without clear cause.^[2][14]

It’s important to note that symptoms of pancreatic neuroendocrine cancer may be different from traditional pancreatic cancer symptoms. Instead of jaundice or weight loss, patients might experience diarrhea and anemia.^[2][14]

Because symptoms are often vague and can be confused with other, less serious conditions, pancreatic cancer is difficult to diagnose early. This is why many patients are diagnosed only after the cancer has already spread.^[4] If you experience any of these symptoms, especially if they persist or worsen, it’s important to see a healthcare provider for evaluation.

Prevention

While pancreatic cancer is not entirely preventable, there are steps people can take to reduce their risk. Technically, pancreatic cancer cannot be completely prevented because if you have a pancreas, there’s always a risk of developing pancreatic cancer.^[10] However, there are some modifiable risk factors that, when addressed, can lower the likelihood of developing the disease.

Smoking is one of the most important modifiable risk factors. Since about 20% of pancreatic cancers are caused by smoking, quitting smoking or never starting in the first place is one of the most effective ways to reduce risk.^[5] Those who smoke cigarettes, cigars, or use other forms of tobacco should seek help to quit.

Maintaining a healthy weight is another key prevention strategy. Obesity is associated with an increased risk of pancreatic cancer, so keeping body weight within a healthy range through balanced diet and regular physical activity can be protective.^[1][4] New research suggests that the combination of smoking, diabetes, and poor diet increases risk significantly, so eating a nutritious diet with plenty of fruits, vegetables, lean proteins, and whole grains is beneficial.^[1]

Managing chronic health conditions like diabetes and pancreatitis is also important. While these conditions themselves are risk factors, proper management and regular medical care can help reduce complications and possibly lower cancer risk.^[4] Reducing alcohol consumption, staying physically active, and limiting intake of red meat and sugary drinks may also help, though these factors are still being studied.^[5]

For individuals with a family history of pancreatic cancer or certain genetic syndromes, genetic testing and counseling may be recommended. Early screening and monitoring in high-risk individuals can sometimes help detect changes earlier, though routine screening for pancreatic cancer is not currently standard for the general population.^[4] Talking with a doctor about personal and family medical history is important for understanding individual risk and what steps might be appropriate.

Overall, living a healthier lifestyle—not smoking, maintaining a healthy weight, eating well, and staying active—can reduce risk. While these measures don’t guarantee prevention, they support overall health and may lower the chances of developing pancreatic cancer.^[10]

Pathophysiology

Understanding how pancreatic cancer changes the normal workings of the body can help patients and families grasp what is happening inside the body. The pancreas is a gland about 6 inches long that is shaped like a thin pear lying on its side. It has three areas: the head, body, and tail. The pancreas is found in the abdomen near the stomach, intestines, and other organs.^[4][11]

The pancreas has two main jobs in the body. First, it makes juices that help break down food into substances the body can use. These are digestive enzymes. Second, it makes hormones such as insulin and glucagon, which help control blood sugar levels and help the body use and store the energy it gets from food.^[4][11] The pancreas produces enzymes that aid in digestion and hormones that regulate blood sugar.^[8]

Pancreatic cancer occurs when cells in the pancreas mutate and multiply out of control, forming a tumor.^[2][14] Most pancreatic cancers start in the ducts of the pancreas. The main pancreatic duct connects the pancreas to the common bile duct.^[2][14] Pancreatic cancer can occur in exocrine pancreas cells, which produce digestive juices, or the endocrine pancreas cells, which produce hormones.^[4][11]

When cancer develops in the exocrine cells, which is the case in over 90% of pancreatic cancers, the tumor disrupts the production and release of digestive enzymes.^[2][14] This can lead to digestive problems, as the body struggles to break down food properly. Patients may experience bloating, gas, nausea, and changes in bowel movements as a result.

As the tumor grows, it can block the bile duct, which is a tube that carries bile from the liver to the small intestine. Bile is a fluid that helps digest fats. When the bile duct is blocked, bile backs up, causing jaundice. This is why the skin and whites of the eyes turn yellow, and urine becomes dark while stools become light-colored.^[4][2]

Pancreatic cancer can also affect the production of hormones, especially insulin. When insulin production is disrupted, blood sugar levels can become difficult to control. This is why some patients develop new-onset diabetes as an early sign of pancreatic cancer.^[2][14]

The tumor can press on nearby organs and nerves, causing pain in the abdomen and back. This pain can be persistent and may worsen over time as the cancer grows.^[4][2] The tumor may also interfere with the stomach, making it difficult for food to pass through, leading to feelings of fullness, lack of appetite, and weight loss.^[2][14]

Early-stage pancreatic tumors don’t show up on imaging tests, which makes the disease hard to detect early.^[2][14] For this reason, many people don’t receive a diagnosis until the cancer has spread (metastasis) to other parts of the body. Pancreatic cancer often spreads to the liver, abdominal wall, lungs, bones, and lymph nodes.^[8] Even when the cancer spreads to other areas of the body, it is still called pancreatic cancer if that is where it started.^[8]

Unfortunately, there is a high frequency of subclinical metastases (cancer spread that cannot be detected) at initial presentation. There is also a high frequency of undetectable extrapancreatic disease (cancer outside the pancreas) at the time of surgical resection, which contributes to poor long-term outcomes.^[13] Pancreatic cancer is also resistant to many common cancer drugs, making it notoriously difficult to treat.^[2][14]

Because of these factors—late detection, aggressive spread, and resistance to treatment—pancreatic cancer has a very low survival rate. Ongoing research focuses on early detection through genetic testing and new imaging methods, but there is still much to learn.^[2][14]

Pancreatic carcinoma is one of the most challenging cancers to treat, but ongoing advances in medicine offer a spectrum of options from proven standard therapies to experimental approaches being tested in clinical trials around the world.

How Treatment Approaches Help Patients Fight Pancreatic Carcinoma

When someone receives a diagnosis of pancreatic carcinoma, the primary goal of treatment is to remove the cancer if possible, slow its progression, manage symptoms, and maintain the best possible quality of life. The treatment plan depends heavily on where the cancer is located in the pancreas, how large the tumor has grown, whether it has spread to nearby blood vessels or distant organs, and the patient’s overall health and ability to tolerate different therapies.^[4]

Pancreatic cancer is particularly difficult because it often does not cause noticeable symptoms until it has reached an advanced stage. By the time many patients are diagnosed, the cancer may have already spread beyond the pancreas, making surgical removal impossible. This is why only about 20% of patients have cancer that can be surgically removed at the time of diagnosis.^[5]

The medical community recognizes standard treatments that have been proven effective through years of research and clinical experience. These are recommended by medical societies and used in hospitals worldwide. At the same time, researchers are actively testing new drugs and treatment combinations in clinical trials, which are carefully designed studies that evaluate whether experimental therapies are safe and effective. Clinical trials represent hope for better outcomes and give patients access to cutting-edge treatments before they become widely available.^[13]

Standard Treatment Options for Pancreatic Carcinoma

Standard treatment for pancreatic carcinoma varies depending on whether the cancer can be surgically removed. Surgery is the only treatment currently available that offers the possibility of cure. However, even when surgery is performed, many patients require additional treatments to reduce the risk of the cancer returning.^[10]

Surgery for Pancreatic Cancer

The type of surgery depends on where the tumor is located within the pancreas. The most common procedure is called pancreaticoduodenectomy, also known as the Whipple procedure. This is typically used when the cancer is in the head of the pancreas. During this operation, surgeons remove the head of the pancreas, part of the small intestine, the gallbladder, part of the bile duct, and sometimes a portion of the stomach. The remaining organs are then reconnected so that digestion can continue.^[10]

When cancer is located in the tail or body of the pancreas, a distal pancreatectomy may be performed. This surgery removes the tail and body of the pancreas, and often the spleen as well. In some cases, if cancer is widespread throughout the pancreas, a total pancreatectomy may be necessary, which removes the entire pancreas along with connected organs. After a total pancreatectomy, patients develop diabetes because their body no longer produces insulin, and they need to take pancreatic enzymes to help with digestion.^[15]

Surgical resection is a major operation that comes with risks such as bleeding, infection, and complications related to reconnecting the digestive organs. Recovery can take several weeks to months. At specialized, high-volume centers, surgeons have more experience performing these complex procedures, which has been shown to improve outcomes and reduce complications.^[15]

Chemotherapy in Standard Treatment

Chemotherapy uses drugs that kill rapidly dividing cancer cells or stop them from growing. In pancreatic cancer, chemotherapy plays a crucial role both after surgery and when surgery is not an option. After surgical removal of the tumor, chemotherapy is often given as adjuvant therapy to destroy any remaining cancer cells that might be too small to detect. This helps reduce the chance of the cancer coming back.^[13]

Common chemotherapy drugs used for pancreatic cancer include gemcitabine, which interferes with the cancer cell’s ability to replicate its DNA, and combinations such as FOLFIRINOX, which includes four different drugs: folinic acid, fluorouracil, irinotecan, and oxaliplatin. These combinations work through different mechanisms to attack cancer cells more effectively than single drugs alone.^[13]

Chemotherapy is typically given in cycles, with periods of treatment followed by rest periods to allow the body to recover. The duration of treatment varies depending on the stage of cancer and how well the patient tolerates the therapy. Treatment may continue for several months.^[11]

Side effects of chemotherapy can include fatigue, nausea and vomiting, loss of appetite, changes in taste, mouth sores, hair loss, and increased risk of infection due to low white blood cell counts. Some drugs, like oxaliplatin, can cause peripheral neuropathy, which is numbness or tingling in the hands and feet. These side effects usually improve after treatment ends, though some may persist longer.^[13]

Radiation Therapy

Radiation therapy uses high-energy beams to damage the DNA of cancer cells, causing them to die. In pancreatic cancer, radiation is sometimes used before surgery to shrink tumors or after surgery to kill any remaining cancer cells in the area. It can also be used to relieve pain and other symptoms when the cancer cannot be removed.^[11]

Radiation is often given five days a week for several weeks. Each treatment session lasts only a few minutes, though setup and positioning take longer. Radiation therapy is usually combined with chemotherapy, which can make the cancer cells more sensitive to radiation. This combination is called chemoradiation.^[15]

Common side effects of radiation therapy to the abdomen include fatigue, skin irritation in the treated area, nausea, diarrhea, and loss of appetite. These effects are usually temporary and gradually improve after treatment ends. The medical team can prescribe medications to help manage these side effects and maintain nutrition during treatment.^[13]

Treatment Being Tested in Clinical Trials

Clinical trials are research studies designed to test whether new treatments are safe and effective. They represent the pathway through which all new cancer treatments must pass before they can be approved for general use. For pancreatic cancer patients, clinical trials offer access to promising new therapies that are not yet available outside of research settings.^[13]

Understanding Clinical Trial Phases

Clinical trials proceed through distinct phases, each designed to answer specific questions. Phase I trials test a new drug in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects. These trials help researchers understand how the human body processes the drug and what dose can be given safely.^[13]

Phase II trials involve larger groups of patients and focus on whether the drug is effective against the cancer. Researchers closely monitor how tumors respond to the treatment and continue to evaluate safety. If a drug shows promise in Phase II, it moves forward to Phase III.^[13]

Phase III trials compare the new treatment to the current standard treatment to determine whether it is more effective, has fewer side effects, or offers other advantages. These trials involve hundreds or thousands of patients and are conducted at multiple hospitals and cancer centers. Successful Phase III trials can lead to approval by regulatory agencies, making the treatment available to all patients.^[13]

Immunotherapy Approaches

Immunotherapy is a type of treatment that helps the body’s own immune system recognize and attack cancer cells. The immune system normally protects us from infections and disease, but cancer cells can hide from immune detection. Immunotherapy drugs work by removing the brakes on the immune system or by teaching immune cells to recognize cancer.^[12]

One type of immunotherapy being tested for pancreatic cancer involves drugs called checkpoint inhibitors. These drugs block proteins that prevent immune cells from attacking cancer. Some patients with pancreatic cancer have genetic changes that make their tumors more likely to respond to checkpoint inhibitors. Researchers are studying whether these drugs can help patients whose tumors have specific genetic features.^[12]

Another approach involves cancer vaccines, which are designed to train the immune system to recognize specific proteins found on pancreatic cancer cells. Unlike vaccines that prevent disease, cancer vaccines are given after diagnosis to help the body fight existing cancer. Several cancer vaccines are being tested in clinical trials, with researchers measuring whether they can help prevent cancer from returning after surgery.^[12]

Targeted Therapy and Precision Medicine

Targeted therapy refers to drugs designed to attack specific molecules or pathways that cancer cells need to grow and survive. Unlike chemotherapy, which affects all rapidly dividing cells, targeted therapies are designed to be more selective, potentially causing fewer side effects on normal cells.^[12]

Researchers have identified several important molecular pathways in pancreatic cancer. One significant discovery involves mutations in a gene called KRAS, which is present in about 90% of pancreatic cancers. For many years, this mutation was considered impossible to target with drugs. However, recent breakthroughs have led to the development of drugs that can block the activity of specific KRAS mutations. These drugs are now being tested in clinical trials for pancreatic cancer patients whose tumors have these specific genetic changes.^[12]

Other targeted therapies focus on blocking growth factor receptors on cancer cells or interfering with the blood vessels that supply tumors with nutrients. Some drugs target the DNA repair mechanisms that cancer cells use to fix damage caused by chemotherapy or radiation. By blocking these repair processes, targeted drugs can make cancer cells more vulnerable to other treatments.^[12]

Innovative Drug Combinations

Clinical trials are testing new combinations of drugs that work through different mechanisms. The goal is to attack cancer cells in multiple ways simultaneously, making it harder for them to develop resistance. For example, researchers are combining chemotherapy with immunotherapy, or targeted therapy with checkpoint inhibitors, to see if these combinations produce better outcomes than single treatments.^[12]

Some trials are investigating whether adding drugs that modify the tumor environment can help other treatments work better. Pancreatic tumors are surrounded by dense tissue that can act as a barrier, preventing chemotherapy and immune cells from reaching the cancer. Drugs that break down this barrier or change the environment around the tumor are being tested to see if they can improve the effectiveness of other treatments.^[12]

Advanced Radiation Techniques

New radiation therapy techniques are being studied in clinical trials. Stereotactic body radiation therapy (SBRT) delivers very high doses of radiation with extreme precision in just a few treatment sessions rather than many weeks. This approach may be especially useful for tumors that are difficult to remove surgically. Clinical trials are evaluating whether SBRT combined with chemotherapy can provide better outcomes with fewer side effects than conventional radiation.^[15]

Who Can Participate in Clinical Trials

Clinical trials have specific requirements about who can participate, called eligibility criteria. These may include the stage and type of cancer, previous treatments received, overall health status, and specific genetic features of the tumor. Some trials are only open to patients who have not yet received treatment, while others are specifically for patients whose cancer has returned after initial therapy.^[13]

Clinical trials for pancreatic cancer are conducted at cancer centers and hospitals in many countries, including the United States, Europe, and other regions. Patients interested in clinical trials can discuss options with their oncology team or contact cancer organizations that maintain databases of available trials. Participation in clinical trials is voluntary, and patients can withdraw at any time.^[13]

Managing Symptoms and Supportive Care

An important aspect of treating pancreatic cancer involves managing symptoms and maintaining quality of life. This is called palliative care or supportive care, and it can be provided alongside treatments aimed at controlling the cancer. The goal is to prevent or relieve symptoms and side effects, address emotional and practical concerns, and help patients and families cope with the disease.^[11]

Pain is a common symptom in pancreatic cancer, particularly when the tumor presses on nerves or other organs. Pain management may involve medications ranging from over-the-counter pain relievers to stronger prescription drugs called opioids. In some cases, procedures that block pain signals from nerves can provide relief. The medical team works to find the right combination of approaches to keep patients comfortable.^[13]

Digestive problems are frequent because the pancreas plays a key role in digestion. When the pancreas is affected by cancer or removed by surgery, patients may not produce enough digestive enzymes. This can lead to difficulty absorbing nutrients, weight loss, and changes in bowel habits. Doctors can prescribe pancreatic enzyme supplements that patients take with meals to help digest food properly.^[13]

If the tumor blocks the bile duct, it can cause jaundice, where the skin and eyes become yellow. This can also cause itching and dark urine. Doctors can place a small tube called a stent in the bile duct to keep it open and allow bile to flow normally, which relieves these symptoms.^[11]

Nutritional support is critical because many pancreatic cancer patients struggle to maintain their weight and strength. Dietitians who specialize in cancer can recommend foods that are easier to digest, suggest eating small frequent meals rather than large ones, and identify nutritional supplements that can help. Good nutrition supports the body’s ability to tolerate treatment and recover from side effects.^[13]

Most Common Treatment Methods

• Surgery
  • Pancreaticoduodenectomy (Whipple procedure) removes the head of the pancreas, part of the small intestine, gallbladder, part of the bile duct, and sometimes part of the stomach
  • Distal pancreatectomy removes the tail and body of the pancreas, often along with the spleen
  • Total pancreatectomy removes the entire pancreas along with connected organs
  • Surgery is the only treatment that offers possibility of cure for pancreatic cancer
  • Only about 20% of patients have surgically removable cancer at diagnosis
• Chemotherapy
  • Gemcitabine interferes with cancer cell DNA replication
  • FOLFIRINOX combines folinic acid, fluorouracil, irinotecan, and oxaliplatin
  • Given in cycles with rest periods to allow body recovery
  • Used as adjuvant therapy after surgery to destroy remaining cancer cells
  • Used as neoadjuvant therapy before surgery to shrink tumors
  • Common side effects include fatigue, nausea, hair loss, and increased infection risk
• Radiation Therapy
  • Uses high-energy beams to damage cancer cell DNA
  • Often combined with chemotherapy as chemoradiation
  • Given five days a week for several weeks
  • Used before surgery to shrink tumors or after surgery to kill remaining cells
  • Can relieve pain and symptoms when cancer cannot be removed
  • Stereotactic body radiation therapy (SBRT) delivers high doses with precision in fewer sessions
• Immunotherapy (in clinical trials)
  • Checkpoint inhibitors block proteins that prevent immune cells from attacking cancer
  • Cancer vaccines train the immune system to recognize specific proteins on cancer cells
  • More likely to work in tumors with specific genetic features
  • Being tested in combination with chemotherapy and targeted therapy
• Targeted Therapy (in clinical trials)
  • Drugs that block specific KRAS mutations found in about 90% of pancreatic cancers
  • Agents that block growth factor receptors on cancer cells
  • Drugs that interfere with blood vessels supplying tumors
  • Treatments targeting DNA repair mechanisms to make cancer cells more vulnerable
  • More selective than chemotherapy, potentially causing fewer side effects
• Palliative and Supportive Care
  • Pain management using medications and nerve block procedures
  • Pancreatic enzyme supplements to help with digestion
  • Stent placement to relieve bile duct blockage and jaundice
  • Nutritional support and dietary counseling
  • Emotional and psychological support services

Diagnosing pancreatic cancer early remains one of the greatest challenges in medicine, as the disease often shows no symptoms until it has progressed significantly. Understanding who should seek testing, which methods doctors use to identify the cancer, and how clinical trials establish qualification criteria can help patients and their families navigate this difficult journey.

Introduction: Who Should Undergo Diagnostics

Pancreatic cancer is notoriously difficult to detect in its early stages. Most people do not experience noticeable symptoms until the disease has already spread to other parts of the body. This means that by the time many patients feel unwell enough to see a doctor, the cancer is often at an advanced stage. In fact, around 80% of people diagnosed with pancreatic cancer present with disease that has already spread beyond the pancreas or grown into surrounding tissues.^[13]

Anyone experiencing persistent symptoms should seek medical attention promptly. Common warning signs include yellowing of the skin and eyes, a condition known as jaundice, which occurs when a tumor blocks the bile duct. Other symptoms include ongoing pain in the upper abdomen or middle back, unexplained weight loss, extreme tiredness, changes in stool color (particularly light-colored stools), dark urine, loss of appetite, nausea, and digestive problems.^[1][2][4]

Healthcare providers might suspect pancreatic cancer if someone develops new-onset diabetes, particularly if it appears suddenly in an older adult without obvious risk factors. Similarly, a painful condition called pancreatitis—inflammation of the pancreas—may prompt doctors to investigate further, especially if it occurs without a clear cause like gallstones or alcohol use.^[2]

Certain individuals face higher risks and should be particularly attentive to symptoms. People who smoke, those over 55 years old, individuals with long-standing diabetes, those with chronic pancreatitis, and people with a family history of pancreatic cancer should discuss screening options with their doctors. Additionally, those with certain inherited conditions, such as hereditary breast and ovarian cancer syndrome, Lynch syndrome, Peutz-Jeghers syndrome, or familial atypical multiple mole melanoma syndrome, have increased risk and may benefit from earlier or more frequent monitoring.^[4][5]

Diagnostic Methods

Diagnosing pancreatic cancer involves multiple steps and various types of tests. Because the pancreas sits deep in the abdomen, tucked behind the stomach and in front of the spine, doctors cannot see or feel tumors during routine physical examinations. This hidden location makes imaging and laboratory tests essential for detection.^[2][11]

Physical Examination and Medical History

The diagnostic process typically begins with a thorough physical examination and discussion of medical history. Your doctor will ask about symptoms, how long they have been present, family history of cancer, smoking habits, and other risk factors. During the physical exam, the doctor may feel the abdomen for lumps or fluid buildup and check for jaundice by examining the skin and eyes.^[10]

Blood Tests

Blood tests play an important role in diagnosis, though no single blood test can definitively confirm pancreatic cancer. Doctors often check liver function tests, which may show abnormal results if a tumor is blocking bile ducts. A test called CA 19-9 measures a protein that can be elevated in people with pancreatic cancer. However, this marker is not perfect—some people with pancreatic cancer have normal CA 19-9 levels, and the protein can also be elevated in other conditions. Therefore, CA 19-9 is most useful for monitoring treatment response rather than initial diagnosis.^[10]

Additional blood tests may check for elevated levels of enzymes called amylase and glucagon, or assess blood sugar levels, since pancreatic cancer can affect insulin production and lead to diabetes.^[10]

Imaging Tests

Imaging tests are crucial for visualizing the pancreas and detecting tumors. Several different imaging techniques are commonly used in pancreatic cancer diagnosis.

Computed Tomography (CT) scans are among the most important imaging tools. These scans use X-rays taken from multiple angles to create detailed, three-dimensional images of the pancreas and surrounding organs. CT scans help doctors determine the size and location of a tumor, whether it has spread to nearby blood vessels or other organs, and whether it might be removable through surgery. A special type called a pancreatic protocol CT scan is specifically designed to evaluate pancreatic abnormalities.^[10]

Magnetic Resonance Imaging (MRI) uses magnets and radio waves instead of radiation to create detailed pictures of soft tissues. MRI is particularly useful for examining the pancreas and can sometimes detect small tumors that CT scans miss. A specialized MRI technique called magnetic resonance cholangiopancreatography (MRCP) can show the bile ducts and pancreatic ducts in detail without requiring invasive procedures.^[10]

Ultrasound uses sound waves to create images of internal organs. Traditional abdominal ultrasound can sometimes detect pancreatic tumors, but the pancreas’s deep location often makes visualization difficult. However, a more advanced technique called endoscopic ultrasound (EUS) provides much clearer images. During EUS, a thin, flexible tube with an ultrasound probe on the end is passed down the throat, through the stomach, and into the small intestine, bringing the probe very close to the pancreas. This allows for highly detailed imaging and also enables doctors to take tissue samples through needle biopsy during the same procedure.^[10]

Positron Emission Tomography (PET) scans involve injecting a small amount of radioactive sugar into the bloodstream. Cancer cells, which consume more sugar than normal cells, show up as bright spots on the scan. PET scans are particularly useful for determining if cancer has spread to other parts of the body.^[10]

Endoscopic Procedures

Endoscopic techniques allow doctors to look inside the digestive system and obtain tissue samples. Endoscopic Retrograde Cholangiopancreatography (ERCP) combines endoscopy with X-ray imaging. A flexible tube is passed through the mouth, down through the stomach, and into the small intestine. A smaller tube is then threaded through the endoscope into the bile and pancreatic ducts. Dye is injected to make these ducts visible on X-rays, helping identify blockages or abnormalities. ERCP can also be used to place stents—small tubes that help keep blocked ducts open.^[10]

Biopsy

A biopsy—removing a small piece of tissue for examination under a microscope—is the only way to definitively confirm pancreatic cancer. Several biopsy techniques are available. Fine needle aspiration, often performed during endoscopic ultrasound, uses a thin needle to extract cells from the suspicious area. Alternatively, biopsies can be performed through the skin using imaging guidance, a technique called percutaneous biopsy. In some cases, tissue samples are obtained during surgical exploration.^[10]

The tissue sample is examined by a specialist called a pathologist, who determines whether cancer cells are present, what type of pancreatic cancer it is, and how aggressive the cells appear. This information, called histologic findings, is essential for treatment planning.^[10]

Staging

Once pancreatic cancer is confirmed, doctors determine its stage—how far the disease has spread. Staging combines information from imaging tests, biopsies, and sometimes surgical exploration. Pancreatic cancer is typically classified as resectable (can be removed by surgery), borderline resectable (might be removable with treatment first), locally advanced (has grown into nearby structures but not spread distantly), or metastatic (has spread to distant organs). Understanding the stage is critical because it guides treatment decisions.^[10][15]

Genetic Testing and Molecular Analysis

Increasingly, doctors recommend genetic testing for patients diagnosed with pancreatic cancer. This involves analyzing the tumor tissue and sometimes the patient’s blood to look for specific genetic mutations. About 10% of pancreatic cancers are linked to inherited genetic changes. Identifying these mutations is important not only for the patient’s treatment options but also because family members might benefit from genetic counseling and increased surveillance. Certain genetic mutations, such as BRCA genes, may make patients eligible for specific targeted therapies.^[10]

Diagnostics for Clinical Trial Qualification

Clinical trials test new treatments and approaches to improve outcomes for pancreatic cancer patients. Patients who participate in clinical trials often have better outcomes than those who receive only standard treatments. Every treatment available today was approved through clinical trials, making participation an important consideration at diagnosis and throughout treatment.^[8]

To enroll in a clinical trial, patients must meet specific qualification criteria, often called eligibility criteria. These requirements ensure that the study tests the treatment in the appropriate patient population and that participants are likely to tolerate the experimental therapy safely. Diagnostic tests play a central role in determining eligibility.^[10]

Standard Diagnostic Requirements

Most pancreatic cancer clinical trials require confirmation of the diagnosis through biopsy and pathology review. The tumor type must be verified—most trials focus on the most common type, called pancreatic ductal adenocarcinoma, which accounts for about 95% of pancreatic cancers. Trials studying rarer types, such as neuroendocrine tumors, have separate enrollment criteria.^[4][11]

Staging information is crucial for trial eligibility. Some trials enroll only patients with resectable disease, others focus on locally advanced or metastatic cancer, and still others include patients across multiple stages. Detailed imaging—typically including CT scans and sometimes MRI or PET scans—is required to accurately determine disease extent and ensure patients meet the trial’s staging criteria.^[10]

Performance Status Assessment

Clinical trials assess patients’ overall health and ability to perform daily activities, measured through something called performance status. Doctors use standardized scales to rate how well patients function. This assessment helps ensure that patients can safely tolerate the experimental treatment. Patients who are very weak or unable to care for themselves may not qualify for trials testing aggressive therapies, though trials specifically designed for patients with lower performance status do exist.^[15]

Laboratory Test Requirements

Blood tests are standard requirements for clinical trial enrollment. Trials typically require adequate organ function, verified through laboratory measurements. Blood cell counts must meet minimum thresholds to ensure patients can tolerate chemotherapy or other treatments. Kidney and liver function tests must fall within acceptable ranges. These laboratory requirements protect patient safety by excluding individuals whose organs might not handle the experimental treatment well.^[10]

Biomarker and Genetic Testing

Many modern clinical trials require specific biomarker or genetic testing before enrollment. Biomarkers are measurable substances in the body that indicate disease characteristics. For pancreatic cancer, tumor tissue may be tested for genetic mutations, protein expression patterns, or other molecular features. Some trials enroll only patients whose tumors have specific genetic changes, while others may exclude patients with certain mutations.^[10]

For example, trials testing drugs called PARP inhibitors typically require testing for BRCA mutations. Tumors may also be tested for changes in genes like KRAS, which is mutated in most pancreatic cancers, or for a characteristic called microsatellite instability. These molecular tests help match patients to treatments most likely to benefit them.^[10]

Imaging for Trial Monitoring

Beyond initial qualification, clinical trials use diagnostic imaging throughout treatment to monitor how tumors respond to therapy. Standardized measurement techniques, often following guidelines called RECIST criteria, track changes in tumor size. Regular CT or MRI scans at predetermined intervals document whether tumors are shrinking, staying stable, or growing. These imaging studies generate the data that ultimately determines whether new treatments work.^[10]

Quality of Life Assessments

Many clinical trials incorporate standardized questionnaires and assessments to measure how treatments affect patients’ daily lives, symptoms, and emotional well-being. While not diagnostic tests in the traditional sense, these quality-of-life assessments are important qualification and monitoring tools in modern trials, recognizing that effective cancer treatment must consider the whole person, not just tumor response.^[10]

Pancreatic carcinoma is a challenging disease with profound effects on patients and their families. Understanding what to expect during the journey—from prognosis and natural progression to daily life adjustments and family support—can help patients and loved ones navigate this difficult time with greater confidence and clarity.

Prognosis

Receiving a diagnosis of pancreatic carcinoma is deeply emotional and often overwhelming. The prognosis for this disease remains challenging, and it is important to approach this topic with honesty and compassion. Pancreatic cancer is the fourth leading cause of cancer deaths in the United States, and unfortunately, survival rates have remained relatively low compared to many other cancers.^[1][5]

The five-year survival rate for pancreatic cancer in the United States ranges between five and fifteen percent, with the overall survival rate hovering around six percent.^[5] This sobering statistic reflects the difficulty in detecting the disease early and the aggressive nature of pancreatic tumors. In fact, around eighty percent of patients are diagnosed when the cancer has already spread beyond the pancreas or reached a locally advanced stage, which makes curative treatment very difficult.^[13]

Surgical removal of the tumor is currently the only treatment option that offers a chance of cure. However, only about twenty percent of patients present with disease that can be surgically removed at the time of diagnosis.^[5] Even among patients who undergo successful surgery at specialized medical centers, only ten to twenty-seven percent survive for at least five years.^[13]

The outlook varies depending on several factors, including the stage of the cancer at diagnosis, whether the tumor can be completely removed with surgery, the patient’s overall health, and how well the cancer responds to treatment. Patients treated at high-volume centers with experienced pancreatic cancer specialists tend to have better outcomes compared to those treated elsewhere.^[7]

Natural Progression

Understanding how pancreatic cancer develops and progresses when left untreated helps patients and families grasp the urgency of timely diagnosis and treatment. Pancreatic cancer typically begins in the ducts of the pancreas—small tubes that carry digestive juices from the pancreas to the intestines. Small changes in the DNA of these duct cells cause them to multiply uncontrollably, forming clusters known as tumors.^[1]

In the early stages, pancreatic tumors are usually small and confined to the pancreas itself. Unfortunately, early-stage pancreatic tumors rarely cause noticeable symptoms and do not show up on standard imaging tests. This silent nature means many people do not know they have the disease until it has grown larger or spread.^[2]

As the tumor grows, it can invade nearby structures such as blood vessels, the bile duct, the stomach, or the intestines. This local spread causes many of the symptoms that eventually bring patients to medical attention, including jaundice (yellowing of the skin and eyes), abdominal or back pain, and digestive problems. The tumor can also block the bile duct, leading to a buildup of bile and causing jaundice, dark urine, and light-colored stools.^[2][4]

If untreated, pancreatic cancer cells can break away from the original tumor and spread to other parts of the body through the bloodstream or lymphatic system. This process, called metastasis, most commonly affects the liver, lungs, abdominal wall, bones, and lymph nodes.^[8] Once the cancer has metastasized, it becomes much harder to control and treat effectively.

Even when a tumor appears to be confined to the pancreas and is removed surgically, there is a high risk of the cancer returning. Studies show that a significant number of patients experience recurrence after surgery, either in the pancreas itself or in distant organs, because microscopic cancer cells may have already spread before the tumor was removed.^[13] This underscores the aggressive nature of pancreatic cancer and the importance of close monitoring and follow-up care after treatment.

Possible Complications

Pancreatic cancer and its treatments can lead to a variety of complications that affect the patient’s health and quality of life. These complications may arise from the cancer itself, from the spread of the disease, or as side effects of treatment. Being aware of potential complications helps patients and caregivers prepare and respond appropriately.

One of the most common complications is digestive difficulty. The pancreas produces enzymes that help break down food, and when the pancreas is affected by cancer or removed during surgery, the body may struggle to digest food properly. This can lead to symptoms such as bloating, gas, diarrhea, and poor absorption of nutrients, which in turn can cause weight loss and malnutrition.^[2]

Jaundice is another frequent complication. When a tumor blocks the bile duct, bile builds up in the body, causing the skin and eyes to turn yellow. This can also lead to severe itching, dark urine, and pale stools. Jaundice may require medical procedures to relieve the blockage and restore bile flow.^[2][4]

Pain is a significant issue for many patients with pancreatic cancer. Tumors can press on nerves or invade nearby tissues, causing persistent pain in the abdomen or back. This pain can be difficult to manage and may require a combination of medications, nerve blocks, or other interventions to keep it under control.^[13]

Pancreatic cancer can also lead to new-onset diabetes or worsen existing diabetes. The pancreas produces insulin, which regulates blood sugar levels. When the pancreas is damaged by cancer, insulin production may be disrupted, leading to high blood sugar levels and the need for diabetes management.^[2][4]

Blood clots are another potential complication. Pancreatic cancer can increase the risk of clots forming in the veins, particularly in the legs (a condition called deep vein thrombosis) or in the lungs (pulmonary embolism). These clots can be dangerous and require prompt medical attention.^[2]

Patients undergoing chemotherapy, radiation therapy, or surgery may experience additional side effects such as fatigue, nausea, vomiting, hair loss, infections, and slow wound healing. These treatment-related complications vary depending on the type and intensity of treatment and require careful management by the healthcare team.^[4][11]

Impact on Daily Life

Living with pancreatic cancer affects nearly every aspect of daily life. The physical symptoms of the disease, combined with the emotional toll of the diagnosis and the demands of treatment, can be overwhelming. Understanding these impacts helps patients and their families develop strategies to cope and maintain the best possible quality of life.

Physically, many patients experience fatigue that goes beyond ordinary tiredness. This cancer-related fatigue can make even simple tasks like getting dressed, cooking, or walking short distances feel exhausting. Rest does not always relieve this fatigue, and it can persist throughout treatment and recovery.^[2][20]

Digestive symptoms such as nausea, loss of appetite, bloating, and changes in bowel habits can make eating difficult and unpleasant. Many patients lose weight and struggle to maintain adequate nutrition, which can further weaken the body and affect overall well-being. Small, frequent meals and working with a dietitian can help manage these challenges.^[20]

Pain, whether from the tumor itself or from treatment, can interfere with sleep, mobility, and the ability to engage in daily activities. Effective pain management is crucial, and patients should work closely with their healthcare team to find the right combination of medications and other pain relief strategies.^[19]

Emotionally, a pancreatic cancer diagnosis brings a rollercoaster of feelings. Patients may experience shock, fear, anger, sadness, and anxiety. These emotions are natural responses to a serious illness. Some patients also feel isolated or overwhelmed by the uncertainty of the future. Talking openly with loved ones, joining support groups, or seeking counseling can provide comfort and help patients process their emotions.^[19][24]

Socially, the disease and its treatment can limit the ability to work, participate in hobbies, and spend time with friends and family. Frequent medical appointments, hospital stays, and the need for rest can disrupt normal routines. Many patients find it helpful to lean on their support network for practical help with tasks like transportation, meal preparation, and household chores.^[17][24]

Maintaining a sense of normalcy and control is important. Patients who stay as active as possible—within their physical limits—often report better mood and energy levels. Gentle exercise such as walking, stretching, or yoga can be beneficial. Engaging in activities that bring joy and meaning, even if they need to be adapted, helps maintain emotional well-being.^[20]

Support for Family

Family members and loved ones play a vital role in supporting patients with pancreatic cancer. They often take on the role of caregivers, advocates, and sources of emotional comfort. However, supporting a loved one through this journey can also be physically and emotionally demanding for families. Understanding how to provide effective support while caring for themselves is essential.

One of the most important ways families can help is by learning about pancreatic cancer and the available treatment options, including clinical trials. Knowledge empowers families to ask informed questions, participate in treatment decisions, and understand what to expect at each stage of the disease. Many organizations and cancer centers offer educational resources specifically designed for patients and families.^[21]

Clinical trials are research studies that test new treatments or combinations of treatments. Patients who participate in clinical trials often have access to innovative therapies that are not yet widely available. Every treatment option available today was once tested in a clinical trial, and participating in such research can contribute to better outcomes. Families can support patients by helping them explore clinical trial options, discussing the potential benefits and risks, and working with the medical team to determine if a trial is a good fit.^[21]

Practical support is equally important. Families can assist with daily tasks such as meal preparation, housework, transportation to medical appointments, and managing medications. Keeping a calendar or checklist of appointments, treatment schedules, and symptoms can help organize care and ensure nothing is overlooked. Some families find it helpful to designate one person as the primary point of contact with the healthcare team to streamline communication.^[17][21]

Emotional support is perhaps the most valuable gift families can offer. Simply being present, listening without judgment, and providing reassurance can make a significant difference. Patients often appreciate honesty and open communication, even when conversations are difficult. Family members should also be mindful of their own emotional needs and seek support from friends, counselors, or support groups when needed.^[17][24]

Caregiving can be overwhelming, and it is important for family members to take care of their own health. Taking breaks, asking for help from others, and engaging in self-care activities can prevent burnout and allow caregivers to provide better support over the long term. Many caregivers find comfort and practical advice through caregiver support groups or by connecting with other families facing similar challenges.^[17][24]

Families should also help patients navigate the healthcare system, including understanding insurance coverage, financial assistance programs, and accessing second opinions. Advocating for the patient’s needs and preferences ensures they receive the best possible care. Involving the entire family in decision-making, when appropriate, helps everyone feel included and supportive.^[21]

Finally, families should be prepared for the possibility of advanced or end-of-life care discussions. While these conversations are difficult, having them early allows patients and families to express wishes, make plans, and ensure that care aligns with the patient’s values and goals. Palliative care teams can provide guidance and support during this time, focusing on comfort and quality of life.^[18]

Metastatic pancreatic cancer represents the most advanced stage of a disease that has already spread beyond the pancreas to distant parts of the body. Understanding this condition, its mechanisms, and available support can help patients and families navigate one of the most challenging diagnoses in oncology.

Understanding Metastatic Pancreatic Cancer

Metastatic pancreatic cancer, also known as stage IV pancreatic cancer, occurs when cancer cells that originated in the pancreas have traveled to other organs or tissues far from where the disease began.^[1] The pancreas is a gland located behind the stomach that produces digestive enzymes and hormones like insulin to regulate blood sugar.^[2] When cancer develops and spreads from this organ, it most commonly reaches the liver, but can also affect the lungs, abdominal wall, bones, or distant lymph nodes.^[3]

This form of cancer is considered unresectable, meaning it cannot be completely removed through surgery.^[3] The cancer has either spread too far or involves critical blood vessels in ways that make surgical removal impossible. Despite being called “metastatic” or “advanced,” this does not mean death is immediate. Many patients live for months or even years with appropriate treatment and symptom management.^[3]

Metastatic pancreatic ductal adenocarcinoma, often abbreviated as mPDAC, accounts for more than 90% of pancreatic cancer cases.^[6] This is a particularly aggressive form that typically advances to metastatic stage either because of late diagnosis or limited response to initial treatments. The disease earns its reputation as lethal partly because the pancreas is surrounded by other organs including the small intestine, liver, and spleen, making early changes difficult to detect.^[6]

Epidemiology: Who Gets Metastatic Pancreatic Cancer

Pancreatic cancer ranks as the seventh leading cause of cancer-related deaths worldwide.^[1] Experts predict it will become the second leading cause of cancer death in Western countries within the next decades.^[1] In 2020, an estimated 57,600 new cases were diagnosed in the United States alone.^[1]

The five-year survival rate across all stages of pancreatic cancer combined stands at just 9%, making it the cancer type with the lowest survival rate.^[1] For metastatic pancreatic cancer specifically, the five-year overall survival is even more devastating at approximately 2%.^[1] The median survival expectancy with current treatments remains less than one year.^[1]

Most cases of pancreatic cancer are diagnosed at an advanced stage, with the majority of patients already having metastatic or locally advanced disease by the time they seek medical care.^[3] This late diagnosis pattern significantly contributes to poor outcomes. Pancreatic cancer rarely occurs before age 40, and more than half of all pancreatic adenocarcinoma cases occur in people over 70 years old.^[5]

Cases of pancreatic cancer are rising. Current trends indicate that both new diagnoses and deaths from pancreatic cancer will more than double by 2030.^[12] Globally, an estimated 460,000 people are diagnosed each year, with approximately 430,000 deaths worldwide attributed to the disease.^[12]

Causes and Risk Factors

Pancreatic cancer develops when certain changes occur in the way pancreatic cells function, particularly how they grow and divide into new cells.^[2] These cancerous cells have the ability to invade other parts of the body, leading to metastatic disease.^[5] The disease is hyperaggressive and evolves from non-invasive precursor lesions, which explains why only minor symptoms may appear initially.^[1]

Several risk factors increase the chance of developing pancreatic cancer, though having these risk factors does not guarantee someone will get the disease. Many people with risk factors never develop pancreatic cancer, while others with no known risk factors do.^[2]

Tobacco smoking is one of the most significant modifiable risk factors. About 25% of pancreatic cancer cases are linked to smoking.^[5] The risk applies to cigarettes, cigars, and other forms of tobacco use.^[7] Other changeable risk factors include having excess body weight, which can contribute to disease development.^[2]

Health conditions also play a role in risk. Having a personal history of diabetes or chronic pancreatitis increases the likelihood of developing pancreatic cancer.^[2] New research has discovered that the specific combination of smoking, diabetes, and poor diet increases the risk of pancreatic cancer beyond any single factor alone.^[4] Some healthcare providers may suspect pancreatic cancer if a patient has recently developed diabetes or pancreatitis, which is a painful condition caused by inflammation in the pancreas.^[7]

Genetic factors cannot be changed but are important to understand. Having a family history of pancreatic cancer or pancreatitis increases risk.^[2] Certain hereditary conditions significantly raise the chances of developing the disease. These include hereditary nonpolyposis colon cancer (also called Lynch syndrome), Peutz-Jeghers syndrome, hereditary breast and ovarian cancer syndrome, familial atypical multiple mole melanoma (FAMMM) syndrome, and ataxia-telangiectasia.^[2]

Symptoms of Metastatic Pancreatic Cancer

One of the greatest challenges with pancreatic cancer is that it typically causes no symptoms in its early stages, making detection extremely difficult.^[2] Symptoms that are specific enough to suggest pancreatic cancer usually do not develop until the disease has reached an advanced stage.^[5] By the time symptoms appear and diagnosis occurs, the cancer has often already spread to other parts of the body.^[5]

The most common symptom is feeling tired and generally unwell.^[18] As the disease progresses, people may notice upper abdominal pain that can spread to the back.^[6] This pain can come and go at first but may worsen after eating meals or when lying down.^[7]

Jaundice, which is yellowing of the skin and the whites of the eyes, is a notable symptom.^[2] This occurs when the cancer blocks the bile duct, preventing bile from flowing properly. Along with jaundice, patients may experience itchy skin, light-colored stools, and dark-colored urine.^[2]

Unexplained weight loss is common, often accompanied by loss of appetite.^[2] Many patients report they simply do not feel like eating, which could be due to the cancer itself or treatments being received.^[18] Nausea and vomiting may also occur, along with changes in bowel movements.^[2]

Additional symptoms specific to advanced pancreatic cancer include fatigue, bloating, and gas.^[7] Some people develop blood clots, which can be an unusual sign of the disease.^[6] A person with advanced pancreatic cancer may also experience ascites, which is a buildup of fluid in the abdomen.^[3]

It is important to note that many of these symptoms are vague and unexplained, meaning they could be caused by many other conditions.^[3] However, if you are experiencing one or more of these symptoms, you should speak to your doctor immediately and specifically reference pancreatic cancer as a possibility.^[3]

Prevention and Early Detection Challenges

Learning about risk factors for pancreatic cancer can help people make changes that might lower their risk of getting the disease.^[2] Some risk factors, like smoking, can be changed. Quitting tobacco use, maintaining a healthy body weight through diet and physical activity, and managing conditions like diabetes may help reduce risk.^[2]

Unfortunately, pancreatic cancer is notoriously difficult to diagnose early.^[2] Early-stage pancreatic tumors do not show up well on standard imaging tests.^[7] There is currently no widely used method for early detection of the disease, and few patients diagnosed with pancreatic cancer have identifiable risk factors.^[12]

The disease often develops without early symptoms, and the pancreas is located deep in the body where physical examination cannot detect problems.^[12] By the time symptoms develop that prompt someone to see a doctor, the cancer has frequently already reached an advanced or metastatic stage. This timing makes prevention and early detection one of the most challenging aspects of pancreatic cancer care.

How Metastatic Pancreatic Cancer Develops: Understanding Pathophysiology

The vast majority of pancreatic cancers, about 95%, begin in exocrine cells, which are the cells that produce digestive juices.^[2] Pancreatic adenocarcinoma, which accounts for about 90% of cases, starts within the part of the pancreas that makes these digestive enzymes.^[5] Most pancreatic cancers begin in the ducts of the pancreas, specifically in the cells that line these passageways.^[7]

At the cellular level, pancreatic cancer arises when cells in the pancreas mutate, meaning their genetic material changes, causing them to multiply out of control and form a mass or tumor.^[7] These cancerous cells develop the dangerous ability to invade other parts of the body, which is what defines metastatic spread.^[5]

The process of metastasis involves cancer cells breaking away from the original tumor in the pancreas and traveling through the bloodstream or lymphatic system to other organs.^[1] The liver is the most common site for pancreatic cancer to spread because of the blood flow patterns between the pancreas and liver. However, cancer cells can also reach the lungs, establish themselves within the abdominal cavity, spread to faraway lymph nodes, or rarely reach the bones.^[3]

Even when pancreatic cancer spreads to another area of the body, it is still called pancreatic cancer because that is where it originated.^[3] For instance, pancreatic cancer that has spread to the liver is not liver cancer, but metastatic pancreatic cancer in the liver. This distinction is important because the treatment approach is based on the original cancer type, not where it has spread.

Several biological mechanisms drive the metastatic process in pancreatic cancer. Research has identified signaling pathways, such as epithelial-mesenchymal transition, NF-κB, and KRAS mutations, that play roles in how pancreatic cancer cells gain the ability to spread.^[1] Understanding these molecular mechanisms presents formidable challenges but also offers insight into promising therapeutic targets for the future.

Diagnosis and Staging

Imaging studies are the only way to visualize a pancreatic tumor.^[3] Doctors commonly use a computed tomography scan, also called a CT scan, to see if cancer has spread to nearby organs.^[3] Other tests such as magnetic resonance imaging (MRI), positron emission tomography (PET), and endoscopic retrograde cholangiopancreatography (ERCP) may be used, though these are less common than CT scans.^[3]

Before moving forward with treatment, it is critical to understand as much about each person’s cancer as possible.^[17] This means capturing the full picture from the time of diagnosis and beyond. In most instances, a CT scan or MRI scan identifies the location of the cancer and possible spread, but standard scans are just one piece of the puzzle.^[17]

PET scans and additional molecular testing play important roles in accurately staging the cancer and assessing its behavior.^[17] They can help determine if treatment is working effectively to shrink the tumor, whereas traditional CT scans have distinct limitations in assessing response in pancreatic primary tumors. If healthcare teams see the response they are anticipating on a PET scan, those are the patients that tend to do very well. If they are not seeing a response, they may need to switch therapies to achieve better outcomes.^[17]

Novel genetic testing developed at specialized centers can test the blood of patients, as well as fluid from the abdomen through a procedure called laparoscopy, to detect cancer DNA.^[17] This method helps experts determine who might be at risk for pancreatic cancer recurrence and individualize treatment to reduce the risk of the cancer returning.

Pancreatic cancer is categorized into five different stages depending on the size and location of the tumor and whether the cancer has spread.^[6] Stage IV, also known as metastatic cancer, means the cancer has spread to distant areas in the body such as the liver, lungs, or abdominal cavity.^[6] At this stage, the cancer is defined as advanced and is considered unresectable.^[3]

Metastatic pancreatic carcinoma represents the most advanced stage of pancreatic cancer, where the disease has spread beyond the pancreas to other parts of the body. This stage is associated with significant challenges in treatment and a difficult outlook, yet understanding what to expect and the support available can help patients and families navigate this journey with greater clarity and hope.

Prognosis and Survival Outlook

When pancreatic cancer has metastasized, meaning it has spread to distant organs such as the liver, lungs, abdominal cavity, or bones, the outlook becomes significantly more challenging. This is classified as stage IV pancreatic cancer, and it represents the most advanced form of the disease.^[1] The prognosis for metastatic pancreatic cancer is among the most serious of all cancer types, with a five-year survival rate as low as 2%.^[1][6]

Most patients with metastatic pancreatic cancer face a median survival expectancy of less than one year with current treatments.^[1] These statistics can be deeply distressing for patients and their loved ones. However, it’s important to understand that survival statistics represent averages across large groups of people and do not predict what will happen to any individual person. Some patients respond better to treatment than others, and advances in treatment approaches have been helping people with pancreatic cancer live longer than in previous years.^[17]

The disease is particularly difficult to detect early because the pancreas sits deep in the abdomen, surrounded by other organs including the small intestine, liver, and spleen.^[6] Early changes are often asymptomatic and hard to detect, which means most cases are discovered only after the cancer has already spread.^[1][4] By the time symptoms become noticeable enough to prompt medical evaluation, the cancer has often reached an advanced stage where it cannot be completely removed by surgery.^[1]

Natural Progression of the Disease

Pancreatic cancer is hyperaggressive and evolves from non-invasive precursor lesions, which is why early symptoms may be minor or completely absent.^[1] When metastatic pancreatic cancer is left untreated or progresses despite treatment, the disease continues to spread to other organs and tissues. The most common site for pancreatic cancer to spread is the liver, but it can also reach the lungs, abdominal cavity, distant lymph nodes, and occasionally the bones.^[3][5]

As the cancer advances, it interferes with the normal function of affected organs. When it spreads to the liver, for example, it can disrupt the liver’s ability to filter toxins and produce essential proteins. If it spreads throughout the abdomen, it may cause a buildup of fluid in the abdominal cavity, a condition called ascites, which can cause discomfort, bloating, and difficulty breathing.^[3][6]

The pancreas itself produces enzymes that aid digestion and hormones that regulate blood sugar levels. As the tumor grows within the pancreas and spreads beyond it, these functions become impaired. Patients may experience worsening digestive problems, difficulty maintaining blood sugar levels, and progressive weight loss even when trying to eat normally.^[6] The cancer can also press on or invade nearby structures such as the bile duct, which carries digestive fluids from the liver to the intestine, causing blockages that lead to jaundice and other complications.^[18]

Without treatment, the disease progresses relatively quickly. The cancer cells continue to multiply and invade surrounding tissues, blood vessels, and organs. This unchecked growth leads to increasing pain, particularly in the abdomen and back, as the tumor presses on nerves and other structures. Patients typically become weaker, more fatigued, and experience a decline in overall function.^[4]

Possible Complications

Metastatic pancreatic cancer can lead to numerous complications that affect multiple body systems. One of the most common complications is a blockage in the bile duct or bowel. When the cancer blocks the bile duct, digestive juices cannot flow properly from the liver into the intestine. This causes a backup that leads to jaundice, characterized by yellowing of the skin and eyes, dark-colored urine, light-colored stools, and intense itching.^[2][18] A blocked bile duct requires intervention, often through placement of a tube called a stent to allow fluids to pass through.^[18]

Bowel obstruction is another serious complication. If the tumor presses on or invades part of the intestine, food and digestive contents cannot pass through normally. This causes severe abdominal pain, nausea, vomiting, bloating, and an inability to pass stool or gas.^[18] Bowel blockages may require stent placement, bypass surgery, or medication to reduce fluid buildup and relieve symptoms.^[18]

Ascites, the abnormal accumulation of fluid in the abdominal cavity, occurs when cancer spreads throughout the abdomen. The fluid causes the abdomen to swell, creating discomfort, difficulty breathing, and reduced appetite because the stomach has less room to expand.^[3] This fluid can sometimes be drained to provide temporary relief.

Many patients with metastatic pancreatic cancer develop blood clots, particularly in the legs, a condition called deep vein thrombosis. These clots can be dangerous if they break loose and travel to the lungs, causing a life-threatening complication called pulmonary embolism.^[6][7] Blood clots occur because cancer can make the blood more prone to clotting than normal.

Uncontrolled pain is a frequent complication, especially pain in the upper abdomen and middle back. The pain can result from the tumor pressing on surrounding nerves, organs, and tissues. Without proper pain management, this pain can become debilitating and severely impact quality of life.^[2][7]

New-onset diabetes or worsening of existing diabetes can occur because the pancreas is responsible for producing insulin, the hormone that regulates blood sugar. As the cancer damages the pancreas, insulin production becomes impaired, leading to difficulty controlling blood glucose levels.^[7][18] This condition is sometimes called Type 3C diabetes or secondary diabetes when it results from pancreatic disease.^[22]

Impact on Daily Life

Living with metastatic pancreatic cancer affects nearly every aspect of daily life. The physical symptoms of the disease and side effects of treatment can make even simple activities exhausting. Profound fatigue is one of the most common and overwhelming symptoms reported by patients.^[18] This is not ordinary tiredness that improves with rest; it’s a deep exhaustion that makes it difficult to get out of bed, perform basic self-care, or engage in activities that once brought joy.

Loss of appetite and unintended weight loss are nearly universal experiences. Food may lose its appeal, or eating may cause nausea and discomfort. The digestive problems caused by the disease and its treatments can make it difficult to absorb nutrients, leading to progressive weakness and muscle wasting.^[18] Patients often need to adjust their diet significantly, eating smaller, more frequent meals and choosing foods that are easier to digest.

Pain, particularly in the abdomen and back, can limit mobility and make it difficult to find comfortable positions for sleeping or resting. Chronic pain affects mood, concentration, and the ability to participate in social activities.^[2] Effective pain management is essential but may require adjustments over time as the disease progresses.

Work and hobbies often need to be curtailed or stopped entirely. The combination of fatigue, pain, frequent medical appointments, and unpredictable symptoms makes it difficult to maintain regular employment or engage in physically demanding activities. Many patients find they need to rely on others for transportation, household tasks, and personal care as the disease advances.

The emotional and psychological impact can be as challenging as the physical symptoms. Fear, anxiety, sadness, and anger are normal responses to a cancer diagnosis, especially one with such a serious prognosis. Patients may struggle with uncertainty about the future, worry about becoming a burden to loved ones, and grief over the loss of independence and the life they had planned.^[15]

Social relationships may change. Some people may withdraw because they feel too ill or don’t want others to see them struggling. Others may find that friends or extended family don’t know what to say or how to help, leading to awkward interactions or isolation. However, many patients also experience deepened connections with those closest to them and find unexpected sources of support and compassion.

Practical strategies for coping with these limitations include pacing activities throughout the day, accepting help from others, using assistive devices when needed, and working with healthcare teams to manage symptoms effectively. Many patients benefit from palliative care services, which focus specifically on improving quality of life by addressing physical symptoms, emotional distress, and practical needs.^[22]

Support for Family Members and Caregivers

When a loved one is diagnosed with metastatic pancreatic cancer, family members and caregivers play a crucial role in their care and wellbeing. Understanding the disease, treatment options, and what to expect can help families provide better support and feel more prepared for the challenges ahead.

Clinical trials represent an important opportunity for patients with metastatic pancreatic cancer. Because the disease is so difficult to treat with currently available therapies, participating in research studies testing new treatments may offer access to potentially beneficial therapies that are not yet widely available.^[12] Patients diagnosed with metastatic pancreatic cancer are highly encouraged to consider clinical trials at all stages of their care.^[12]

Family members can help by researching available clinical trials and discussing these options with the patient and their healthcare team. Many organizations maintain databases of ongoing clinical trials specifically for pancreatic cancer. Understanding the patient’s specific cancer characteristics, including genetic and molecular features, can help identify trials that might be particularly relevant.^[17]

Preparing for trial participation involves gathering complete medical records, understanding the trial requirements and potential risks and benefits, and ensuring the patient meets eligibility criteria. Family members can assist with this process by organizing documents, taking notes during appointments, asking questions, and providing transportation to trial sites if needed.

Genetic testing is increasingly important in pancreatic cancer care. About 5% of pancreatic cancer patients in the general population have inherited mutations in genes called BRCA1 or BRCA2.^[9] Patients with these mutations may benefit from specific treatments, including a medication called olaparib, which has been shown to improve outcomes when used as maintenance therapy after platinum-based chemotherapy.^[9] Families can encourage patients to undergo genetic testing early in their diagnosis to identify whether they might benefit from these targeted treatments.

Practical support involves helping with daily activities such as preparing meals, managing medications, attending medical appointments, keeping track of symptoms and side effects, and communicating with the healthcare team. Many families find it helpful to designate one person as the primary point of contact with doctors and nurses to ensure consistent communication.

Emotional support is equally important. Simply being present, listening without judgment, and validating the patient’s feelings can provide enormous comfort. Family members should avoid forcing positivity or minimizing the patient’s fears and concerns. Honest, compassionate communication about difficult topics, including end-of-life wishes and advance care planning, though challenging, helps ensure the patient’s values and preferences are honored.^[22]

Many families benefit from palliative care services, which can be provided alongside active cancer treatment. Palliative care teams include doctors, nurses, social workers, and counselors who specialize in managing symptoms, improving quality of life, and supporting both patients and families through the challenges of serious illness.^[22] These services can help with pain management, symptom control, care coordination, and assistance with difficult decisions.

Recurrent pancreatic cancer represents the return of cancer after initial treatment, presenting unique challenges for patients, families, and medical teams as they navigate this difficult journey together.

Understanding Prognosis and Survival Outlook

When pancreatic cancer returns after treatment, the outlook becomes a delicate topic that requires honest yet compassionate understanding. The prognosis for recurrent pancreatic cancer is generally more challenging than for newly diagnosed disease, though each person’s journey remains unique and influenced by multiple factors.^[2]

Research shows that after recurrence is detected, the median overall survival is approximately 21.2 months, though this varies considerably among individuals.^[6] Some patients who experience recurrence after a longer disease-free interval may have better outcomes than those whose cancer returns quickly. For patients who achieved long-term survival after their initial treatment—meaning they lived at least five years—and then experienced recurrence, the median survival after diagnosis of that recurrence was reported as 33 months in one study.^[2]

The location and pattern of recurrence matter significantly. When cancer returns only in the pancreas area (local recurrence) versus spreading to distant organs like the liver or lungs (distant recurrence), treatment options and survival expectations differ. Patients with isolated local recurrence may have more treatment possibilities available to them, though these situations remain relatively uncommon.^[2]

The timing of recurrence provides important information about how the cancer behaves. Studies indicate that most recurrences happen within the first two years after initial surgery, with up to 80 percent of patients experiencing some form of cancer return even after what appeared to be successful removal of the tumor.^[10] Early recurrence—within six months of surgery—generally suggests more aggressive disease and is associated with poorer outcomes.^[4]

What happened during the initial treatment also influences prognosis. Patients who received and responded well to chemotherapy before their first surgery, who had complete tumor removal with clear margins, and who were able to complete adjuvant therapy after surgery generally have better outcomes if recurrence occurs.^[4] The biology of the tumor itself—including genetic characteristics and how aggressively it grows—plays a fundamental role in determining survival that researchers are still working to fully understand.^[7]

Natural Progression Without Treatment

Understanding how recurrent pancreatic cancer develops when left untreated helps patients and families make informed decisions about care. The natural progression of this disease varies depending on where the cancer has returned and how quickly it grows.

When pancreatic cancer recurs, it almost always has either spread to distant parts of the body (metastasized) or grown extensively into tissues surrounding the pancreas, making surgical removal impossible in most cases.^[5] This is why recurrent pancreatic cancer is typically managed similarly to advanced, unresectable disease rather than as a new, potentially curable cancer.

Without treatment, local recurrence in the pancreas area or nearby lymph nodes gradually enlarges and may begin to compress or invade nearby structures. This can lead to worsening symptoms over time. The tumor may press against nerves, causing increasing pain. It may obstruct the bile duct, leading to jaundice (yellowing of skin and eyes) and digestive problems. Growth into blood vessels can cause complications related to blocked circulation.^[3]

Distant metastases—when cancer spreads to organs such as the liver, lungs, or the lining of the abdomen—follow different patterns. Liver metastases may cause that organ to function less effectively, leading to accumulation of toxins in the blood, fluid buildup in the abdomen, and progressive weakness. Lung metastases can cause breathing difficulties, cough, and reduced oxygen levels. Peritoneal spread (cancer throughout the abdominal lining) often causes fluid accumulation in the belly, discomfort, and bowel dysfunction.^[10]

The speed of progression varies considerably among individuals. Some patients experience rapid growth and symptom development over weeks to months, while others have slower-growing recurrences that progress over a longer period. Factors including the tumor’s biology, the patient’s overall health, and the specific locations involved all influence this timeline.

Without treatment interventions, most patients with recurrent pancreatic cancer experience gradually worsening symptoms that increasingly affect their ability to carry out daily activities. Pain management becomes more challenging. Nutritional status deteriorates due to digestive problems, loss of appetite, and the cancer’s effects on metabolism. Fatigue intensifies. Eventually, vital organ functions are compromised to the point where life can no longer be sustained.^[10]

Possible Complications

Recurrent pancreatic cancer can lead to various complications—some related to the cancer itself and others resulting from treatments. Understanding these possibilities helps patients and caregivers prepare and respond appropriately when problems arise.

Pain represents one of the most common and challenging complications. As recurrent tumors grow, they may press on nerves in the abdomen and back, causing discomfort that ranges from mild to severe. This pain can be persistent and aching, or it may be sharp and intermittent. Managing cancer-related pain often requires a combination of medications and sometimes additional procedures to block nerve signals.^[6]

Jaundice occurs when a tumor blocks the bile duct, preventing bile from flowing normally from the liver into the intestines. This causes a buildup of bilirubin in the blood, leading to yellowing of the skin and whites of the eyes, dark urine, light-colored stools, and intense itching. Jaundice may require procedures to place a stent (a small tube) to reopen the blocked duct or surgery to create a bypass around the obstruction.^[3]

Digestive problems frequently develop because the pancreas normally produces enzymes essential for breaking down food. When recurrent cancer affects pancreatic function or blocks digestive pathways, patients may experience nausea, vomiting, difficulty eating, bloating, and changes in bowel movements including diarrhea with oily, foul-smelling stools. Weight loss often accompanies these digestive issues and can become severe if not addressed.^[3]

Diabetes or worsening of existing diabetes can occur when recurrent cancer damages the parts of the pancreas that produce insulin. This leads to elevated blood sugar levels that require monitoring and management. New-onset diabetes or sudden difficulty controlling previously stable diabetes may actually signal cancer recurrence in some cases.^[6]

Blood clots represent a serious complication that pancreatic cancer patients face at higher risk than the general population. These clots can form in leg veins (deep vein thrombosis) or travel to the lungs (pulmonary embolism), causing leg swelling, chest pain, or breathing difficulty. Blood clots require urgent medical attention and treatment with anticoagulation medications.

Fluid accumulation in the abdomen, called ascites, develops when cancer spreads throughout the abdominal lining or when liver function is compromised. This causes the belly to swell, creates discomfort or pain, makes breathing difficult, and reduces appetite. Draining the fluid provides temporary relief, though it often reaccumulates and may require repeated procedures.^[10]

Bowel obstruction can occur if tumors grow into or press against the intestines, preventing normal passage of food and waste. This causes severe nausea, vomiting, cramping pain, and inability to have bowel movements. Bowel obstruction constitutes a medical emergency requiring hospitalization and may need surgical or non-surgical interventions to relieve the blockage.

Bleeding complications may arise if tumors erode into blood vessels or if the cancer causes blood clotting problems. This can manifest as vomiting blood, black tarry stools, or internal bleeding detected through falling blood counts. Serious bleeding requires immediate medical care.

Impact on Daily Life

Living with recurrent pancreatic cancer affects virtually every aspect of daily existence—physically, emotionally, socially, and practically. Understanding these impacts helps patients and families adjust expectations and find ways to maintain the best possible quality of life during this challenging time.

Physical limitations often become more pronounced as recurrent cancer progresses. Fatigue stands out as one of the most pervasive symptoms, described by many patients as an overwhelming tiredness that doesn’t improve with rest. This exhaustion makes even simple tasks like bathing, dressing, or walking short distances feel overwhelming. Many people find they need to pace activities carefully, taking frequent breaks and prioritizing what matters most to conserve limited energy.^[18]

Eating and maintaining nutrition becomes a daily challenge for most patients. Appetite loss, early satiety (feeling full after eating very little), nausea, and food aversions make it difficult to consume enough calories and nutrients. The social and emotional aspects of mealtimes change when eating becomes difficult or unpleasant. Families may struggle to find foods their loved one can tolerate, and patients often feel guilty or frustrated about their inability to eat normally.^[18]

Pain and discomfort can significantly limit activities and enjoyment. Abdominal or back pain may make sitting for extended periods uncomfortable, interfere with sleep, or make it difficult to find comfortable positions. Managing pain often requires taking medications on a strict schedule, which can have side effects including drowsiness, constipation, or mental cloudiness that further affect daily functioning.

Work and financial concerns weigh heavily on many patients and families. Some people with recurrent cancer can continue working in a reduced capacity, while others must stop employment entirely. This loss of income, combined with ongoing medical expenses, creates financial stress even for families with insurance. Practical matters like paying bills, managing insurance claims, and coordinating medical appointments become additional burdens during an already overwhelming time.

Emotional and mental health challenges accompany the physical symptoms. Anxiety about the future, fear of suffering, sadness about losses, and worry about loved ones are common and completely natural responses. Some patients experience depression, characterized by persistent low mood, loss of interest in activities, difficulty concentrating, and feelings of hopelessness. These emotional struggles deserve attention and treatment just as much as physical symptoms.^[21]

Relationships undergo changes as roles within families shift. A patient who was previously the family caregiver may now need to accept help from others. Spouses or partners take on additional responsibilities while also managing their own emotional reactions. Children, regardless of age, struggle to adapt to their parent’s illness. Open communication about feelings, needs, and expectations helps families navigate these transitions, though difficult conversations remain challenging even with the best intentions.

Social activities and hobbies often must be modified or abandoned. Fatigue, treatment schedules, and physical limitations may prevent participation in previously enjoyed activities like travel, sports, or social gatherings. This loss of normal activities contributes to feelings of isolation and grief over the life one had before cancer recurrence. Finding adapted activities or new sources of meaning becomes important for maintaining quality of life.^[25]

Coping strategies that patients have found helpful include maintaining routines to provide structure and normalcy, engaging in gentle activities like short walks or sitting outside when energy allows, practicing relaxation techniques such as deep breathing or meditation, journaling thoughts and feelings, and finding moments of connection with loved ones. Some people discover new sources of spiritual meaning or strengthen existing beliefs that provide comfort.^[21]

Practical adaptations can make daily life more manageable. Using mobility aids if needed, arranging furniture to minimize walking distances, keeping frequently needed items within easy reach, preparing simple meals or accepting prepared foods from others, and wearing comfortable, easy-to-manage clothing all reduce physical demands. Accepting home health assistance or hiring help for tasks like cleaning can preserve energy for activities that matter most to the patient.

Support for Families: Understanding Clinical Trials and Helping Your Loved One

Family members play crucial roles in supporting patients with recurrent pancreatic cancer, including helping explore all available treatment options such as clinical trials. Understanding what clinical trials offer and how to assist in this process empowers families to provide meaningful support during this challenging journey.

Clinical trials are research studies that test new approaches to treating cancer. For recurrent pancreatic cancer, trials may evaluate new chemotherapy drugs, combinations of existing treatments used in novel ways, targeted therapies that attack specific characteristics of cancer cells, immunotherapy approaches that harness the body’s immune system, or new technologies for delivering treatments more effectively.^[8]

Many patients and families initially feel hesitant about clinical trials, worried about being “experimented on” or receiving inferior care. In reality, trials follow strict ethical guidelines and safety protocols. Patients in trials often receive more intensive monitoring than those receiving standard care. While trials may involve some uncertainty about whether a new approach will work better than existing treatments, they also offer access to promising therapies not yet widely available. For recurrent disease where standard options may be limited, trials sometimes provide the best chance for benefit.^[8]

Families can help patients learn about and consider clinical trial options in several important ways. Start by discussing the topic openly with your loved one and their medical team. Oncologists can explain whether any trials might be appropriate for your family member’s specific situation. Many cancer centers have research coordinators whose job includes matching patients with suitable trials and explaining the details in understandable terms.

Online resources can help identify trials that might be relevant. The National Cancer Institute maintains a database of clinical trials at all locations across the country. Organizations like the Pancreatic Cancer Action Network offer services to help patients and families search for and understand trial options. When researching trials, pay attention to eligibility criteria, which specify what characteristics patients must have to participate—factors like prior treatments received, overall health status, and specific features of the cancer all influence eligibility.^[13]

Families can assist with the practical aspects of trial participation. Clinical trials often require additional clinic visits for monitoring and testing. Help with transportation to appointments, keeping track of the schedule, organizing medication doses, monitoring for side effects, and communicating with the research team all represent valuable support. Keeping notes about symptoms, side effects, and questions helps ensure important information gets shared with the medical team at appointments.

Understanding the informed consent process is important for both patients and families. Before enrolling in any trial, patients receive detailed information about the study’s purpose, what participation involves, potential benefits and risks, alternative options, and the right to withdraw at any time. This consent document is often lengthy and complex. Families can help by reading through the information together, writing down questions, and ensuring the patient fully understands before making a decision. Never feel pressured to enroll in a trial—this decision should be made thoughtfully with adequate time to consider all factors.

Financial considerations around clinical trials deserve attention. The trial itself typically provides the investigational treatment at no cost, but other aspects of care may generate expenses. Insurance usually covers standard medical care costs, while the trial sponsor covers research-specific costs, but understanding exactly what expenses might arise helps families plan. Research coordinators can clarify financial aspects before enrollment.

Emotional support remains essential throughout trial participation. Patients may experience anxiety about whether the treatment is working, disappointment if they don’t qualify for a desired trial, or frustration with additional testing requirements. Family members can provide encouragement, help manage expectations by remembering that trials involve uncertainty, celebrate small victories, and ensure the patient knows they have support regardless of trial outcomes.

Beyond helping with trial participation specifically, families support patients with recurrent cancer in many other ways. Attending medical appointments provides extra ears to hear information and ask questions. Helping research treatment options, seek second opinions, and make informed decisions empowers patients during an overwhelming time. Managing practical matters like coordinating care, handling insurance issues, and organizing medications reduces burden on the patient. Most importantly, simply being present, listening without trying to fix everything, respecting the patient’s choices, and maintaining hope while also accepting reality provides irreplaceable emotional support.^[21]

Caregivers must also remember to care for themselves. Supporting someone with recurrent cancer takes enormous physical and emotional energy. Accepting help from extended family and friends, maintaining your own medical appointments and health needs, taking breaks when possible, joining caregiver support groups, and seeking counseling if feeling overwhelmed all represent important self-care steps. You cannot pour from an empty cup—taking care of yourself enables you to better support your loved one over the long term.^[1]

Stage IV pancreatic cancer represents the most advanced form of this disease, where cancer cells have traveled beyond the pancreas to distant organs. Understanding what happens at this stage can help patients and families prepare for the journey ahead and make informed decisions about care.

Understanding Stage IV Pancreatic Cancer

When doctors talk about stage IV pancreatic cancer, they are describing a situation where the disease has metastasized, which means it has spread from the pancreas to other parts of the body. At this point, the cancer is no longer confined to where it started. The tumors themselves can be any size, but what defines this stage is the presence of cancer in distant locations. This stage is also commonly referred to as metastatic or advanced pancreatic cancer.^[1]

Staging is an important tool that helps doctors understand how far the cancer has progressed and what treatment options might work best. In the case of stage IV pancreatic cancer, the disease has moved beyond the pancreas and nearby tissues to reach organs that are farther away. Even though the cancer has spread to other areas, it is still called pancreatic cancer because that is where it originated.^[1]

Where Does the Cancer Spread?

Pancreatic cancer cells tend to travel to specific organs when they metastasize. The most common destinations include the liver, which is often the first stop for spreading cancer cells due to its proximity and blood supply connections to the pancreas. The cancer can also reach the abdominal wall, which is the lining that surrounds organs in the belly. Other frequent sites include the lungs, bones, and lymph nodes that are far from the original tumor site.^[1]

The location where cancer cells settle can affect what symptoms a person experiences and what treatments doctors might recommend. For example, cancer that has spread to the liver might cause different problems than cancer that has reached the lungs. However, regardless of where the cancer has traveled, it retains the characteristics of pancreatic cancer cells, which is why treatment is still focused on targeting pancreatic cancer.^[2]

How Common Is Stage IV Pancreatic Cancer?

Stage IV pancreatic cancer makes up a significant portion of all pancreatic cancer diagnoses. Research from Veterans Affairs hospitals across the United States found that stage IV disease accounts for just over half of all pancreatic cancer cases, representing about 52 percent of diagnoses. This statistic underscores how challenging it is to catch pancreatic cancer before it spreads.^[5]

The difficulty in early detection stems from the location of the pancreas itself. This organ sits deep in the abdomen, tucked behind the stomach and near the spine. Because of this hidden position, tumors can grow for quite some time without causing obvious symptoms. By the time symptoms do appear, the cancer has often already spread to other organs.^[3]

In the VA hospital study, researchers found that men made up nearly all cases, at about 97 percent. The most commonly affected age groups were people over 70 years old and those between 60 and 70 years old, who together represented more than three-quarters of all cases. Interestingly, the study also noted that stage IV pancreatic cancer was less likely to originate in the head of the pancreas compared to earlier-stage cancers. This pattern exists because tumors in the head of the pancreas tend to cause symptoms earlier, such as jaundice from blocked bile ducts, leading to diagnosis at an earlier stage.^[5]

What Causes Pancreatic Cancer?

Pancreatic cancer develops when cells in the pancreas undergo certain changes that affect how they function, particularly how they grow and divide. These changes occur at the level of the cell’s DNA, which contains the instructions that tell cells what to do. When DNA becomes damaged in specific ways, cells can begin to multiply uncontrollably and form tumors.^[3]

The pancreas itself is an organ about six inches long, shaped somewhat like a thin pear lying on its side. It has three main sections: the wider end called the head, the middle section called the body, and the narrow end called the tail. This organ performs two crucial jobs in the body. First, it produces digestive juices that help break down food. Second, it makes hormones like insulin and glucagon that help control blood sugar levels and help the body use and store energy from food.^[3]

Approximately 95 percent of pancreatic cancers begin in the cells that make up the outer part of the pancreas, which produces digestive enzymes. These are called exocrine cells. A much smaller percentage of pancreatic cancers start in the hormone-producing cells, which are called endocrine cells.^[3]

Risk Factors for Pancreatic Cancer

While scientists understand that DNA changes in pancreatic cells lead to cancer, certain factors increase the likelihood that these changes will occur. A risk factor is anything that raises a person’s chance of developing a disease. It’s important to understand that having one or more risk factors does not mean someone will definitely get pancreatic cancer. Many people with multiple risk factors never develop the disease, while some people with no known risk factors do.^[3]

Smoking is one of the most significant risk factors that a person can control. The harmful chemicals in tobacco smoke can damage DNA in cells throughout the body, including in the pancreas. People who smoke have a substantially higher risk of developing pancreatic cancer compared to those who never smoked.^[3]

Having excess body weight is another modifiable risk factor. When a person carries extra weight that is unhealthy for their body, it can affect hormone levels and create inflammation, both of which may contribute to cancer development. Recent research has found that the combination of smoking, diabetes, and poor diet increases the risk of pancreatic cancer even more than any single factor alone.^[4]

Certain medical conditions can also increase risk. People with diabetes have a higher chance of developing pancreatic cancer, and sometimes diabetes can actually be an early sign of pancreatic cancer. Chronic pancreatitis, which is long-term inflammation of the pancreas, also raises the risk. This condition can result from heavy alcohol use, certain genetic conditions, or other factors that repeatedly injure the pancreas.^[3]

Family history plays a role as well. People who have close relatives with pancreatic cancer or pancreatitis face an increased risk. Additionally, several inherited genetic conditions are associated with higher rates of pancreatic cancer. These include hereditary nonpolyposis colon cancer (also called Lynch syndrome), Peutz-Jeghers syndrome, hereditary breast and ovarian cancer syndrome, familial atypical multiple mole melanoma syndrome, and ataxia-telangiectasia.^[3]

Symptoms of Stage IV Pancreatic Cancer

One of the most challenging aspects of pancreatic cancer is that it rarely causes symptoms in its early stages. By the time a tumor grows large enough or spreads far enough to cause noticeable problems, the disease is often already advanced. This is why so many people are diagnosed at stage IV.^[3]

When symptoms do appear, they can vary depending on where the cancer has spread and how large the tumors have become. Jaundice, which is a yellowing of the skin and the whites of the eyes, is a common symptom. This occurs when a tumor blocks the bile duct, preventing bile from flowing normally. Along with jaundice, people might notice that their stools become light-colored and their urine becomes dark.^[3]

Pain is another frequent symptom, particularly in the upper or middle part of the abdomen and in the back. This pain can range from mild discomfort to severe, persistent aching. The pain often worsens after eating or when lying down flat. As the cancer grows, the pain can become more constant and harder to manage.^[3]

Unexplained weight loss is very common in people with pancreatic cancer. This happens for several reasons. The tumor can interfere with normal digestion, making it difficult for the body to absorb nutrients from food. People may also experience a loss of appetite or feel full quickly after eating only small amounts. The cancer itself changes the body’s metabolism, causing weight loss even when a person tries to maintain their normal eating habits.^[3]

Why Early Detection Is So Difficult

Pancreatic cancer is notoriously difficult to diagnose early, which is a major reason why so many cases are found at stage IV. The pancreas is located deep inside the body, behind the stomach and in front of the spine. This position means that small tumors cannot be felt during a physical examination. Additionally, there are no routine screening tests recommended for people at average risk of pancreatic cancer, unlike screening tests that exist for breast, colon, or prostate cancer.^[3]

The symptoms that eventually do appear are often vague and can be easily mistaken for other, less serious conditions. Stomach pain, back pain, and digestive problems are common complaints that could have many different causes. Because of this, people and their doctors might not immediately think of pancreatic cancer as a possibility. By the time specific tests are ordered and cancer is diagnosed, the disease has typically progressed significantly.^[4]

Treatment Approaches for Stage IV Pancreatic Cancer

The goal of treatment for stage IV pancreatic cancer is different from treating earlier-stage cancers. At this advanced stage, the aim is to help control or prevent symptoms rather than to cure the disease. While treatment cannot eliminate stage IV pancreatic cancer, it may help people live longer and maintain a better quality of life.^[2]

Surgery to remove the tumor is not an option at stage IV because the cancer has spread too far. At this point, doctors say the cancer is unresectable, meaning it cannot be surgically removed. Surgery offers the best chance for long-term survival in pancreatic cancer, but it is only possible when the tumor is still localized. Once the cancer has metastasized to distant organs, removing the primary tumor in the pancreas would not eliminate the cancer cells that have traveled elsewhere.^[1]

Chemotherapy is typically the main treatment for stage IV pancreatic cancer. This type of treatment uses powerful drugs that travel through the bloodstream to reach cancer cells throughout the body, wherever they may be. Because stage IV cancer has spread to multiple locations, a systemic treatment like chemotherapy that can reach all these areas is the most appropriate approach. Some patients may also receive radiotherapy, depending on their overall health and specific situation.^[2]

A small number of people with stage IV pancreatic cancer may be candidates for targeted cancer drugs or immunotherapy drugs. These newer types of treatments work differently than traditional chemotherapy. They may target specific characteristics of cancer cells or help the patient’s own immune system recognize and attack cancer cells. Whether these treatments are appropriate depends on various factors, including the specific genetic features of the tumor.^[2]

Clinical trials offer another important option for people with stage IV pancreatic cancer. These research studies test new treatments or new combinations of existing treatments to see if they work better than current standard approaches. Participating in a clinical trial can give patients access to cutting-edge therapies that are not yet widely available. Medical organizations strongly recommend that patients consider clinical trials at diagnosis and during every treatment decision.^[1]

Biomarker testing of the tumor can help determine the best treatment options. This testing looks at specific characteristics of the cancer cells to understand what makes them grow and how they might respond to different treatments. The results can guide doctors in choosing therapies that are most likely to be effective for each individual patient’s cancer.^[1]

Treatment rates for stage IV pancreatic cancer have been gradually increasing over time. Data from Veterans Affairs hospitals showed that the percentage of patients receiving first-line chemotherapy rose from about 33 percent in 2000 to nearly 42 percent in 2014. This increase in treatment has corresponded with improvements in survival rates, suggesting that more aggressive treatment approaches are helping patients live longer.^[5]

Managing Symptoms and Side Effects

Supportive care, also called palliative care, plays a crucial role in treating stage IV pancreatic cancer. This type of care focuses on managing symptoms, improving quality of life, and addressing the patient’s physical, emotional, and spiritual well-being. Palliative care is not the same as giving up on treatment. Instead, it works alongside cancer-fighting treatments or can be the main focus of care, depending on the patient’s goals and situation.^[1]

Pain management is often a key component of supportive care. As the cancer grows and spreads, it can cause significant pain that requires careful attention. Doctors can prescribe various medications and use different techniques to help control pain and keep patients as comfortable as possible. Finding the right combination of pain management strategies may take some time and adjustment.^[2]

Some patients with stage IV pancreatic cancer may need procedures to relieve specific symptoms. For example, if a tumor blocks the bile duct and causes jaundice, doctors can place a small tube called a stent into the duct to keep it open. This allows bile to flow normally and can relieve the yellowing of the skin and eyes as well as other related symptoms.^[2]

Nutrition becomes particularly important when dealing with pancreatic cancer. The pancreas plays a vital role in digestion, and when it is not working properly due to cancer, the body may have trouble breaking down and absorbing nutrients from food. Many patients benefit from taking pancreatic enzymes, which are supplements that help digest fats and proteins. Working with a registered dietitian who understands the unique nutritional challenges of pancreatic cancer can make a significant difference in how well a patient tolerates treatment and maintains their quality of life.^[1]

Because the pancreas also produces hormones that control blood sugar, some patients may develop diabetes if their pancreas stops working properly. Managing blood sugar levels through diet, medication, or insulin may become necessary as part of overall care.^[2]

Why Stage IV Is Particularly Challenging

Pancreatic cancer is difficult to treat at any stage, but stage IV presents unique challenges. The more widely cancer has spread, the harder it becomes to control. When cancer cells exist in multiple organs throughout the body, eliminating all of them becomes extremely difficult. Even when treatment successfully shrinks tumors, cancer cells may remain hidden in small amounts that can later grow again.^[1]

The location and biology of pancreatic cancer also contribute to treatment challenges. The pancreas is surrounded by important blood vessels and organs, making it a complex area to treat. Additionally, pancreatic cancer cells tend to be particularly aggressive and resistant to many treatments. They can develop ways to evade the effects of chemotherapy and other therapies, allowing them to continue growing despite treatment.^[2]

How the Body Changes at This Stage

At stage IV, the cancer affects the body in multiple ways beyond just the presence of tumors. The disease disrupts normal bodily functions both where the original tumor is located and where it has spread. In the pancreas, the tumor interferes with the production of digestive enzymes and hormones. This can lead to problems with breaking down food and controlling blood sugar levels, which is why digestive issues and diabetes are common.^[3]

When cancer spreads to the liver, it can affect that organ’s many vital functions, including processing nutrients, filtering blood, and producing proteins needed for blood clotting. Liver involvement may cause a buildup of toxins in the body because the liver cannot perform its filtering role effectively. This can lead to confusion, fatigue, and other symptoms.^[1]

Cancer that reaches the lungs can interfere with breathing and oxygen exchange. Patients may experience shortness of breath, coughing, or a feeling of not getting enough air. When cancer affects the bones, it can cause pain and increase the risk of fractures because the tumors weaken the bone structure.^[1]

The cancer also changes the body’s metabolism in ways that promote weight loss and muscle wasting. Cancer cells release substances that alter how the body processes nutrients and energy. They essentially hijack the body’s resources for their own growth, leaving less available for normal body functions. This is why maintaining adequate nutrition becomes such a challenge and why weight loss is so common.^[3]

Survival and Quality of Life

Life expectancy with stage IV pancreatic cancer is limited, with statistics showing that about 3 percent of people with distant pancreatic cancer survive five years after diagnosis. However, these are overall statistics, and individual experiences can vary. Some people live longer than expected, while others may have a shorter time.^[3]

Recent data suggests that survival rates are gradually improving. The VA hospital study found that one-to-five-year survival rates increased from about 9 percent in 2000 to nearly 23 percent in 2014. While these numbers are still sobering, they represent meaningful progress. The improvement appears to be linked to increased treatment rates and better treatment approaches.^[5]

Quality of life during treatment is just as important as length of survival. Many factors contribute to quality of life, including how well symptoms are controlled, the person’s ability to do activities they enjoy, their emotional well-being, and the support they receive from family and healthcare providers. Focusing on these aspects can help patients make the most of the time they have.^[1]

Prevention Considerations

While stage IV pancreatic cancer cannot be prevented once earlier disease has progressed, understanding risk factors can help people make choices that may reduce their overall risk of developing pancreatic cancer in the first place. Not all risk factors can be changed, but some important ones can.^[3]

Quitting smoking is the most impactful change a person can make. Because smoking significantly increases pancreatic cancer risk, stopping this habit reduces risk over time. Even for people who have smoked for many years, quitting still provides benefits.^[4]

Maintaining a healthy weight through balanced eating and regular physical activity may also help reduce risk. While no specific diet has been proven to prevent pancreatic cancer, eating a variety of nutritious foods and limiting processed foods appears to be beneficial for overall cancer prevention.^[4]

For people with a strong family history of pancreatic cancer or known genetic syndromes that increase risk, talking with a doctor about screening options may be worthwhile. While routine screening is not recommended for the general population, high-risk individuals may benefit from specialized surveillance programs at certain medical centers.^[3]

Ductal Adenocarcinoma of Pancreas

Pancreatic ductal adenocarcinoma is the most common and deadliest form of pancreatic cancer, affecting thousands of people each year. Understanding this disease, its symptoms, and treatment options can help patients and their families navigate the difficult journey ahead.

Table of contents

• What is Pancreatic Ductal Adenocarcinoma?
• How Common is This Cancer?
• Signs and Symptoms
• Risk Factors
• Diagnosis and Testing
• Treatment Options
• Outlook and Survival
• Living with Pancreatic Ductal Adenocarcinoma

What is Pancreatic Ductal Adenocarcinoma?

Pancreatic ductal adenocarcinoma, often called PDAC, is a type of cancer that begins in the cells that line the small tubes, or ducts, inside the pancreas^[1]. These ducts normally carry digestive juices containing enzymes (special proteins that help break down food) from the pancreas into the small intestine^[4].

• Pancreas
• Pancreatic ducts
• Small intestine

The pancreas is a small gland, about 6 inches long, that sits behind the stomach. It has three main parts: the head (wider end), the body (middle section), and the tail (narrow end)^[11]. This gland performs two important jobs: it makes digestive juices that help break down food, and it produces hormones like insulin and glucagon that help control blood sugar levels^[11].

PDAC is a type of exocrine cancer, meaning it develops from the cells that form the ducts and glands of the pancreas^[5]. It can grow anywhere in the pancreas, though it most often appears in the head of the pancreas^[3].

How Common is This Cancer?

Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer, making up more than 80% to 90% of all cases^[4][5]. About 95 out of 100 (95%) of all pancreatic cancers are exocrine cancers, and most of these are PDAC^[3].

This disease is the fourth most common cause of cancer-related deaths worldwide^[4]. In 2012, around 44,000 new cases were diagnosed in the United States alone, with more than 37,000 deaths from the disease, affecting both men and women^[4]. The number of cases is expected to rise in the future, with projections showing a more than two-fold increase within the next ten years^[6].

Pancreatic cancer rarely occurs before the age of 40, and more than half of cases happen in people over 70 years old^[12].

Signs and Symptoms

Unfortunately, pancreatic ductal adenocarcinoma does not usually cause symptoms in the early stages^[1][8]. Early-stage tumors don’t show up on imaging tests, which is why many people don’t receive a diagnosis until the cancer has spread to other parts of the body^[8]. This late detection makes the disease particularly difficult to treat.

As the cancer grows and begins to affect other organs in the digestive system, symptoms may start to appear. Common signs and symptoms include^[3][7][8]:

• Jaundice (yellowing of the skin and the whites of the eyes), which happens when the cancer blocks the bile duct
• Pain in the upper abdomen or stomach area that may spread to the back
• Unexplained weight loss
• Loss of appetite
• Light-colored or clay-colored bowel movements
• Dark-colored urine
• Itchy skin
• Nausea and vomiting
• Fatigue (extreme tiredness)
• Gas or bloating
• Swollen gallbladder
• Blood clots
• New-onset diabetes (high blood sugar that develops suddenly)

Some people develop vague symptoms up to one year before they receive a diagnosis^[8]. Many people report that their first symptoms were back pain or stomach pain. These symptoms can come and go at first, but may get worse after meals or when lying down^[8].

A doctor might suspect pancreatic cancer if a patient has recently developed diabetes or pancreatitis (a painful condition caused by inflammation in the pancreas)^[8].

Risk Factors

While the exact cause of pancreatic ductal adenocarcinoma is not fully understood, several risk factors increase the chance of developing this disease^[11]:

Tobacco smoking is a major risk factor. People who smoke are two times more likely to develop pancreatic cancer compared to those who have never smoked. About 20-35% of pancreatic cancers are caused by cigarette smoking^[7]. About 25% of cases are linked to smoking^[12].

Obesity and being overweight also increase risk. About 20% of obese people have an increased risk of developing pancreatic cancer, and the risk is even higher in people who have been obese since childhood^[7].

Diabetes is another important risk factor. Having diabetes increases the chances of developing this cancer^[11]. The connection between diabetes, obesity, and type 2 diabetes is particularly concerning, as these are emerging public health challenges^[6].

Other risk factors include^[11][12]:

• A family history of pancreatic cancer
• History of chronic pancreatitis (long-term inflammation of the pancreas)
• Certain rare genetic conditions, such as hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial atypical multiple mole melanoma syndrome, and ataxia-telangiectasia
• Alcohol abuse
• Tobacco abuse (including cigars and other forms)

The specific combination of smoking, diabetes, and poor diet increases the risk of pancreatic cancer the most beyond any one factor alone^[1].

For a small group of approximately 5-6% of all PDAC patients, genetic factors such as germline mutations (inherited changes in genes) in BRCA1/2, ATM, MLH1, TP53, or CDKN2A represent additional risk factors^[6].

Life style habits, including alcohol and tobacco abuse, which are well-known to increase the risk for several other types of cancer, also appear to be involved in PDAC development^[6].

Diagnosis and Testing

Pancreatic cancer is difficult to diagnose early because it typically doesn’t cause symptoms until it has reached an advanced stage^[11]. Early-stage pancreatic tumors don’t show up on imaging tests^[8].

Tests that examine the pancreas are used to diagnose and determine the stage of pancreatic cancer^[11]. These may include:

• Medical imaging tests such as CT scans (computed tomography), MRI scans (magnetic resonance imaging), and ultrasound to create pictures of the inside of the body^[5]
• Blood tests to check for certain markers or substances that might indicate cancer^[5]
• Tissue biopsy, where a small sample of tissue is removed and examined under a microscope to look for cancer cells^[5]
• Endoscopy procedures to look inside the digestive tract

A particular challenge for diagnosing PDAC is that pancreatic tumors contain a relatively low percentage of cancerous cells compared to normal or surrounding tissue^[4]. This makes it harder to get clear results from tests.

Some people decide to get a second opinion after receiving a diagnosis^[11]. Regular checkups can be important, especially for people with risk factors, as they may show subtle signs on bloodwork or a medical exam^[5].

Treatment Options

How well pancreatic ductal adenocarcinoma responds to treatment depends largely on the stage of disease at the time of diagnosis^[6]. Only 10-20% of PDAC patients have cancer that can be surgically removed at diagnosis, while the remaining 80-90% have locally advanced, non-removable stages or distant metastases (cancer that has spread to other parts of the body)^[6].

Surgery followed by chemotherapy is the only possibly curative therapy available^[6]. Surgery aims to remove the cancerous part of the pancreas. However, metastatic pancreatic cancer is not curable and cannot be completely removed by surgery^[7].

Chemotherapy uses drugs to kill cancer cells. It is commonly employed as first-line treatment in patients with non-resectable or borderline-resectable tumors^[6]. Common chemotherapy drugs include:

• Gemcitabine and capecitabine (nucleoside analogues)
• 5-fluorouracil or 5-FU (a pyrimidine analogue)
• FOLFIRINOX, a combination of folinic acid, 5-FU, irinotecan, and oxaliplatin, which has been reported to nearly double median survival in the metastasized stage compared to gemcitabine alone^[6]
• The combination of gemcitabine and nab-paclitaxel (nanoparticle albumin-bound paclitaxel), which has shown significant improvement in overall survival^[6]

However, these more intensive protocols are associated with higher toxicity, often preventing their use in elderly patients or those with poor overall health^[6].

Radiation therapy (also called radiotherapy) uses high-speed energy to kill cancer cells^[7]. Radio(chemo)therapy has been rather infrequently used for treating PDAC, since the majority of patients have disseminated stages where local treatment is of secondary importance^[6]. However, neoadjuvant radiotherapy (radiation given before surgery) has the potential to improve PDAC resectability in some cases^[6].

Immunotherapy activates or suppresses the immune system to fight cancer^[7]. Targeted therapy uses drugs directed at blocking certain genes or proteins^[7]. Research showed that 42% of tumors studied had a genomic alteration that may qualify for a current clinical trial^[4].

Supportive (palliative) care may help control symptoms and side effects caused by the disease and treatments, and can impact quality of life^[5].

Outlook and Survival

Pancreatic ductal adenocarcinoma is one of the deadliest forms of cancer^[5]. The disease is almost always fatal^[4]. The 5-year overall survival rate is less than 8%^[6]. Five-year survival rates are around 8%, though some sources indicate even lower rates^[5].

Late detection and a particularly aggressive biology are the major challenges which determine therapeutic failure^[6]. Because most pancreatic cancers are not found until advanced stages, the outlook is poor^[5].

However, survival rates are constantly changing with new treatments, and the main factor determining survival is whether it is possible to surgically remove the cancer^[5]. Certain factors affect prognosis (chance of recovery) and treatment options^[11].

A person with PDAC should discuss the outlook with their doctor because each case varies^[5]. A variety of treatment options can slow the disease, reduce pain, and in less common cases, cure the cancer in its early stages^[5].

Metastatic pancreatic cancer is defined as Stage 4 pancreatic cancer and is not curable^[7].

Living with Pancreatic Ductal Adenocarcinoma

A diagnosis of pancreatic cancer requires a patient to adapt to many life changes. The disease brings a wide range of new emotions, various physical symptoms, and numerous decisions regarding care^[18].

Developing a strong support system is crucial. This includes family, friends, clergy, and a good medical team. A support network will help patients deal with different aspects of pancreatic cancer^[18]. Patients may find comfort in talking to their support network about emotions and physical feelings on a day-to-day basis. They may also need help with practical aspects of house chores and daily living during periods of care^[18].

Connecting with others who have been in similar situations can be valuable. This can happen through one-on-one connections or support groups. Other patients can often validate feelings, share experiences, and provide companionship^[18].

Dietary needs will change. Resources are available to help patients adjust to these changes and better understand nutritional needs^[5]. Eating healthy and maintaining a healthy weight may help. A balanced diet that includes a variety of fruits and vegetables, choosing whole grains over processed grains, and limiting or avoiding intake of red and processed meats, alcohol consumption, and reducing intake of sugary and high-fat foods is recommended^[17].

Staying physically active can be beneficial. Regular exercise has many benefits for those with pancreatic cancer, including improved mood, energy levels, and overall physical health. Types of exercise recommended include walking, swimming, and yoga. Gradually incorporating exercise into a daily routine can help to build strength and endurance^[17]. Aim for at least 30 minutes of physical activity per day^[17].

Quitting smoking can have many benefits, including reducing the risk of cancer recurrence. Strategies to quit smoking include nicotine replacement therapy, counseling, and support groups^[17].

Managing stress is important, as stress can have a negative impact on cancer treatment. Techniques for stress management such as meditation, deep breathing, and yoga can help to reduce stress and improve overall well-being^[17].

Self-care should be a priority. This includes enjoying the little things and taking time to do things you enjoy. You may need to adapt an activity, but it doesn’t mean activities are impossible. A change in life events can also spark interest in new hobbies and pursuits. Consider journaling, meditation, yoga and other relaxation exercises, as well as social activities in the community^[5].

Maintaining a positive outlook can be difficult but important. Staying positive and hoping for the best can push a patient to continue battling the disease and follow medical advice. A positive outlook can help a patient take better care of themselves and appreciate meaningful things in the present^[18].

Regular follow-up appointments are important. Monitoring for recurrence is essential for early detection and treatment^[17].

Remember that you are not your cancer. Even though you have the disease, you get to decide how you want to live the rest of your life. You can choose to live with hope^[16].

It is important to recognize when you need additional support. If you’re feeling consistently overwhelmed, anxious, or depressed, it may be time to speak with a healthcare professional. Mental health care is an important part of cancer recovery^[17].

Ductal adenocarcinoma of the pancreas is a serious disease that requires a carefully planned approach to care, blending proven medical treatments with emerging therapies being tested in research settings worldwide.

Understanding Treatment Pathways for Pancreatic Ductal Adenocarcinoma

When someone receives a diagnosis of ductal adenocarcinoma of the pancreas, also called PDAC, treatment planning becomes a journey shaped by several important factors. The stage of the disease at diagnosis, the patient’s overall health, and the location of the tumor within the pancreas all influence which treatments doctors will recommend. The main goals of treatment include controlling symptoms, slowing the disease’s progression, and improving the patient’s quality of life.^[1][2]

This type of cancer accounts for more than 90% of all pancreatic cancers and is considered one of the most challenging forms of the disease to treat.^[3][4] The difficulty lies partly in the fact that most people don’t develop symptoms until the cancer has already grown or spread to other organs. By the time doctors discover the disease, only about 10 to 20% of patients have tumors that surgeons can completely remove.^[6]

Treatment approaches fall into two main categories: standard treatments that medical societies have approved based on years of research and evidence, and experimental therapies currently being evaluated in clinical trials. Standard treatments represent the foundation of care, while clinical trials offer hope for better outcomes through innovative approaches. Patients and their families should discuss both options with their medical team to understand which path might be most appropriate for their specific situation.^[10][11]

The medical team typically includes surgeons, oncologists (doctors who specialize in cancer treatment), radiation specialists, nutritionists, and other support professionals. This team works together to create a personalized treatment plan. Because PDAC can affect digestion and nutrition, and because treatments often cause side effects, supportive care forms an essential part of the overall treatment strategy.^[6]

Standard Treatment Approaches

The cornerstone of PDAC treatment remains surgical removal of the tumor whenever possible. Surgery offers the only chance for cure, but it’s only an option when the cancer hasn’t spread to distant organs or wrapped around major blood vessels. The most common surgical procedure is called the Whipple procedure, particularly when the tumor is located in the head of the pancreas. This complex operation removes the head of the pancreas, part of the small intestine, the gallbladder, and sometimes portions of the stomach and nearby lymph nodes.^[10][21]

After surgery, doctors typically recommend adjuvant chemotherapy, which means chemotherapy given after the tumor has been removed. This additional treatment aims to eliminate any cancer cells that might remain in the body, reducing the risk that the cancer will return. The therapy usually continues for several months following recovery from surgery.^[11]

Chemotherapy forms the backbone of treatment for most patients with PDAC, whether their disease can be surgically removed or not. Several chemotherapy regimens have become standard treatments over the past decades. Gemcitabine, a nucleoside analogue that interferes with cancer cell DNA, has been used for many years either alone or in combination with other drugs. Nucleoside analogues work by mimicking the building blocks of DNA, tricking cancer cells into incorporating them during cell division, which ultimately leads to cell death.^[6]

Another chemotherapy option is 5-fluorouracil (5-FU), a pyrimidine analogue that works similarly to gemcitabine but through a slightly different mechanism. Pyrimidine analogues also disrupt DNA and RNA production in rapidly dividing cancer cells.^[6]

For patients who are relatively healthy and able to tolerate more intensive treatment, doctors may recommend FOLFIRINOX, a combination of four drugs: folinic acid, 5-fluorouracil, irinotecan, and oxaliplatin. Clinical studies have shown that FOLFIRINOX can nearly double survival time compared to gemcitabine alone in patients with metastatic disease (cancer that has spread to other organs). However, this regimen causes more side effects, including fatigue, nausea, diarrhea, low blood counts, and numbness or tingling in the hands and feet. Because of these side effects, FOLFIRINOX is typically reserved for patients with good overall health and performance status.^[6]

Another combination approach pairs gemcitabine with nab-paclitaxel, a form of the chemotherapy drug paclitaxel bound to albumin protein. This combination has also been shown to significantly improve overall survival compared to gemcitabine alone, though with increased side effects. The albumin binding helps deliver the drug more effectively to tumors.^[6]

The duration of chemotherapy varies depending on the situation. For patients receiving treatment after surgery, chemotherapy typically continues for about six months. For those with advanced or metastatic disease, treatment may continue as long as it’s working and the patient tolerates it reasonably well. Doctors monitor patients regularly with blood tests and imaging scans to assess how well the treatment is controlling the cancer.^[11]

Radiation therapy, which uses high-energy beams to kill cancer cells, has been used less frequently for PDAC than for some other cancers. This is partly because most patients have widespread disease by the time of diagnosis, making local treatments like radiation less useful. However, radiation may be recommended in certain situations, such as treating cancer that has spread to a specific area causing pain, or as part of treatment for cancer that cannot be removed surgically but hasn’t spread to distant organs. Radiation is sometimes combined with chemotherapy, an approach called radiochemotherapy or chemoradiation, which may make the radiation more effective.^[6]

Common side effects of chemotherapy for PDAC include nausea and vomiting, loss of appetite, fatigue, hair loss, diarrhea or constipation, increased risk of infection due to low white blood cell counts, and hand-foot syndrome (redness, swelling, and pain on the palms and soles). Radiation therapy side effects depend on the area treated but may include skin irritation, fatigue, and digestive problems if the abdomen is treated. Medical teams have many medications and strategies to help manage these side effects and maintain patients’ quality of life during treatment.^[6][8]

Innovative Treatments Being Tested in Clinical Trials

Because standard treatments for PDAC have limited effectiveness, researchers around the world are actively testing new approaches in clinical trials. These studies follow a structured process to determine whether new treatments are safe and effective. Phase I trials focus primarily on safety, testing the treatment in a small number of patients to find the appropriate dose and identify side effects. Phase II trials examine whether the treatment shows signs of effectiveness against the cancer. Phase III trials compare the new treatment against current standard treatments in larger groups of patients to determine if the new approach is better.^[2]

One particularly important discovery in PDAC research involves understanding the genetic changes that drive the cancer. Scientists have found that about 93% of PDAC tumors have mutations in a gene called KRAS. This gene produces a protein involved in controlling cell growth and division. When KRAS is mutated, it becomes stuck in an “on” position, constantly signaling cells to grow and divide. Understanding this mechanism has led researchers to develop drugs that specifically target KRAS mutations or the pathways affected by these mutations.^[4]

Research has also revealed that PDAC creates a unique environment around tumor cells called the tumor microenvironment. This environment includes not just cancer cells but also normal cells, blood vessels, and dense scar-like tissue that forms a barrier around the tumor. This barrier makes it difficult for chemotherapy drugs to reach cancer cells and also prevents the body’s immune system from attacking the tumor effectively. Scientists are testing treatments designed to break down this barrier and make tumors more accessible to both drugs and immune cells.^[2][9]

Immunotherapy represents one of the most exciting areas of cancer research. These treatments work by helping the patient’s own immune system recognize and attack cancer cells. Several types of immunotherapy are being tested for PDAC, including checkpoint inhibitors that remove the “brakes” cancer cells put on immune responses, and vaccines designed to train the immune system to recognize specific proteins on pancreatic cancer cells. While immunotherapy has shown remarkable success in some other cancer types, PDAC has proven more resistant. Researchers are working to understand why and to develop combination approaches that might overcome this resistance.^[2][6]

Targeted therapy refers to drugs designed to attack specific molecules involved in cancer growth. For example, some PDAC patients have mutations in genes called BRCA1 or BRCA2, which normally help repair damaged DNA. Patients with these mutations may benefit from drugs called PARP inhibitors, which interfere with another DNA repair pathway. When cancer cells can’t repair DNA damage through either pathway, they die. Clinical trials are testing PARP inhibitors in PDAC patients with BRCA mutations.^[6]

Another area of investigation involves drugs that target blood vessel formation. Tumors need to develop new blood vessels to grow beyond a certain size, a process called angiogenesis. Drugs that block signals promoting blood vessel growth may help starve tumors of nutrients and oxygen. Researchers are testing whether combining these drugs with chemotherapy improves outcomes in PDAC.^[2]

Some clinical trials are examining whether analyzing the specific genetic and molecular characteristics of each patient’s tumor can guide treatment selection, an approach called precision medicine or personalized medicine. Research has shown that about 42% of PDAC tumors have genetic alterations that might be targetable with drugs currently being tested or already approved for other cancer types. This suggests that matching patients to treatments based on their tumor’s molecular profile could improve outcomes.^[4]

Researchers are also investigating novel combinations of existing treatments. For instance, studies are examining whether combining immunotherapy with chemotherapy, radiation, or targeted drugs might enhance the immune system’s ability to fight PDAC. Other trials are testing three-way combinations of different drug classes to attack the cancer through multiple mechanisms simultaneously.^[6]

Early results from some clinical trials have shown promise. Certain combination approaches have demonstrated improvements in tumor shrinkage rates and progression-free survival (the length of time before the cancer starts growing again after treatment). Some trials have also reported acceptable safety profiles, meaning patients could tolerate the treatments without excessive side effects. However, it’s important to remember that trial results are preliminary until confirmed in larger studies.^[2]

Most Common Treatment Methods

• Surgery
  • Whipple procedure for tumors in the head of the pancreas, removing the head of the pancreas, part of the small intestine, gallbladder, and sometimes portions of the stomach
  • Only possible in 10-20% of patients when cancer hasn’t spread to distant organs or major blood vessels
  • Represents the only potentially curative treatment option
• Chemotherapy
  • Gemcitabine, a nucleoside analogue used alone or in combination with other drugs
  • 5-fluorouracil (5-FU), a pyrimidine analogue that disrupts DNA and RNA production
  • FOLFIRINOX combination (folinic acid, 5-FU, irinotecan, and oxaliplatin) for patients with good health status
  • Gemcitabine plus nab-paclitaxel combination therapy
  • Adjuvant chemotherapy given after surgery to eliminate remaining cancer cells
  • Neoadjuvant chemotherapy given before surgery to shrink tumors
• Radiation Therapy
  • High-energy beams used to kill cancer cells in specific areas
  • Sometimes combined with chemotherapy (chemoradiation) for enhanced effectiveness
  • Used for locally advanced disease that cannot be surgically removed
  • May be used to control symptoms such as pain from cancer spread
• Targeted Therapy
  • PARP inhibitors for patients with BRCA1 or BRCA2 gene mutations
  • Drugs targeting the KRAS gene mutation or related pathways
  • Agents blocking blood vessel formation (angiogenesis inhibitors)
  • Treatment selection based on tumor genetic and molecular profiling
• Immunotherapy
  • Checkpoint inhibitors that help the immune system recognize cancer cells
  • Cancer vaccines designed to train the immune system
  • Combination approaches with chemotherapy or radiation to overcome resistance
  • Strategies to modify the tumor microenvironment to improve immune cell access

Adenocarcinoma of the Pancreas

Adenocarcinoma of the pancreas is the most common type of pancreatic cancer, accounting for about 90% of cases. This disease often develops without early warning signs, making it difficult to detect until it has advanced. Understanding this cancer, its symptoms, and available treatments can help patients and their families navigate this challenging diagnosis.

Table of contents

• What is Pancreatic Adenocarcinoma?
• The Pancreas and Its Function
• Symptoms and Warning Signs
• Risk Factors
• How is it Diagnosed?
• Outlook and Survival
• Treatment Options
• Managing Quality of Life

What is Pancreatic Adenocarcinoma?

Pancreatic adenocarcinoma is a type of cancer that begins in the cells lining the small tubes inside the pancreas, called ducts. These ducts normally carry digestive juices that contain enzymes to help break down food.^[1][2]

About 95 out of 100 pancreatic cancers are exocrine cancers, which means they start in the exocrine cells that make digestive enzymes. Most of these exocrine cancers are adenocarcinomas. In fact, about 9 out of 10 people with pancreatic cancer have this specific type of tumor.^[4][5]

Pancreatic adenocarcinoma can grow anywhere in the pancreas, though it is most often found in the head of the pancreas, which is the widest part of the organ.^[5] When people or doctors refer to “pancreatic cancer” without specifying the type, they are usually talking about adenocarcinoma.^[6]

The Pancreas and Its Function

The pancreas is a gland located in your abdomen, between your spine and stomach. It sits behind the stomach and is shaped like a thin pear lying on its side. The organ is about 6 inches long and has three main parts: the widest end is called the head, the middle section is the body, and the narrow end is the tail.^[1][7]

• Pancreas
• Stomach
• Small intestine
• Bile duct

Your pancreas has two main jobs in your body. First, it makes digestive juices that help break down food into substances the body can use. Second, it makes hormones like insulin and glucagon that help control blood sugar levels and help the body use and store energy from food.^[1][7]

Symptoms and Warning Signs

Unfortunately, pancreatic adenocarcinoma does not cause noticeable symptoms in its early stages. Most patients are without symptoms during the early course of disease, which often leads to delays in diagnosis.^[1][2] This is one reason why the disease is often not discovered until it has already spread to other parts of the body.^[3]

As the cancer grows and begins to affect other organs in the digestive system, symptoms typically emerge. The signs of pancreatic cancer, when present, are similar to the signs of many other illnesses, such as pancreatitis (inflammation of the pancreas) or an ulcer.^[7]

Common symptoms include:^[1][3][7]

• Jaundice (yellowing of the skin and whites of the eyes)
• Light-colored stools or dark urine
• Pain in the upper or middle abdomen
• Back pain
• Unexplained weight loss
• Loss of appetite
• Fatigue
• Nausea and vomiting
• Gas or bloating
• Blood clots
• New-onset diabetes

Some people develop vague symptoms up to one year before receiving a diagnosis. Many people report that their first symptoms were back pain or stomach pain. These symptoms can come and go at first but may worsen after meals or when lying down.^[3]

Risk Factors

While the exact cause of pancreatic adenocarcinoma is not fully understood, experts have identified several factors that increase a person’s chances of developing the disease. Having one or more risk factors does not mean you will definitely get pancreatic cancer, and many people with no known risk factors do develop the disease.^[7]

The most common risk factors include:^[1][2][3]

• Cigarette smoking: This appears to be one of the strongest risk factors and is likely associated with as many as one quarter of all pancreatic tumors. About 25% of cases are linked to smoking.^[2][6]
• Age: Most pancreatic cancer is diagnosed after age 65, and it rarely occurs before age 40.^[1][6]
• Diabetes mellitus: Type 2 diabetes may play a role in development of pancreatic cancer. Patients with type 2 diabetes often have years of insulin resistance with high insulin levels, and insulin’s ability to promote cell growth may explain the association.^[2]
• Chronic pancreatitis: Long-term inflammation of the pancreas increases risk.^[1]
• Family history: Having family members with pancreatic cancer raises your risk.^[1]
• Certain genetic syndromes: Including hereditary nonpolyposis colon cancer (Lynch syndrome), hereditary breast and ovarian cancer syndrome, and others.^[7]
• Obesity: Carrying extra weight increases risk.^[1]
• Alcohol use: Heavy drinking is associated with increased risk.^[2]

Research has found that the specific combination of smoking, diabetes, and poor diet increases the risk of pancreatic cancer more than any single factor alone.^[1] Additionally, the disease is more common in African-Americans and slightly more common in men.^[2]

How is it Diagnosed?

Pancreatic cancer is difficult to detect and diagnose early because there are no noticeable signs or symptoms in the early stages, and the pancreas is hidden behind other organs in the abdomen, making it difficult to see clearly on imaging tests.^[7]

To diagnose pancreatic adenocarcinoma and determine its extent, doctors use several tests:^[7][8]

• Imaging tests: These include computed tomography (CT) scans, magnetic resonance imaging (MRI), and endoscopic ultrasonography to look at the pancreas and surrounding areas.
• Blood tests: These can measure tumor markers like CA 19-9, though this marker has low specificity. Most patients with pancreatic cancer have an elevated CA 19-9 level at diagnosis.^[12]
• Tissue biopsy: A small sample of tissue is removed and examined under a microscope to confirm cancer and determine its type.^[3]
• Endoscopic procedures: Tools inserted through the mouth or other openings can help visualize and sample tissue from the pancreas.

Doctors may also use PET scans and genetic testing to stage the cancer accurately and assess its behavior. These newer tests help determine if treatment is working effectively.^[20]

Outlook and Survival

The outlook for pancreatic adenocarcinoma is generally poor. The overall one- and five-year survival rates are 24% and 6%, respectively, making it the only cancer with an overall 5-year survival rate in the single digits.^[2][15]

Approximately 80% of patients have disease that has spread to nearby areas or other parts of the body at the time of diagnosis.^[2] Pancreatic cancer is the fourth leading cause of cancer death in men and women in the United States, and it is expected to become the second leading cause of cancer death by 2030.^[2][3]

The primary factors that influence prognosis include:^[12]

• Whether the tumor can be completely removed by surgery
• Whether the tumor has spread to lymph nodes or other parts of the body
• The patient’s overall health and ability to tolerate treatment

However, there is reason for hope. People with pancreatic cancer are living longer thanks to improved treatment approaches. New methods of treatment and better ways to detect and manage the disease are helping improve outcomes for patients.^[20]

Treatment Options

Treatment for pancreatic adenocarcinoma depends on several factors, including where the tumor is located, whether it can be removed by surgery, and whether it has spread. The main treatment approaches include surgery, chemotherapy, radiation therapy, and supportive care.^[2]

Surgery

Surgery is the primary treatment that offers any chance of curing the disease. However, fewer than 20% of patients are eligible for surgery because the cancer has often already spread by the time of diagnosis.^[15] The most common surgical procedure is the Whipple procedure (also called pancreaticoduodenectomy), which removes the head of the pancreas, part of the small intestine, the gallbladder, and part of the bile duct.^[8][21]

Other surgical options include distal pancreatectomy, which removes the tail and sometimes the body of the pancreas, and total pancreatectomy, which removes the entire pancreas.^[14]

Chemotherapy

Chemotherapy uses drugs to kill cancer cells. It may be given before surgery (neoadjuvant therapy) to shrink the tumor, after surgery (adjuvant therapy) to kill any remaining cancer cells, or as the main treatment when surgery is not possible.^[9][21]

Common chemotherapy combinations include FOLFIRINOX and gemcitabine-based regimens. The choice depends on the patient’s overall health and the specific characteristics of the cancer.^[10]

Radiation Therapy

Radiation therapy uses high-energy beams to kill cancer cells. It is often combined with chemotherapy (called chemoradiotherapy) and may be used before or after surgery, or as the main treatment for tumors that cannot be removed.^[9]

Targeted Therapy and Immunotherapy

For some patients, newer treatments like targeted therapy and immunotherapy may be options. Immunotherapy drugs like pembrolizumab (Keytruda) and dostarlimab (Jemperli) are approved for small subsets of patients whose tumors have specific characteristics, such as high microsatellite instability or DNA mismatch repair deficiency.^[15]

Palliative Care

Palliative care focuses on relieving symptoms and improving quality of life rather than curing the disease. This type of care is important for all patients with pancreatic cancer, regardless of whether they are receiving other treatments. Palliative care can help manage pain, digestive problems, and other symptoms.^[10]

Managing Quality of Life

A pancreatic cancer diagnosis brings many life changes, both physical and emotional. While the disease and its treatment can be stressful, there are several ways patients can better cope and maintain their quality of life.^[17]

Nutrition and Diet

Maintaining proper nutrition is essential but can be challenging. Patients often experience loss of appetite, feeling full quickly, and digestive difficulties. Eating multiple small meals throughout the day rather than three large meals can help. Some patients benefit from taking pancreatic enzyme supplements prescribed by their doctor to help digest food better.^[19]

Staying hydrated is crucial, especially if experiencing diarrhea or vomiting. Water, herbal teas, and clear broths are good choices. It may help to avoid fatty foods, very spicy foods, and foods high in sugar, as these can be harder to digest.^[18]

Physical Activity

Staying physically active can help improve mood, increase energy levels, and support overall health. Even light exercise like walking, gentle stretching, or yoga can be beneficial. The key is to start slowly and listen to your body, resting when needed.^[18][19]

Managing Symptoms

Common symptoms like pain, fatigue, and depression can be managed with proper medical care. Pain can be controlled with medications, and it’s important to work with a pain specialist if needed. Anti-depressant medications and counseling can help with depression and anxiety. Don’t hesitate to ask your medical team for help managing these symptoms.^[19]

Support Systems

Developing a strong support system is vital. This includes family, friends, clergy, and your medical team. Talking openly about your feelings and concerns can help everyone cope better. Many patients find comfort in support groups where they can connect with others facing similar challenges.^[17][16]

Remember that you are not alone. Organizations like the Pancreatic Cancer Action Network offer one-on-one support, counseling connections, and resources to help you throughout your journey.^[16]

Finding Your “New Normal”

Life changes after a pancreatic cancer diagnosis, but living each day as normally as you can is important. Being open to new meaning in life and embracing a “new normal” can help. This might mean adapting activities you enjoy or discovering new hobbies. Taking time for self-care, relaxation, and activities that bring joy can make a significant difference in your well-being.^[16]

Pancreatic adenocarcinoma is a challenging disease that affects the pancreas, a vital organ tucked behind the stomach that helps digest food and regulate blood sugar levels. Understanding this condition can empower patients and families to make informed decisions during their cancer journey.

Understanding Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma is the most common type of pancreatic cancer, making up approximately 90 to 95 percent of all pancreatic cancer cases.^[4][5] This disease develops when cells in the pancreas begin to multiply uncontrollably and form a tumor. The pancreas is a small, fish-shaped organ about six inches long that sits between the stomach and the spine.^[1][3] It performs two essential jobs: creating enzymes that help break down food, and producing hormones like insulin that control blood sugar levels.^[7]

Most pancreatic adenocarcinomas begin in the cells that line the small tubes inside the pancreas called ducts. These ducts carry digestive juices containing enzymes into the main pancreatic duct.^[5] The disease can develop anywhere in the pancreas, though it most commonly appears in the head, which is the widest part of the organ.^[5] The middle section is called the body, and the narrowest end is known as the tail.^[3]

One of the most troubling aspects of this disease is that it typically does not cause noticeable symptoms in its early stages. Many people only begin to experience signs when the cancer has already grown large enough to affect nearby organs or has spread to other parts of the body.^[1][2] This delayed detection makes pancreatic adenocarcinoma particularly difficult to treat and contributes to its reputation as one of the most challenging cancers to manage.

How Common Is This Disease

Pancreatic cancer is the second most common gastrointestinal cancer in the United States. Each year, approximately 53,000 to 67,000 people receive a diagnosis of pancreatic cancer in this country.^[2][12] While pancreatic cancer represents only about 3 percent of all cancers diagnosed in the United States, it has a disproportionately high death rate.^[3] It stands as the fourth leading cause of cancer-related deaths in both men and women, despite being less common than cancers of the prostate, lung, or colon.^[2]

The disease shows some interesting patterns across different groups of people. It is more common in African Americans compared to other racial groups, and slightly more common in men than in women.^[2] Pancreatic adenocarcinoma is usually a disease of older adults, with most diagnoses occurring after age 65.^[1] In fact, it rarely occurs before the age of 40, and more than half of all cases are diagnosed in people over 70 years old.^[6]

The incidence of pancreatic cancer has been steadily increasing over recent decades. Current trends suggest that by 2030, pancreatic cancer may become the second leading cause of cancer death in the United States, highlighting the urgent need for better detection and treatment methods.^[3] Globally, around 460,000 people are diagnosed with pancreatic cancer each year, and it causes approximately 430,000 deaths worldwide.^[15]

What Causes Pancreatic Adenocarcinoma

The exact cause of pancreatic adenocarcinoma remains unclear, and researchers are still working to understand why this disease develops. What scientists do know is that the cancer begins when small changes occur in the DNA (the genetic material inside cells) of pancreatic cells. These changes cause the cells to grow and divide in an uncontrolled way, eventually forming clusters called tumors.^[1] If left untreated, these abnormal cells can spread beyond the pancreas to other parts of the body through a process called metastasis.^[6]

While we cannot point to a single cause, experts have identified several factors that increase the likelihood of developing this disease. These are called risk factors, and understanding them can help people make informed choices about their health.

Risk Factors for Pancreatic Adenocarcinoma

Cigarette smoking stands out as one of the strongest risk factors for pancreatic adenocarcinoma. Smoking is likely associated with as many as one in four pancreatic tumors, making it a significant contributor to the disease.^[2] The harmful chemicals in tobacco smoke damage cells throughout the body, including those in the pancreas, increasing the chance that these cells will develop cancer. This applies not only to cigarettes but also to cigars and other forms of tobacco use.^[3]

Diabetes mellitus, particularly type 2 diabetes (a condition where the body cannot properly use or produce insulin), plays a complex role in pancreatic cancer development. People with type 2 diabetes often experience years or decades of insulin resistance (when cells don’t respond well to insulin), which leads to higher than normal levels of insulin in the blood. Insulin has properties that can encourage cell growth, which may help explain why diabetes is connected to various types of cancer, including pancreatic adenocarcinoma.^[2] Interestingly, new-onset diabetes can sometimes be an early sign of pancreatic cancer itself.^[3][7]

Carrying extra body weight, especially obesity, increases the risk of developing pancreatic cancer. Where the extra weight is located on the body also matters, with abdominal fat appearing particularly concerning.^[3] A sedentary lifestyle and poor dietary habits compound these risks. Research has found that the specific combination of smoking, diabetes, and poor diet increases the risk of pancreatic cancer more than any single factor alone.^[1]

Chronic pancreatitis (long-term inflammation of the pancreas) is another risk factor. This ongoing inflammation can damage the pancreas over time and create an environment where cancer is more likely to develop.^[2][7] Heavy alcohol use contributes to pancreatitis and is therefore indirectly linked to pancreatic cancer risk.^[2]

Family history plays a role as well. People who have close relatives with pancreatic cancer face a higher risk of developing the disease themselves.^[7][12] Certain inherited genetic conditions also increase risk, including hereditary nonpolyposis colon cancer (also called Lynch syndrome), hereditary breast and ovarian cancer syndrome (often involving mutations in the BRCA1 or BRCA2 genes), and several other rare genetic syndromes.^[1][7][12]

When multiple risk factors are present together, their effects can combine and multiply, creating an even greater risk than would be expected from adding them up individually.^[2] This synergistic effect underscores the importance of addressing modifiable risk factors like smoking and maintaining a healthy weight.

Signs and Symptoms

Unfortunately, early-stage pancreatic adenocarcinoma rarely causes symptoms that would alert someone to its presence. This silent nature in the beginning stages is one reason why the disease often goes undetected until it has progressed.^[1][2] Symptoms typically only become noticeable once the tumor has grown large enough to press on nearby organs or block important structures in the digestive system.

When symptoms do appear, they can be vague and easily mistaken for other, less serious conditions like indigestion or a stomach ulcer. Some people develop vague symptoms up to one year before receiving a diagnosis.^[3] Many patients report that their first noticeable symptoms were pain in the back or stomach area. This pain can come and go initially but may worsen after eating meals or when lying down.^[3]

Jaundice (yellowing of the skin and the whites of the eyes) is a common and distinctive symptom. This occurs when the tumor blocks the bile duct, preventing bile from flowing normally from the liver to the intestine. Along with the yellow appearance of skin, jaundice often causes dark-colored urine and light-colored or pale stools.^[3][7] The backup of bile can also lead to intense itching of the skin, which can be quite uncomfortable.^[3]

Pain is another frequent complaint. Patients may experience discomfort in the upper or middle part of the abdomen, which sometimes radiates to the middle of the back. This pain results from the tumor pressing on nerves or other structures near the pancreas.^[3][7]

Digestive problems often accompany pancreatic adenocarcinoma. These can include nausea, vomiting, gas, and bloating. Many patients feel full quickly when eating or experience a general lack of appetite, which contributes to another common symptom: unexplained weight loss.^[3][7] Even when people try to maintain their normal diet, they may lose weight because the tumor interferes with digestion and the body’s ability to absorb nutrients.

Extreme tiredness or fatigue is common and can result from the cancer itself, poor nutrition, or the body’s response to the disease.^[3] Some patients also develop blood clots or notice the sudden onset of diabetes without other obvious causes, which should prompt further investigation.^[3][7]

Prevention and Risk Reduction

While pancreatic adenocarcinoma cannot be completely prevented, there are steps people can take to reduce their risk. The most impactful change someone can make is to stop smoking or never start. Given that smoking contributes to roughly 25 percent of pancreatic cancers, quitting tobacco use significantly lowers risk and brings numerous other health benefits as well.^[2]

Maintaining a healthy body weight through a balanced diet and regular physical activity is another important preventive measure. This approach not only reduces cancer risk but also helps prevent or manage diabetes, which itself is a risk factor for pancreatic cancer. A diet rich in fruits, vegetables, whole grains, and lean proteins supports overall health, while limiting red meat, processed foods, and sugary items may offer protective benefits.^[7]

Limiting alcohol consumption is advisable, as heavy drinking can lead to chronic pancreatitis, which increases cancer risk. Managing chronic health conditions like diabetes and pancreatitis with the help of healthcare providers is also important for reducing long-term risk.^[2]

For people with a family history of pancreatic cancer or known genetic mutations that increase risk, regular consultations with healthcare providers are essential. In some cases, doctors may recommend genetic counseling and testing to better understand inherited risk. Individuals with certain genetic syndromes may benefit from specialized screening programs, though routine screening for the general population is not currently recommended due to the rarity of the disease and limitations of available screening methods.^[2][7]

How the Disease Affects the Body

Understanding how pancreatic adenocarcinoma changes normal body functions helps explain many of the symptoms patients experience. The disease disrupts the pancreas’s normal activities in producing digestive enzymes and hormones. When tumors block the pancreatic duct or invade the pancreatic tissue itself, the organ cannot release enough enzymes into the small intestine to properly break down food, especially fats.^[2] This leads to poor digestion and absorption of nutrients, contributing to weight loss and nutritional deficiencies.

The pancreas also produces insulin and other hormones that regulate blood sugar. When cancer damages these hormone-producing cells, it can lead to diabetes or worsen existing diabetes. This explains why some patients first discover they have pancreatic cancer after developing sudden, unexplained diabetes.^[7]

As tumors grow, they can press on or invade nearby structures. The pancreas sits close to major blood vessels, the stomach, the small intestine, and the bile duct. When a tumor grows into the bile duct, which carries bile from the liver and gallbladder to the intestine, bile cannot flow normally. This backup causes jaundice and affects the body’s ability to digest fats and absorb certain vitamins.^[3]

Tumors can also wrap around or grow into blood vessels, including the portal vein and superior mesenteric vein, which carry blood from the intestines to the liver. In some cases, even major arteries like the superior mesenteric artery or celiac artery can be affected. When blood vessels are compromised, it complicates treatment options and can affect blood flow to vital organs.^[14]

Cancer cells from pancreatic adenocarcinoma can break away from the primary tumor and travel through the bloodstream or lymphatic system to other parts of the body. Common sites where pancreatic cancer spreads include the liver, lungs, and the membrane lining the abdominal cavity (peritoneum). Approximately 80 percent of patients have cancer that has spread to lymph nodes or distant organs by the time they receive a diagnosis.^[2]

The disease also triggers systemic changes throughout the body. Many pancreatic cancers release compounds into the bloodstream that break down muscle and fat tissue, a condition called cachexia. This process causes progressive weakness and weight loss even when patients try to eat well and maintain their nutrition. The body’s inflammatory response to cancer contributes to fatigue, loss of appetite, and overall decline in wellbeing.^[19]

Pancreatic adenocarcinoma represents one of the most challenging forms of cancer to treat, but advances in medical care are offering new pathways forward. Treatment approaches depend heavily on the stage of disease and individual patient characteristics, combining surgery, chemotherapy, radiation, and supportive care to help patients manage symptoms and maintain quality of life throughout their journey.

Understanding Your Treatment Path After Diagnosis

When you receive a diagnosis of pancreatic adenocarcinoma, you are suddenly thrust into a complex medical landscape. The primary goals of treatment vary depending on the stage of your cancer, but they often include slowing the progression of the disease, managing symptoms, and improving your quality of life.^[1] Understanding that treatment decisions must be tailored to your specific situation is crucial from the very beginning.

Pancreatic adenocarcinoma is the most common type of pancreatic cancer, accounting for about 95% of all pancreatic cancers.^[5] This cancer develops from cells that line the small tubes, called ducts, in the pancreas. These ducts carry digestive juices containing enzymes into the main pancreatic duct. The location of the tumor within the pancreas—whether in the head, body, or tail—can significantly influence which treatment options are available to you.

Standard treatments for pancreatic adenocarcinoma are approved by medical societies and have been studied extensively. However, research into new therapies continues at a rapid pace. Clinical trials are testing innovative approaches that may one day become standard care, offering hope that the treatment landscape will continue to improve for patients diagnosed in the future.^[9]

Standard Treatment Approaches for Pancreatic Adenocarcinoma

Surgery remains the primary mode of treatment when pancreatic cancer has not spread beyond the pancreas and can be completely removed.^[14] However, only about 20% of patients are candidates for surgery at the time of diagnosis because the disease often spreads before causing symptoms.^[2] For those who qualify, the most common surgical procedure is the Whipple procedure, also known as pancreaticoduodenectomy. This complex operation removes the head of the pancreas, part of the small intestine, the gallbladder, part of the stomach, and the bile duct.^[8]

When the tumor is located in the body or tail of the pancreas, surgeons may perform a distal pancreatectomy, which removes the tail and sometimes the body of the pancreas, often along with the spleen. In some cases where cancer is more extensive within the pancreas but has not spread to other organs, a total pancreatectomy—removal of the entire pancreas—may be necessary. These procedures are major surgeries that carry risks of complications and require recovery time, but they offer the best chance for long-term survival when the cancer can be completely removed.^[12]

Chemotherapy plays a vital role in treating pancreatic adenocarcinoma, both before and after surgery. When given before surgery, it is called neoadjuvant therapy, and when given after surgery, it is termed adjuvant therapy. The rationale for neoadjuvant therapy includes treating pancreatic cancer as a systemic disease from the start, potentially shrinking the tumor to make surgery more successful, and identifying patients whose cancer may not respond well to treatment.^[14]

For patients whose cancer has spread or cannot be surgically removed, chemotherapy becomes the primary treatment. Several chemotherapy regimens have been established as standard care. One of the most commonly used combinations is called FOLFIRINOX, which includes four different drugs: folinic acid (leucovorin), fluorouracil (5-FU), irinotecan, and oxaliplatin. This combination has shown effectiveness in extending survival but can cause significant side effects including fatigue, nausea, diarrhea, numbness or tingling in the hands and feet (peripheral neuropathy), and lowered blood cell counts that increase infection risk.^[9]

Another standard chemotherapy option combines gemcitabine with a drug called nab-paclitaxel (also known as Abraxane). Gemcitabine has been used for pancreatic cancer for many years, and adding nab-paclitaxel has improved its effectiveness. This combination tends to have fewer severe side effects than FOLFIRINOX but can still cause fatigue, nausea, hair loss, and lowered blood cell counts. The choice between different chemotherapy regimens depends on the patient’s overall health, the stage of cancer, and how well they can tolerate potential side effects.^[10]

The duration of chemotherapy treatment varies considerably. For adjuvant therapy after surgery, treatment typically continues for about six months. For patients with advanced disease, chemotherapy may continue as long as it appears to be working and the side effects remain manageable. Your medical team will monitor your response to treatment through imaging scans and blood tests, adjusting the plan as needed based on how the cancer responds and how you tolerate the medications.^[7]

Radiation therapy uses high-energy beams to kill cancer cells and is sometimes incorporated into treatment plans. It may be given before surgery to shrink tumors, after surgery to eliminate any remaining cancer cells, or as palliative care to relieve symptoms such as pain when surgery is not an option. Radiation is often combined with chemotherapy, a treatment approach called chemoradiotherapy, which can make the radiation more effective. Side effects of radiation therapy can include fatigue, nausea, vomiting, and skin irritation in the treated area.^[14]

Clinical guidelines from organizations such as the National Comprehensive Cancer Network emphasize the importance of multidisciplinary care, meaning that decisions about your treatment should involve input from specialists including gastroenterologists, radiologists, medical oncologists, surgical oncologists, and radiation oncologists. This team approach helps ensure that all aspects of your care are considered when developing your treatment plan.^[12]

Innovative Treatments Being Tested in Clinical Trials

While standard treatments remain the foundation of care, researchers are actively investigating new approaches that may improve outcomes for patients with pancreatic adenocarcinoma. Clinical trials test these innovative therapies in carefully designed studies that progress through different phases. Phase I trials primarily evaluate safety and determine the appropriate dose of a new treatment. Phase II trials assess whether the treatment appears effective against the cancer. Phase III trials compare the new treatment directly with existing standard treatments to determine if it offers advantages.^[15]

One area of active research involves immunotherapy, which harnesses the body’s own immune system to fight cancer. However, pancreatic adenocarcinoma has proven particularly resistant to many immunotherapy approaches that work well for other cancer types. Currently, two immunotherapy drugs have received approval for a small subset of pancreatic cancer patients whose tumors have specific genetic characteristics. Pembrolizumab (marketed as Keytruda) and dostarlimab (marketed as Jemperli) are checkpoint inhibitors that target the PD-1/PD-L1 pathway, helping immune cells recognize and attack cancer cells.^[15]

These immunotherapy drugs are only approved for patients whose tumors show high microsatellite instability (MSI-H), DNA mismatch repair deficiency (dMMR), or high tumor mutational burden (TMB-H). These characteristics are found in only about 1-2% of pancreatic cancers, but when present, patients may respond well to immunotherapy. This highlights the importance of comprehensive testing of your tumor, including genetic and biomarker testing, to determine if you might be a candidate for these treatments.^[15]

Researchers are investigating ways to make immunotherapy effective for more pancreatic cancer patients. One promising approach involves therapeutic vaccines designed to train the immune system to recognize cancer cells. Studies have tested vaccines that use parts of cancer cells or proteins that are more common in cancer cells. Some early research has shown that combining vaccines with standard chemotherapy may help some patients live longer, though these approaches remain experimental and are not yet approved as standard treatments.^[15]

Another innovative area of research focuses on targeted therapies that attack specific molecular changes in cancer cells. Scientists have identified that many pancreatic cancers have mutations in genes such as KRAS, which plays a role in cell growth. KRAS mutations are found in approximately 90% of pancreatic adenocarcinomas, making this an important target for drug development. Recently, drugs that can target specific KRAS mutations have been developed and tested in clinical trials. While these drugs have shown promise in other cancer types with KRAS mutations, research continues to determine how effective they may be specifically for pancreatic cancer.^[9]

Clinical trials are also investigating drugs that target other molecular pathways involved in pancreatic cancer growth and spread. Some studies are testing inhibitors of proteins that help cancer cells survive and grow, such as MEK inhibitors and PI3K inhibitors. These drugs work by blocking specific signals that cancer cells use to multiply and survive. When used alone, these targeted therapies have shown limited effectiveness against pancreatic cancer, but researchers are studying whether combining them with chemotherapy or other treatments might improve results.^[11]

A particularly innovative approach being studied involves personalized mRNA vaccines. This cutting-edge technology creates a vaccine specifically designed for each individual patient based on the unique genetic characteristics of their tumor. After surgery, researchers analyze the genetic makeup of the removed tumor and design an mRNA vaccine that teaches the patient’s immune system to recognize and attack cells with those specific characteristics. Early-phase clinical trials of this approach are underway at specialized cancer centers, including some in the United States.^[11]

Some clinical trials are exploring completely new ways to deliver treatments directly to tumors. For example, researchers are testing methods to inject drugs or viral agents directly into pancreatic tumors. Some of these approaches use modified viruses that can infect and kill cancer cells while stimulating an immune response. Other studies are investigating tiny particles called nanoparticles that can carry chemotherapy drugs directly to cancer cells, potentially reducing side effects on healthy tissues.^[9]

Clinical trials for pancreatic cancer are being conducted at major cancer centers across the United States and in other countries including many European nations. Eligibility for clinical trials depends on many factors including the stage of your cancer, previous treatments you have received, your overall health status, and the specific characteristics of your tumor. Organizations such as the Pancreatic Cancer Action Network maintain databases of active clinical trials and can help patients and families identify trials that might be appropriate.^[15]

It’s important to understand that treatments in clinical trials are experimental and may not work better than standard treatments. However, participating in a clinical trial gives you access to new therapies that are not otherwise available and contributes to advancing medical knowledge that may help future patients. The decision to participate in a clinical trial is highly personal and should be made after thorough discussion with your medical team about the potential benefits and risks.^[20]

Most common treatment methods

• Surgery
  • Whipple procedure (pancreaticoduodenectomy) removes the head of the pancreas, gallbladder, part of the stomach, part of the small intestine, and bile duct
  • Distal pancreatectomy removes the tail and sometimes body of the pancreas, often with the spleen
  • Total pancreatectomy removes the entire pancreas when cancer is more extensive but localized
  • Available only for patients whose cancer has not spread and can be completely removed
• Chemotherapy
  • FOLFIRINOX combination: folinic acid, fluorouracil, irinotecan, and oxaliplatin
  • Gemcitabine combined with nab-paclitaxel (Abraxane)
  • Can be given before surgery (neoadjuvant), after surgery (adjuvant), or as primary treatment for advanced disease
  • Treatment duration typically six months after surgery or ongoing for advanced disease
• Radiation Therapy
  • Uses high-energy beams to kill cancer cells
  • May be given before surgery to shrink tumors or after surgery to eliminate remaining cancer cells
  • Often combined with chemotherapy (chemoradiotherapy) for enhanced effectiveness
  • Can provide palliative relief from symptoms such as pain
• Immunotherapy
  • Pembrolizumab (Keytruda) approved for tumors with MSI-H, dMMR, or TMB-H characteristics
  • Dostarlimab (Jemperli) approved for tumors with dMMR
  • Checkpoint inhibitors that target the PD-1/PD-L1 pathway
  • Available only for small subset of patients with specific tumor characteristics
• Targeted Therapy
  • Drugs targeting specific molecular changes such as KRAS mutations
  • MEK inhibitors and PI3K inhibitors blocking specific cancer cell signals
  • Currently being tested in clinical trials for effectiveness in pancreatic cancer
• Experimental Approaches in Clinical Trials
  • Personalized mRNA vaccines designed based on individual tumor genetics
  • Therapeutic cancer vaccines to train the immune system
  • Direct tumor injection of drugs or modified viruses
  • Nanoparticle delivery systems for chemotherapy

Managing Symptoms and Supporting Quality of Life

Beyond cancer-directed treatments, managing symptoms and maintaining quality of life are essential components of comprehensive pancreatic cancer care. Many patients experience symptoms related to the cancer itself or as side effects of treatment. Supportive care, also called palliative care, focuses on relieving these symptoms and helping patients maintain the best possible quality of life regardless of the stage of disease.^[7]

Pain management is particularly important for many patients with pancreatic cancer. Pain can result from the tumor pressing on nearby nerves or organs. Various approaches can help control pain, including medications ranging from over-the-counter pain relievers to prescription opioids. Some patients benefit from procedures such as nerve blocks, where medication is injected near nerves to interrupt pain signals. Working with a pain specialist can help ensure that pain is adequately controlled.^[19]

Digestive issues are common because the pancreas plays a crucial role in digestion. Many patients experience bloating, particularly after eating, loss of appetite, and difficulty maintaining weight. Eating multiple small meals throughout the day rather than three large meals can help. Over-the-counter medications called proton pump inhibitors may reduce stomach discomfort. Pancreatic enzyme replacement therapy, available by prescription, can help improve digestion when the pancreas is not producing enough digestive enzymes.^[19]

Nutritional support is vital for maintaining strength during treatment. A balanced diet rich in fruits, vegetables, lean proteins, and whole grains provides necessary nutrients to support healing and energy levels. However, patients should avoid fatty foods such as fried foods and high-fat meats, which can be difficult to digest. Sugary foods may cause blood sugar spikes that worsen fatigue. Staying well hydrated is crucial, especially if experiencing diarrhea or vomiting. Water, herbal teas, and clear broths are excellent choices.^[18]

Physical activity offers numerous benefits including improved mood, increased energy levels, and better overall health. Regular exercise can help reduce fatigue, enhance physical function, and improve mental health. Simple activities such as walking can be adjusted to any fitness level. Swimming provides gentle, low-impact exercise. Yoga combines gentle stretching with mindfulness to promote relaxation and flexibility. Starting with small, achievable goals and gradually increasing activity levels as tolerated is recommended.^[19]

Emotional and psychological support is just as important as physical care. Depression and anxiety are common among cancer patients. Seeking help from mental health professionals, including psychiatrists who can prescribe medications if needed, can significantly improve quality of life. Many patients find that connecting with others who have faced similar challenges through support groups or one-on-one connections provides valuable emotional support and practical advice.^[17]

Developing a strong support system including family, friends, and your medical team helps you navigate the challenges of living with pancreatic cancer. Open communication about your feelings, symptoms, and concerns with your support network allows them to provide the help you need. Many patients find value in keeping a journal, which can help process emotions and track symptoms. Maintaining connections to activities and hobbies that bring joy, even if they need to be adapted, helps preserve a sense of normalcy and purpose.^[17]

Taking an active role in your care by asking questions, seeking information, and participating in decisions about treatment can help you feel more in control during a difficult time. While a cancer diagnosis brings many changes, focusing on the aspects of life you can control and maintaining hope for positive outcomes supports both physical and emotional wellbeing throughout your cancer journey.^[16]

Diagnosing pancreatic adenocarcinoma requires a careful combination of imaging, blood tests, and tissue examination, especially since early symptoms are often absent or vague, making timely detection challenging.

Introduction: Who Should Seek Diagnostic Testing and When

Pancreatic adenocarcinoma, the most common type of pancreatic cancer, represents about 95% of all pancreatic cancers and is notoriously difficult to detect in its early stages.^[5] One of the biggest challenges in diagnosing this disease is that there are typically no noticeable signs or symptoms during the early course of illness, which often leads to delays in diagnosis.^[2] By the time symptoms appear, the cancer has often already spread to other parts of the body.

People should consider seeking medical evaluation if they experience certain warning signs. These include yellowing of the skin and eyes, known as jaundice, which happens when the tumor blocks the bile duct.^[3] Other concerning symptoms include persistent pain in the upper abdomen or middle back, unexplained weight loss without trying, loss of appetite, constant fatigue, nausea and vomiting, gas or bloating, and changes in stool color or urine color.^[3] Light-colored stool or dark urine can be particularly telling signs that something is wrong with the digestive system.

Healthcare providers might also suspect pancreatic cancer in patients who have recently developed diabetes without obvious cause or those who suddenly develop pancreatitis, which is inflammation of the pancreas causing severe pain.^[3] Some patients report that their first symptoms were back pain or stomach pain that came and went initially but worsened after meals or when lying down.^[13] Unfortunately, many people develop only vague symptoms up to one year before receiving an actual diagnosis, which highlights how subtle the early presentation can be.

Certain individuals face higher risks and might benefit from discussing screening with their doctor. Risk factors include cigarette smoking, which is linked to as many as one quarter of all pancreatic tumors, as well as obesity, type 2 diabetes, chronic pancreatitis, and having a family history of pancreatic cancer.^[2] People with specific genetic syndromes, such as those associated with the BRCA1, BRCA2, PALB2, and ATM genes, also carry increased risk.^[12] African-Americans, men, and older adults are also at higher risk, with most cases occurring after age 65.^[1][2]

Classic Diagnostic Methods for Identifying Pancreatic Adenocarcinoma

Diagnosing pancreatic cancer is challenging because the pancreas is positioned deep within the abdomen, hidden behind the stomach and other organs, making it difficult to see or feel during routine physical examinations.^[7] When a doctor suspects pancreatic cancer based on symptoms or risk factors, several diagnostic methods are typically employed to confirm the presence of disease and distinguish it from other conditions with similar presentations.

Imaging Tests

Imaging tests play a crucial role in visualizing the pancreas and detecting abnormalities. A helical computed tomographic scan, or CT scan, is one of the most common first-line imaging tools used to identify pancreatic cancer.^[12] This test uses X-rays and computer processing to create detailed cross-sectional images of the pancreas and surrounding structures. The CT scan can reveal the location and size of tumors and help determine whether the cancer has spread to nearby blood vessels or other organs.

Magnetic resonance imaging, or MRI, is another valuable imaging technique that uses magnets and radio waves instead of radiation to create detailed pictures of soft tissues in the body.^[12] MRI scans can be particularly helpful in visualizing the pancreatic ducts and detecting smaller tumors that might be missed on CT scans.

Endoscopic ultrasonography, often shortened to EUS, combines endoscopy with ultrasound technology.^[12] During this procedure, a thin, flexible tube with an ultrasound probe on the end is passed through the mouth, down the esophagus and stomach, to reach the area near the pancreas. Because the probe is positioned very close to the pancreas, it can create highly detailed images. This technique is also valuable because it allows doctors to perform biopsies if suspicious areas are found.

Some medical centers also use PET scans, which involve injecting a small amount of radioactive sugar into the bloodstream.^[20] Cancer cells, which typically consume more sugar than normal cells, show up as bright spots on the scan. PET scans can be helpful in determining whether the cancer has spread beyond the pancreas and can also help assess how well treatment is working.

Blood Tests and Tumor Markers

Blood tests are another important component of pancreatic cancer diagnosis, though they cannot definitively diagnose the disease on their own. One commonly measured substance is CA 19-9, which stands for cancer antigen 19-9.^[12] This is a protein that is often elevated in people with pancreatic cancer. However, CA 19-9 has limitations because it lacks specificity, meaning it can also be elevated in other conditions, and some people with pancreatic cancer do not have elevated levels at all. Despite these limitations, most patients with pancreatic cancer do have an elevated CA 19-9 level at diagnosis, and tracking this marker over time can help doctors monitor disease progression or response to treatment.^[12]

It is important to note that no truly tumor-specific markers exist for pancreatic cancer, which is why blood tests must be interpreted alongside other diagnostic findings rather than used in isolation.^[12]

Tissue Biopsy and Pathological Examination

The most definitive way to diagnose pancreatic cancer is through a biopsy, which involves removing a small sample of tissue from the suspicious area and examining it under a microscope.^[8] Biopsies can be obtained in several ways. During endoscopic ultrasonography, doctors can use a thin needle to extract tissue samples from the pancreas. Other times, biopsies may be performed using CT guidance, where imaging helps guide a needle through the skin to reach the pancreatic mass.

Once tissue is obtained, a pathologist examines it to look for cancer cells and determine the specific type of pancreatic cancer. In pancreatic adenocarcinoma, the cancer develops from cells lining the small tubes, called ducts, that carry digestive juices through the pancreas.^[5] The pathologist can confirm whether cancer is present and provide information about its characteristics, which helps guide treatment decisions.

Additional Diagnostic Procedures

Endoscopic retrograde cholangiopancreatography, abbreviated as ERCP, is sometimes used when there is suspicion of bile duct obstruction.^[8] This procedure uses an endoscope passed through the mouth to reach the area where the bile duct and pancreatic duct empty into the small intestine. Dye is injected through the scope to make the ducts visible on X-ray images, allowing doctors to see blockages or narrowing that might indicate cancer.

In some cases, minimally invasive techniques such as laparoscopy may be used.^[12] During laparoscopy, small incisions are made in the abdomen and a tiny camera is inserted to directly visualize the pancreas and surrounding organs. This can help determine whether the cancer has spread to the abdominal lining or other nearby structures that might not be visible on standard imaging tests. Doctors may also sample fluid from the abdomen during this procedure to check for cancer cells.

Peritoneal cytology, which involves examining fluid from the abdominal cavity for cancer cells, has proven useful in some cases.^[12] In one case series of 228 patients, positive peritoneal cytology had a very high specificity of 98% and a positive predictive value of 94% for determining that the cancer could not be completely removed by surgery, though its sensitivity was only 25%.

Distinguishing Pancreatic Cancer from Other Conditions

One of the challenges in diagnosing pancreatic adenocarcinoma is that its symptoms overlap with many other, less serious conditions. Jaundice can occur with gallstones or hepatitis. Abdominal pain and digestive problems can result from ulcers, gastritis, or chronic pancreatitis. Weight loss and fatigue are nonspecific symptoms that accompany countless illnesses. This is why a combination of clinical evaluation, imaging, blood tests, and tissue analysis is necessary to arrive at an accurate diagnosis and rule out other possible explanations for a patient’s symptoms.

Diagnostics for Clinical Trial Qualification

When patients with pancreatic adenocarcinoma consider participating in clinical trials, they typically undergo additional testing beyond what was required for initial diagnosis. Clinical trials are research studies that test new treatments or combinations of treatments, and they often have specific requirements, called eligibility criteria, that patients must meet before they can enroll.

Staging and Resectability Assessment

Before enrolling in a clinical trial, doctors must thoroughly evaluate the stage of the cancer, which describes how much the disease has grown and spread.^[12] Staging involves detailed imaging tests, typically including high-quality CT scans and sometimes MRI or PET scans. The goal is to determine whether the tumor is confined to the pancreas or has spread to nearby blood vessels, lymph nodes, or distant organs.

Clinical trials often categorize patients based on resectability, meaning whether the tumor can potentially be removed by surgery. Patients may be classified as having resectable disease, where the tumor has not grown into important blood vessels and can be removed; borderline resectable disease, where the tumor has grown close to or into major blood vessels but surgery might still be possible; locally advanced disease, where the cancer has grown too extensively into blood vessels or nearby tissues to allow for safe removal; or metastatic disease, where the cancer has spread to distant organs.^[12] Many clinical trials are designed specifically for patients in one of these categories.

Genetic and Molecular Testing

Modern clinical trials increasingly require genetic and molecular testing of both the patient and the tumor. Germline testing looks at the patient’s own DNA, inherited from their parents, to identify mutations that might affect how the cancer behaves or responds to treatment.^[12] Certain inherited mutations, particularly in genes like BRCA1, BRCA2, PALB2, and ATM, can make pancreatic cancer cells more vulnerable to specific treatments.

Biomarker testing of the tumor tissue itself is also crucial for clinical trial enrollment and treatment selection.^[4] This testing examines the tumor’s biology at a molecular level to identify specific characteristics that might predict response to targeted therapies or immunotherapies. For example, some clinical trials accept only patients whose tumors have high microsatellite instability, abbreviated as MSI-H, or DNA mismatch repair deficiency, known as dMMR, because these tumors may respond to immunotherapy drugs.

Some advanced medical centers are now using novel genetic testing to examine the blood of patients for traces of cancer DNA, as well as testing fluid from the abdomen during laparoscopy.^[20] This approach can help identify patients who might be at higher risk for cancer recurrence after treatment and can guide individualized therapy plans.

Performance Status and Organ Function Tests

Clinical trials typically require patients to have adequate organ function and overall physical condition to tolerate the treatments being studied. This usually involves blood tests to check kidney function, liver function, and bone marrow function by measuring things like creatinine, liver enzymes, and blood cell counts. Patients often need to have a certain performance status score, which is a measure of how well they can carry out daily activities, to be eligible for enrollment.

Additional Specialized Testing

Depending on the specific clinical trial, additional specialized tests may be required. Some trials require repeat biopsies or imaging at specific time points to monitor how the tumor is responding to treatment. Others may require specialized PET scans that use novel tracers to measure metabolic activity or other features of the tumor. Patients considering clinical trial participation should discuss with their medical team what specific tests will be required and what the purpose of each test is in determining eligibility and monitoring response.

Adenocarcinoma of the pancreas is the most common form of pancreatic cancer, a disease that remains one of the most challenging to treat. Understanding what to expect after diagnosis, how the disease may progress, and how it can affect daily life is essential for patients and their families as they navigate this difficult journey together.

Prognosis

When a person receives a diagnosis of adenocarcinoma of the pancreas, also known as pancreatic ductal adenocarcinoma or PDAC, understanding what lies ahead can be both daunting and necessary. This type of cancer develops in the cells that line the small tubes, called ducts, within the pancreas. These ducts normally carry digestive juices that help break down food. Adenocarcinoma accounts for about 90 to 95 percent of all pancreatic cancers, making it by far the most common type.^[4][5]

The outlook for pancreatic adenocarcinoma is sobering, and patients and families deserve honest information. Overall, the one-year survival rate is approximately 24 percent, and the five-year survival rate stands at about 6 percent, making pancreatic cancer the only major cancer with a five-year survival rate in the single digits.^[2][4] For all stages combined, the one-year relative survival rate is 27 percent and the five-year rate is 9 percent.^[4] These numbers reflect the reality that pancreatic cancer is extraordinarily difficult to detect early and often resists standard treatments.

However, these statistics represent averages across all patients and all stages of disease. Individual outcomes can vary significantly based on several factors. The stage at which cancer is discovered plays a crucial role. Patients whose tumors are found early and can be completely removed by surgery have better chances than those diagnosed after the cancer has spread. Other important factors include the patient’s overall health, age, how well they tolerate treatment, and increasingly, the specific genetic characteristics of their tumor.^[12]

One of the greatest challenges with pancreatic adenocarcinoma is that approximately 80 percent of patients already have cancer that has spread to nearby areas or distant organs by the time they receive their diagnosis.^[2] This late detection significantly limits treatment options and affects survival outlook. The pancreas sits deep within the abdomen, hidden behind the stomach and surrounded by other organs, which makes early tumors nearly impossible to detect through routine physical examinations or standard imaging tests.

Recent reports suggest encouraging developments. Some medical centers are seeing improved survival rates thanks to more sophisticated diagnostic approaches, including better imaging with PET scans, genetic testing of tumors and blood, and carefully tailored treatment plans. These methods help doctors identify which patients are most likely to benefit from surgery and which treatments might work best for each individual’s specific cancer.^[20]

Natural Progression

Understanding how pancreatic adenocarcinoma develops and progresses helps patients and families grasp why early detection is so challenging and why prompt treatment is essential. The natural course of this disease, if left untreated, follows a pattern that underscores the importance of intervention.

Pancreatic adenocarcinoma typically begins as small changes in the DNA of cells lining the pancreatic ducts. These cellular changes cause the cells to multiply out of control rather than following the normal cycle of growth and death. As these abnormal cells accumulate, they form a mass or tumor within the pancreas.^[1] If this process continues unchecked, the cancerous cells develop the ability to invade nearby tissues and eventually spread to other parts of the body through the bloodstream or lymphatic system, a process called metastasis.

In the early stages of disease, pancreatic adenocarcinoma rarely causes noticeable symptoms. The tumor can grow silently for months or even longer without producing any signs that something is wrong. This is one of the disease’s most dangerous characteristics. By the time symptoms appear, the cancer has often grown large enough to press on nearby organs or has already begun spreading.^[1][12]

As the tumor enlarges, it may block the bile duct, which is a tube that carries digestive fluid from the liver to the small intestine. This blockage causes bile to build up, leading to jaundice, where the skin and whites of the eyes turn yellow. Patients may also notice their urine becoming dark and their stool becoming light-colored. These signs typically prompt people to seek medical attention, but by this point, the cancer has often already reached an advanced stage.

Without treatment, the tumor continues to grow, eventually invading important blood vessels near the pancreas, such as the superior mesenteric vein or portal vein, and potentially the superior mesenteric, celiac, and hepatic arteries. When cancer reaches these blood vessels, surgical removal becomes increasingly difficult or impossible.^[14] The disease may spread to the lymph nodes, which are small bean-shaped structures that help fight infection, and from there to distant organs such as the liver, lungs, or the lining of the abdomen.

As pancreatic adenocarcinoma progresses, many patients experience worsening pain in the upper abdomen or middle back. This pain can be persistent and may worsen after eating or when lying down.^[3][13] Weight loss becomes pronounced, not just because patients lose their appetite, but because the cancer itself releases substances into the bloodstream that break down muscle and fat tissue, a condition known as cachexia. Even if a patient eats adequately, their body may struggle to absorb nutrients because the diseased pancreas cannot produce enough digestive enzymes.^[19]

Possible Complications

Pancreatic adenocarcinoma can lead to numerous complications that affect various parts of the body and significantly impact a patient’s quality of life. Understanding these potential complications helps patients and caregivers recognize warning signs and seek appropriate medical attention.

One common complication occurs when the tumor blocks the bile duct completely, causing severe jaundice. Beyond the yellowing of skin and eyes, this blockage can lead to intense itching, dark urine, and pale stools. If left untreated, the backed-up bile can cause liver damage and increase the risk of infection in the bile ducts, a serious condition called cholangitis.^[7]

Digestive problems frequently develop as the disease progresses. The pancreas normally produces enzymes that help break down food, especially fats. When cancer disrupts this function, patients may experience difficulty digesting food, leading to bloating, gas, nausea, and diarrhea. Food may not be properly absorbed, resulting in nutritional deficiencies even when eating regularly.^[5][19] Stools may become oily or fatty, a condition called steatorrhea, which indicates that the body is not absorbing fats properly.

Diabetes can develop as a complication of pancreatic cancer. The pancreas produces insulin and other hormones that regulate blood sugar levels. When cancer damages the hormone-producing cells of the pancreas, blood sugar control becomes impaired. In fact, new-onset diabetes or a sudden worsening of existing diabetes can sometimes be an early warning sign of pancreatic cancer.^[1][2] Managing blood sugar levels becomes an additional challenge during cancer treatment.

Pain represents one of the most distressing complications. As the tumor grows and presses on nearby nerves, particularly a bundle of nerves behind the pancreas called the celiac plexus, patients can experience severe, persistent pain in the upper abdomen or back. This pain may be difficult to control with standard pain medications and can significantly reduce quality of life.^[19]

Patients with pancreatic adenocarcinoma face an increased risk of blood clots forming in the veins, a condition called venous thromboembolism. These clots can develop in the legs, causing swelling, pain, and redness, a condition known as deep vein thrombosis. More dangerously, pieces of these clots can break off and travel to the lungs, causing a life-threatening condition called pulmonary embolism.^[3][13] The cancer releases substances into the blood that make clotting more likely to occur.

As cancer spreads to other organs, additional complications arise depending on where metastases develop. Liver metastases can cause the liver to enlarge and fail to function properly. Spread to the lungs can cause breathing difficulties and persistent cough. If cancer spreads to the lining of the abdomen, fluid can accumulate in the abdominal cavity, a condition called ascites, causing swelling and discomfort.

Bowel obstruction can occur if the tumor grows large enough to press on or invade the small intestine or stomach. This can prevent food from passing through the digestive tract normally, causing severe nausea, vomiting, abdominal cramping, and inability to eat. In some cases, surgical intervention or placement of a tube to bypass the obstruction becomes necessary.

Impact on Daily Life

A diagnosis of pancreatic adenocarcinoma transforms daily life in profound ways, affecting not just physical health but emotional well-being, relationships, work, and social activities. Understanding these impacts can help patients and families prepare for changes and find ways to maintain the best possible quality of life during treatment.

Physical limitations often emerge as one of the first noticeable changes. The disease itself, along with treatments like chemotherapy and surgery, can cause significant fatigue. Patients frequently describe feeling exhausted even after minimal activity, and this tiredness does not always improve with rest. Simple tasks that once seemed effortless, such as climbing stairs, grocery shopping, or preparing meals, may become challenging or impossible without help.^[18] This loss of independence can be frustrating and emotionally difficult.

Digestive symptoms substantially affect daily routines and food choices. Patients often lose their appetite or find that foods they once enjoyed now taste different or cause discomfort. Nausea, bloating, and changes in bowel habits may make eating unpleasant or socially awkward. Many patients need to switch to small, frequent meals rather than three larger meals per day. Some foods, particularly fatty or greasy items, may need to be avoided entirely because the pancreas cannot produce enough enzymes to digest them properly.^[19]

Pain can significantly limit activities. Abdominal or back pain may worsen with certain movements or positions, making it difficult to sit for long periods, lie down comfortably, or participate in physical activities. Managing pain often requires a combination of medications, which themselves can cause side effects like drowsiness or constipation that further impact daily functioning.

The emotional toll of pancreatic cancer diagnosis cannot be overstated. Many patients experience a range of emotions including shock, fear, anger, sadness, and anxiety. Depression is common among pancreatic cancer patients, affecting mood, energy, sleep, and overall outlook.^[3][17] Worries about the future, treatment outcomes, and family can feel overwhelming. Some patients describe feeling like their cancer diagnosis has taken control of their life, leaving them uncertain about what comes next.

Work life often requires significant adjustments. Depending on the stage of disease and treatment intensity, some patients may need to reduce their hours, take extended leave, or stop working entirely. Treatment appointments, medical tests, and recovery from surgery can make maintaining a regular work schedule difficult. The cognitive effects of chemotherapy, sometimes called “chemo brain,” can affect concentration, memory, and decision-making, making complex work tasks more challenging.^[16]

Social relationships may change in unexpected ways. Some friends and acquaintances may not know how to respond to a cancer diagnosis and may withdraw or say unhelpful things. Conversely, cancer can strengthen bonds with others who provide genuine support and understanding. Patients often find that relationships with family members deepen, though these relationships may also experience strain from the stress of illness and caregiving responsibilities.

Many patients find value in connecting with others who have experienced similar diagnoses. Support groups, whether in-person or online, provide opportunities to share experiences, learn coping strategies, and feel less alone. Talking with someone who truly understands what it is like to live with pancreatic cancer can be profoundly validating and comforting.^[16][17]

Despite these challenges, many patients discover sources of meaning and purpose during their cancer journey. Some find solace in spending quality time with loved ones, pursuing creative activities like writing or art, connecting with their spirituality, or helping others by sharing their story. Maintaining some level of physical activity, adapted to current abilities, can improve mood, reduce fatigue, and provide a sense of accomplishment. Even gentle exercises like walking, swimming, or yoga can offer physical and emotional benefits.^[18][19]

Self-care becomes increasingly important. This includes not just medical care but also attention to emotional needs, rest, proper nutrition within the limits of what can be tolerated, and activities that bring comfort or joy. Patients should feel empowered to set boundaries, ask for help when needed, and prioritize their own well-being.

Support for Family

When someone is diagnosed with pancreatic adenocarcinoma, the entire family faces a difficult journey together. Family members and loved ones play essential roles in providing emotional support, helping with practical needs, and making important decisions about care. Understanding how to best support a loved one with pancreatic cancer, including participating in clinical trials, can help families feel more confident and effective in their caregiving roles.

Clinical trials represent an important consideration for pancreatic cancer patients at all stages of disease. Because current treatment options for pancreatic cancer remain limited and the prognosis is often poor, patients are strongly encouraged to consider participating in clinical trials.^[4][15] These research studies test new treatments, new combinations of existing treatments, or new approaches to managing symptoms and side effects. Participation in clinical trials gives patients access to cutting-edge therapies that may not yet be widely available and contributes to medical research that could help future patients.

Family members can help their loved one learn about clinical trial options. This involves researching available trials, which can be done through several resources. Many cancer centers maintain lists of clinical trials they are conducting. Online databases allow patients and families to search for trials based on the type and stage of cancer. Organizations dedicated to pancreatic cancer research often provide information about trials and can connect patients with opportunities that match their situation.^[16]

When considering a clinical trial, family members can assist by helping gather information and asking important questions. It is essential to understand what the trial involves, including what treatment will be given, how often visits will be required, what tests will be performed, and what potential risks and benefits exist. Families should ask about the goals of the trial, whether it compares a new treatment to standard treatment or tests something entirely experimental, and what happens if the treatment does not work or causes unacceptable side effects.

Practical support in preparing for trial participation involves helping with logistics. Clinical trials often require frequent visits to the medical center, which may involve travel if the trial is not available locally. Family members can help arrange transportation, accommodation if needed, and coordination with other medical appointments. Keeping track of paperwork, consent forms, and appointment schedules can be overwhelming for patients, and family assistance with organization can reduce stress.

Understanding the trial process helps families provide better support. Clinical trials have specific eligibility criteria, and not every patient will qualify for every trial. The process typically begins with screening to determine if the patient meets the requirements. If accepted, patients receive detailed information about what participation involves and must provide informed consent, meaning they understand the potential risks and benefits and agree to participate voluntarily. Throughout the trial, patients undergo regular monitoring and testing to assess how the treatment is working and whether it causes any problems.

Emotional support during clinical trial participation is crucial. Patients may feel hopeful about trying a new treatment but also anxious about unknowns. They might worry about receiving a placebo (an inactive substance used for comparison in some trials) or about experiencing unexpected side effects. Family members can provide reassurance, accompany patients to appointments, help monitor for side effects, and communicate concerns to the medical team.

Beyond clinical trials, families can support their loved ones in numerous other ways. Creating a strong support network is vital. This might include family members, friends, members of a faith community, and professional counselors or therapists. Different people can help in different ways—some by providing practical assistance like meals or transportation, others by offering emotional support or companionship.^[17]

Open communication within the family helps everyone cope better with the stress and uncertainty of cancer. Talking honestly about fears, hopes, and feelings can bring family members closer together and prevent misunderstandings. However, it is also important to respect that people cope differently, and some may need more time alone or less conversation about the illness than others.

Practical caregiving often falls heavily on family members. This might include helping with daily activities like bathing, dressing, or preparing meals if the patient becomes too weak or ill. Families may need to manage medications, track symptoms, and communicate with doctors about changes in condition. They might need to help with financial matters, insurance paperwork, and decisions about care. This level of caregiving can be exhausting, and it is important for caregivers to also take care of their own health and well-being.

Caregivers should not hesitate to ask for and accept help from others. Many communities have resources for cancer patients and caregivers, including meal delivery programs, transportation services, and respite care that gives primary caregivers a break. Support groups specifically for cancer caregivers can provide valuable advice and emotional support from others in similar situations.

Families should work together with the medical team as partners in care. This means attending appointments when appropriate, asking questions, expressing concerns, and participating in decision-making. It also means being honest with doctors about what is happening at home, including how well treatments are being tolerated and whether symptoms are being adequately controlled. Good communication with healthcare providers ensures that the patient receives the best possible care tailored to their needs and preferences.